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Abstract 
Cystic fibrosis (CF) is a recessive disease caused by a mutation in the cystic fibrosis 
transmembrane conductance regulator (CFTR) gene which encodes a cAMP 
regulated chloride ion channel. The consequence of such a mutation is abnormal 
water and ion transport in exocrine tissue such as the lung, pancreas and 
gastrointestinal tract. The disease is fatal and premature death is primarily a result 
of chronic pulmonary infection. Gastrointestinal problems also contribute to poor 
nutrition and 10-20% of patients suffer from meconium ileus and/or recurrent 
intestinal obstruction in later life. Current gene therapy strategies for CF have 
many attendant problems including targeting gene delivery to the correct cell type; 
efficiency and frequency of delivery; immune response to gene delivery vectors and 
expression profiles very different to that of the endogenous wild type CFTR. One 
possible solution to these problems would be to correct the cystic fibrosis mutation 
in epithelial stem cells using homologous recombination, before ultimately grafting 
the corrected cells back into the host. Correcting the Cftr gene mutation in the 
chromosome would mean gene expression is under the control of the endogenous 
promoter and so will display the same precise temporal and spatial control as 
heterozygotes which show no phenotype. At the same time, by targeting a 
sufficient number of stem cells the ultimate aim is to correct the mutant phenotype 
in a single delivery. I have used the mouse intestinal epithelium as a model system 
to develop this approach. 
As a first step towards mutation correction by homologous recombination I have 
constructed a targeting vector which contains wild type Cftr genomic DNA 
covering the region mutated in the majority of CF mouse models and shown that it 
is capable of targeting the Cftr locus in ES cells. In order to test this strategy in a 
more relevant system, I have generated several cell lines from the small intestine of 
both wild type and CF mice carrying the Cftr" IGU  mutation. These lines have been 
characterised and used in a pilot targeting experiment. 
The absence of intestinal stem cell markers necessitates the need for a functional 
assay in order to identify stem cells and ensure that any manipulation does not alter 
their stem cell properties. I have developed such an assay using aggregates of 
mouse intestinal cells which when grafted into a suitable host, develop into cysts 
lined with an intestinal mucosa containing all four epithelial cell lineages and full 
crypt-villus architecture suggesting the presence of intestinal stem cells in the 
original population. Detailed characterisation of graft development revealed a 
process highly similar to regeneration of intestinal epithelium following tissue 
damage and suggests the continued presence of a stem cell population. 
Intestinal epithelial stem cells will need to be maintained in tissue culture if an ex 
vivo approach to gene therapy is to be successful. To this end, I have established 
primary cultures of mouse intestinal epithelium and shown that two different 
proliferative epithelial colonies can be identified. Characterisation of these colonies 
suggests that they are derived from two different proliferative epithelial 
populations with properties similar to those of transit amplifying cells and stem 
cells of the mouse small intestine. 
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hapter One 	 Introduction 
Introduction 
1.1 Somatic Gene Therapy 
The ability to identify disease causing genes and the development of techniques for 
transferring genetic material into mammalian cells led to the concept of somatic 
gene therapy. Originally this was developed as a means to correct genetic defects in 
_-----the-tissues of individuals affected by mutations in a particular gene. This therapy 
would not alter the genetic make up of the germline in any way and therefore any 
exogenous DNA would not be carried on to any offspring. The government Gene 
Therapy Advisory Committee (GTAC) have stated that somatic gene therapy is 
acceptable but germline gene therapy is not appropriate at this time (Report on the 
Committee on the Ethics of Gene Therapy, 1992). 
In the early 1960's the first steps towards somatic gene therapy were 
unconsciously made with the development of stable mammalian cell lines. These 
could be used to test the feasibility of introducing DNA into cells and studying its 
stability, expression and heritability. The discovery in the late 1960's of the events 
involved in the integration of SV40 and polyoma virus DNA into the genonle. of 
target cells (Sambrook et al., 1968, Westphal and Dulbecco, 1968) raised the 
possibility that therapeutic genes could also be inserted. The development in the 
early 1970's of gene transfer technology using calcium phosphate coprecipitation 
(Graham and Van der Eb, 1973) and the cloning of specific genes such as -g1obin 
(Maniatis et al., 1976), further increased the possibility that gene therapy could 
become a plausible objective. Particularly after it was shown that this gene could be 
inserted into mammalian cells and be shown to function (Mulligan et al., 1979) 
In the early 1980's a major step forward came with the development of 
highly efficient vectors utilising the infective and DNA delivery properties of 
retroviruses which could potentially carry therapeutic genes (Shimotobno and 
Temin, 1981; Wei et al., 1981; Tabin et al., 1982). This was followed by the 
production of efficient helper cell lines which could produce high titre, helper free 
vectors (Mann et al., 1983, Miller & Buttimore 1986, Markowitz et al., 1988). 
Retroviral based vectors were shown to be able to rescue the disease phenotype in 
vitro of cells taken from patients with a human disease (Miller et al., 1983, Willis et 
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al., 1984). By the late 1980's it was shown that these vectors could be used to correct 
the genetic defect in a wide range of target cells such as keratinocytes (Morgan et al., 
1987), fibroblasts (Selden et al.,1987), bone marrow stem cells (Williams et al., 1984) 
and hepatocytes (Ledley et al., 1987). 
Initially much of the work on gene therapy concentrated on inherited 
inimunodeficiencies since haematopoietic cells were readily accessible and able to 
be manipulated. A further advantage in targeting this system was the existence of 
stem cells known to he in the bone marrow and occasionally in the circulating blood 
(Till et al., 1977). If these cells could be targeted then long term correction of the 
disease may be possible. The recent advances in our understanding of the 
molecular aspects of many diseases and how they relate to gene expression, 
coupled with the development of these new molecular techniques, have moved the 
theoretical concept of gene therapy closer to reality. However, despite all the 
publicity and attention gene therapy has obtained, no genetic disease has yet been 
cured by this approach. 
Somatic gene therapy is now being investigated not just to correct single 
gene defects, but as a possible strategy for the correction of complex, multigenic and 
multifactorial diseases such as cancer through a wide range of techniques. 
Increasing the immune response of the host to tumour cells (Gansbacher et al., 
1990), introduction of foreign human leukocyte antigens to tumour cells to induce 
"non-self" identity, restoration of expression of tumour suppressor genes (Tanaka et 
al., 1991), or the introduction of toxic genes into tumour cells to induce suicide 
(Huber et al., 1991) are some of the approaches being investigated. The grafting of 
genetically modified cells in vivo in order to produce potential therapeutic proteins 
at an ectopic site has also been investigated for conditions such as lysosomal storage 
disease (Moullier et al., 1995), and Parkinsons and Alzheimers disease (Wolff et al., 
1989, Gage et al., 1987). Genetic approaches are now being explored for infectious 
diseases such as AIDS, where cells infected with HIV are the target for expression of 
toxic genes (Harrison et al.,1991). The expression of HIV genes to immunise against 
HIV infection is also a potential approach (Bolognesi, 1991). 
The first clinical trial for somatic cell gene therapy occurred in 1990 
(Editorial, Human Gene Therapy, 1990) and involved the transfer of the adenosine 
deaminase gene to a child with severe combined immunodeficiency (SCID). This 
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milestone has since led .to clinical trials for a wide variety of conditions including 
haemophilia B (Lu et al., 1993), familial hypercholesterolaemia (Grossman et al., 
1994), AIDS (Galpin et al., 1994), various cancers (Oldfield et al., 1995, Cascineffi et 
al., 1994, Hesdorffer et al., 1994) as well as cystic fibrosis itself (Zabner et al., 1993, 
Crystal et al., 1994, Caplen et al., 1995, Porteous et al., 1997). 
In many ways somatic cell gene therapy is not fundamentally different to 
other conventional therapies. Essentially it is a therapeutic regime which utifises a 
drug to treat a clinical condition. The novel factor in these treatments is that the 
drug is DNA and that it can be manipulated or altered in many different ways by 
changing the sequence of DNA bases. Many problems require to be overcome 
before gene therapy is a viable therapeutic strategy. DNA must be delivered to the 
correct cell type where it must then be transported across the cell membrane. Once 
inside the cell, the DNA must avoid identification as a foreign agent and the 
resulting degradation by lysosomes which normally follows. It must then travel to 
the nucleus, cross the nuclear membrane and once inside make itself available to the 
transcriptional machinery of the cell. The level of gene expression must also be 
carefully regulated to ensure that uncontrolled expression does not lead to new 
problems. 
The ability to achieve these goals is determined to a large extent by the type. 
of vector used to carry the DNA. There are many different vector systems currently 
in use, each with its own advantages and disadvantages, and it is likely that no 
single approach will be universally suitable. The choice of vector must take into 
consideration the method of application as well as the nature of the disease itself. 
The different approaches to gene therapy can be split into two broad groups, ex vivo 
and in vivo. The ex vivo approach requires removal of the cells of interest from the 
body, maintenance of these cells in culture where the DNA can be delivered 
followed by transplantation of the corrected cells back in to the body. This is a 
rather invasive process and requires hospitalisation of the patient. At the present 
time this approach has a limited range of applications since not all cell types are 
amenable to transplantation, are accessible for surgical removal or are able to be 
cultured in the laboratory. The advantages of this approach however are that gene 
transfer techniques used are generally more efficient in culture, cells containing the 
therapeutic DNA can be enriched for if some sort of selection procedure is included 
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in the protocol, and the efficiency of DNA delivery can be assessed prior to 
transplantation. Such a strategy was used by Moullier et al., (1995) who were able 
to assess the level of gene transfer and functional activity of human 0-
glucuronidase cDNA introduced into canine fibroblasts prior to their 
transplantation. 
The in vivo approach to gene therapy involves either systemic delivery of the 
vector to the host or direct delivery to the tissue of interest. Depending on the 
target tissue, this can be a relatively non-invasive approach and therefore less 
stressful to the patient requiring only a short stay in hospital. However, problems 
may arise concerning the specificity of cell targeting since it could be undesirable to 
have the gene expressed in naturally non-expressing cells. Ideally, vectors should 
incorporate some form of cell or tissue specificity either at the level of cell delivery 
or transcription. The use of vectors in vivo is generally an inefficient process and as 
a result it is likely that more than a single dose would be required, increasing the 
risk of a potential immune response, as was found by Zabner et al. (1994) who 
detected anti-adenoviral antibodies in Rhesus monkeys given repeated doses of 
adenoviral vector. 
1.2 Gene Delivery Systems 
The number of different gene delivery systems under investigation at the present 
time is extremely large. These systems can be split into two groups, those utilising 
viral DNA delivery systems and those using an artificial delivery system. It is 
becoming increasingly likely however that the different advantages which both 
types of delivery system possess will need to be combined to create a delivery 
vector which has the advantages of both systems. 
1.2.1 Viral Vectors 
The use of viruses to deliver therapeutic DNA to mammalian cells was first 
speculated when it was discovered that both DNA and RNA tumour viruses had 
the ability to transfer their genetic material into host cells. Originally retroviruses 
(Sorge et al., 1984) were first investigated for the purpose of gene delivery but as 
knowledge of the mechanisms with which different viruses target specific cell types 
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and express their genes has increased, so has the number of viral based vector 
systems. The long list of viruses currently under investigation for gene therapeutic 
purposes includes lentiviruses (Poeschla et al., 1996), papovaviruses (Madzak et al., 
1992), vaccinia virus (Moss, 1992), adenovirus (Stratford-Perricaudet, 1990), adeno-
associated virus (Ohi et al., 1990) and herpes viruses (Fink et al., 1992), each of which 
have their own advantages and disadvantages as gene delivery systems. Currently 
the majority of viral vector systems being developed for gene therapy are those 
based on the retrovirus, adenovirus and adeno-associated virus. 
1.2.2 Retroviral vectors 
To date, the majority of gene therapy research has been performed using retroviral 
delivery systems. These viruses have a single-stranded RNA genome which upon 
entry into the host cell is converted to a double-stranded DNA molecule. If the cell 
is actively dividing, the DNA stably integrates into the host cell genome (Varmus, 
1988). The viral genome consists of the genes gag-pol and env which are flanked by 
two long terminal repeat (LTR) sequences. A packaging signal, psi, is found 
between the left-hand LTR and the viral genes. This signal allows the packaging of 
viral RNA into virus particles. It was found that if the gag-pol and env genes were 
replaced with an exogenous gene, the recombinant virus particle could deliver this 
gene into a host genome without the production of new viral particles and could 
therefore be used for potentially therapeutic purposes. The production of these 
recombinant retroviral particles however requires the assistance of what are known 
as packaging cell lines. These are cells that have had functional copies of the viral 
gag-pol and env genes inserted into their genome along with a mutated psi sequence 
(Mann et al., 1983, Danos & Mulligan, 1988). These cells produce viral RNA and 
proteins but are unable to package them together into virus particles. If a 
recombinant retroviral DNA molecule containing a gene of interest is inserted into 
these host packaging cells, the host cell integrates the molecule into its genome, 
transcribes from it many viral RNA molecules which contain a correct packaging 
signal and encapsidates them producing new virions. Most retroviral vectors and 
packaging cell lines produced so far are based on disabled murine retroviruses such 
as the Moloney murine leukaemia virus (MMuLV) which is capable of carrying 
approximately 7-8 kilobase pairs (kb) of insert DNA. 
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The major advantages of the retrovirus vectors are that they are capable of 
very high rates of gene transfer (almost 100% efficiency using dividing cells in 
culture), they stably integrate into the host genome without causing gross 
chromosomal rearrangements resulting in long term expression and are well 
characterised (Mitani et al., 1993). There are however a number of drawbacks with 
this system in that only actively dividing cells can be transduced (Miller et al., 1990), 
the requirement of packaging cell lines which so far can produce viral particles at a 
litre of —iO infectious particles per ml (Cosset et al., 1995), limits the number of cells 
that can be transduced, the possibility of producing a replication competent 
retrovirus carrying the inserted gene by recombination with a wild-type or helper 
retrovirus (Donahue et al., 1992) and the random integration of DNA into the host 
genome. This last point must be a major concern since the random nature of DNA 
integration may result in insertional mutagenesis. Random integration may induce 
neoplastic changes in several different ways. Genes controlling cellular growth and 
differentiation, genes controlling the cell cycle, genes which control responsiveness 
to cytokines and hormones, and promoter sequences which control gene expression 
are all potential targets for tumour initiation. Despite this however, a large number 
of human gene therapy trials have used retroviral vectors (Anderson, 1998). 
1.2.3 Adenoviral vectors 
Adenoviruses consist of an outer protein capsid which surrounds a genome of 
double stranded DNA. They have a natural tropism for primate cells of the 
respiratory and gastrointestinal tract (Horwitz 1990) but are capable of infecting a 
wide range of tissues such as the liver (Kozarsky et al., 1996), muscle (Ragot et al., 
1994), neuronal cells (BilangBleuel et al., 1997) and respiratory epithelium 
(Engelhardt et al., 1993). Adenovirus infect cells by binding to coxsackievirus and 
adenovirus receptor (CAR) protein (Bergelson et al., 1997), a transmembrane protein 
of unknown function, and are internalised by a process requiring the integrin cell 
adhesion receptors alphabeta 3 or a1phabeta5 (Wickham et al., 1993) which results in 
the entry of the virus into the endosomal pathway. The adenovirus is able to avoid 
lysosomal degradation by disruption of the endosome prior to lysosomal fusion 
(Seth et al., 1984). This is achieved through conformational change of its viral coat 
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proteins, resulting in a drop in pH and membrane breakdown. The virion is 
transported to the nucleus where its DNA is uncoated and exists in a 
transcriptionally active episomal form. The adenoviral genome contains 
approximately 35kb of DNA which code for various genes (at least 30mRNA 
species) including the E1A gene, a multi-functional transcriptional regulator 
required to activate the expression of other genes (Grand, 1987). In a productive 
life-cycle of wild-type adenovirus, E1A activity allows transcription of the early 
genes, this is followed by DNA replication, late gene expression, assembly of viral 
particles and cell lysis. Replacing the E1A (and frequently the E3) region with a 
foreign gene creates a gene delivery vector which requires a helper cell line 
(commonly 293-1 cells which constitutively . express E1A) to provide deleted viral 
gene activity. The resulting vector particles are E1A and can enter target cells and 
express the recombinant gene, although it has been shown that expression of 
adenoviral genes does occur at a very low level even without E1A activity (Yang et 
al., 1994). 
Adenoviral vectors have some advantages over retroviral vectors in that 
they, can infect non-replicating cells and be grown to a relatively high titre (1012 
pfutml (Cheng et al., 1997)). They have already been shown to transfect cells of the 
respiratory epithelium both in vitro and in vivo (Rosenfeld et al., 1992), though a 
study by Grubb et-al. (1994) showed that gene transfer in vivo was inefficient. The 
extrachromosomal status of the majority of adenoviral vectors reduces the 
possibility of insertional mutagenesis, but because the vector does not replicate, 
there is an eventual loss of the vector during cell division. Gene expression has also 
been shown to diminish rapidly despite the continuing presence of the vector. This 
is thought to involve stimulation of the immune system against residual activity of 
adenoviral genes (Yang et al., 1994) mediated through tumour necrosis factor alpha 
(Elkon et al., 1997) leading to destruction of the genetically modified cell. In many 
cases the use of adenoviral vectors would require repeated delivery which has been 
shown to induce the production of both anti-adenoviral antibodies and neutralising 
antibodies to the adenoviral coat proteins in Rhesus monkeys (Zabner et al., 1994). 
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1.2.4 Adeno-associated viral vectors 
Adeno-associated viruses (AAV) are small single stranded DNA parvoviruses with 
a genome of approximately 5kb (Hermonat and Muzyczka, 1984). The virus can 
infect a variety of host cells ranging in species from chicken to man using cell 
surface heparan sulphate proteoglycan for both attachment and infection of cells 
(Summerford and Samulski, 1998). Despite its ubiquitous distribution, with 
approximately 85% of the adult population in the United States possessing 
antibodies for the virus, it has never been associated with clinical disease. 
However, recent studies have suggested that in vitro at least, infection with wild-
type AAV can induce cell cycle arrest (Hermanns et al., 1997). Infection of. a cell can 
result in viral replication followed by cell lysis under permissive conditions, or 
insertion of the AAV genome into a host chromosome under non-permissive 
conditions. Permissive status is conferred by the expression of genes from a helper 
virus such as the Herpes simplex virus or adenovirus (Laughlin et al., 1982). It is the 
ability of the virus to stably integrate its DNA into human cells at a specific site on 
chromosome 19 (Kotin et al., 1990) which first raised the possibility of its use as a 
gene delivery vector capable of stable integration to a 'safe' genomic site. The AAV 
genome consists of two large open reading frames (orfs) flanked by inverted 
terminal repeats (itrs). The generation of a gene delivery vector requires 
replacement of the two open reading frames with the gene of interest to create a 
vector which requires co-transfection into a cell with a helper plasmid containing 
the deleted AAV sequences flanked by two copies of the adenoviral itr (McLaughlin 
et al., 1988). The host cell then has to be transfected again with adenovirus to 
produce packaged vector. The advantages of the AAV vector system are the lack of 
association of disease, the ability to infect a wide range of cell types such as 
respiratory epithelium (Zeitlin et al., 1995), neuronal cells (During et al., 1998), 
muscle cells (Monahan et al., 1998), and liver cells (Snyder et al., 1997), the ability to 
infect non-dividing cells (Robbins et al., 1998), a high infection rate in cultured cells 
-and the possible advantage of site specific integration. This last point requires 
further investigation since it has been shown that even in wild-type only 70-100% 
(Kotin et al., 1992) of the integrants may be found at a specific site on chromosome 
19. The rep genes which are normally encoded by the 5 orf in wild-type AAV are 
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believed to be involved in site specific recombination and consequently, 
recombinant AAV vectors have lost this ability. In culture conditions under 
selection pressure, recombinant vectors have been shown to be able to integrate at a 
variety of sites, but under non-selective conditions fluorescent in situ hybridisation 
(FISH) analysis was able to detect only a low level of chromosome integration and 
episomal copies of the vector were abundant (Kearns et al., 1996). It is not known if 
episomal maintenance of the vector is a common occurrence in vivo. Further 
engineering of these vectors may make site specific integration possible but there 
could still be problems. The site of integration has been shown to he at 19q13.3-qter 
(Kotin et al., 1991) and involves the presence of critical chromosomal sequences 
(Giraud et al., 1994). These sequences have been shown to be expressed in several 
tissues and despite the lack of any phenotypic effect of this insertion, the function of 
this transcript remains to be elucidated. 
The removal of all coding sequences from the wild type AAV still only 
leaves room for a maximum insert size of about 4.5kb. This limits the range of 
gene/promoter constructs that can be used with this system, though several have 
already been used to infect cells in vivo including the human y globin gene under a y 
globin/LCR site II promoter (Walsh et al., 1992), CFTR under an AAV p5 promoter 
(Flotteet al., 1993) and factor IX under the CMV promoter (Monahan et al., 1998). 
1.2.5 Non-viral Vectors 
In an attempt to avoid problems with pathogenicity, immunogenicity and the 
possibility of replication competent virions arising through recombination with 
wild type virus, artificial delivery systems have also been developed. These 
systems also have practical advantages over viral vectors in that it is easier to 
regulate the bulk production and quality control of reagents, which is an important 
consideration for the safe clinical use of gene therapeutic vectors. There are now a 
variety of different artificial delivery systems under investigation, some of which 
are completely synthetic, while others utilise components from both viral and non-
viral systems. The two non-viral systems which have been the focus of most 
attention are liposomes and receptor mediated gene delivery. 
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1.2.6 Liposomes 
Liposomes are self assembling particles made from lipids. There are two main 
types of liposomes based on the charges of the lipids used. Neutral lipids form 
structures in an aqueous solution which can encapsulate a portion of the medium 
within the particle. If the medium contains DNA (or drugs) then this allows the 
DNA to be carried within the liposome core. Liposomes were first tested as a 
delivery system for DNA in 1977 (Ostro et al., 1977). These liposomes were usually 
negatively charged and required calcium ions and a "fusogen" such as glycerol to 
induce cell contact. Early liposomes delivered their contents into :ceils by 
endocytosis or phagocytosis which led to lysosomal degradation and limited gene 
expression (Fraley et al., 1981). Systemic delivery of these liposomes into animal 
models show that the majority of liposomes are taken up by the reticulo-endothelial 
system (Gregordiadis, 1993) and are therefore very inefficient for the targeting of 
other organs. Large plasmid based constructs encapsulated by a liposome are 
inefficient in encapsulation and cellular uptake, due to size constraints. 
The development of cationic liposomes removed these size constraints. 
These lipids are positively charged and do not encapsulate the DNA, but are 
thought to form charge-charge interaction complexes with it (Brigham and Schreier, 
1993). This neutralises the negative charge of the DNA while at the same time 
condensing it. Many studies have shown the cellular uptake of DNA using these 
vectors but the exact mechanism is still not clear. Some believe cationic liposomes 
to be taken up by endocytosis (Stamatatos et al., 1988) while others suggest that the 
lipid bilayer fuses with the cell membrane, releasing its contents into the cell 
(Duzgunes et al., 1989). It may well be that both processes can take place depending 
on the lipid and cell type. DNA delivered to cells using a variety of non-viral 
approaches (Coonrod et al., 1997) showed that no matter which technique was used 
to deliver the DNA, transport via endosomes and lysosomes was necessary for 
DNA delivery to the nucleus. It was also found that normal human fibroblasts 
which are difficult to transfect were capable of removing the DNA from the nucleus 
very efficiently, whereas HeLa cells which are relatively easy to transfect exhibited 
prolonged nuclear stability of the exogenous DNA. 
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Liposome-mediated gene delivery can be used to deliver any desired form 
of therapeutic DNA, ie. plasmid or viral based DNA vectors, linear DNA molecules 
as well as artificial chromosomes. Gene delivery has been reported to cells of many 
different tissue types in vivo such as bone marrow progenitor cells (Aksentijevich et 
al., 1996), kidney cells (Lai et al., 1997), spinal cord (Yang et al., 1997), oesophagus 
(Schmid et al., 1997), heart (Aleksic et al., 1997) and lung (McLachlan et al., 1995). 
One major draw back of using liposomes for in vivo purposes is their non-specificity 
in cell targeting. Attempts to overcome this problem are being investigated using a 
receptor, antibody, or ligand specific for a cell surface protein, incorporated into the 
lipid bilayer. Stavridis et al. (1986) used transferrin molecules coupled to liposomes 
to significantly increase localisation of complexes to bone marrow erythroblasts as 
did Cheng (1996) using HeLa cells as target cells. Straubinger et al. (1988) coupled 
an antibody directed against an antigen common to many human ovarian cancers to 
improve delivery of cytotoxic drugs to cancer cells. A similar approach has also 
been used to deliver DNA to specific cell types. Mizuno et al. (1990) used an 
antibody against glioma cells coupled to liposomes to increase the efficiency of gene 
delivery to cells in culture by sevenfold. 
1.2.7 Receptor-mediated Gene Transfer 
The concept behind receptor-mediated gene transfer is similar to that mentioned 
above using cell surface receptors to direct cell specificity. The majority of receptor-
mediated gene transfer systems use a DNA construct containing the gene of interest 
bound in an electrostatic complex to a cross-linked, polycation-receptor ligand 
complex. Polylysine is frequently used as the polycation which binds to the DNA 
and condenses it leaving the ligand exposed on the surface to bind to its receptor on 
the target cell (Michael and Curiel, 1994). Binding of the ligand/receptor complex 
must induce endocytosis for efficient cellular uptake of the DNA. Most early 
research in this area used a polylysine/asialoglycoprotein complex (Wu and Wu, 
1987; 1988; Wu et al., 1991; Wilson et al., 1992; Plank et al., 1992) which is targeted to 
the asialoglycoprotein receptor found only on hepatocytes, but since then many 
more ligands such as transferrin (Michael and Curiel, 1994), insulin (Rosenkranz et 
al., 1992), erythrocyte growth-factor receptor (Shimizu et al., 1996) and epidermal 
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growth factor receptor (Chen et al., 1994) have been used. One major problem with 
using this approach is finding a suitable ligand that is not only specific for the 
tissue(s) to be targeted but must also induce endocytosis upon binding to its 
receptor. Unfortunately, this is not the only problem since endocytosis involves the 
lysosomal pathway which will degrade the DNA before reaching the nucleus. This 
problem has been addressed, at least partially by exploiting the endosomal 
disruption properties of the adenovirus. Curiel et al. (1991) found that co-infection 
with adenovirus increased the efficiency of gene expression but this requires the 
presence of a DNA complex and an adenovirus within the same endosome. To 
resolve this problem the adenovirus was directly conjugated to the DNA complex 
(Wagner et al., 1992) which again improved efficiency but at the same time 
specificity was lost due to the wide range of expression of the adenovirus receptor. 
Monoclonal antibodies to the adenovirus fiber have been used to block binding to 
adenovirus receptor (Michael et al., 1993). This resulted in a vector which was 
correctly targeted to a specific group of cells and also avoided lysosomal 
degradation. This has yet to be repeated in vivo where problems may still remain 
with the possibility of an immune response to the adenoviral proteins, and the size 
of the whole complex which is approximately lOOnm in diameter and therefore 
prohibits extravasation and tissue penetration. 
1.3 Cystic Fibrosis 
Cystic fibrosis (CF) is a disease characterised by impaired chloride ion transport 
across epithelial cell membranes (Quinton, 1983; Welsh and Liedtke, 1986; Frizzell et 
al., 1986; Boat et al., 1989; Taussig, 1984), which results in abnormal water transport 
giving rise to highly viscous mucoid secretions in exocrine tissues such as the 
respiratory, digestive and reproductive tracts. The resulting complications lead to 
premature death, primarily as a result of severe pulmonary infection. 
CF was first identified as a genetic disease in 1946 (Anderson and Hodges). 
It is inherited as an autosomal recessive disorder affecting 1 in 2000 live births in the 
Caucasian population, implying a carrier frequency of approximately 1 in 22. 
Despite such a high occurrence it is only since the cloning of the gene responsible 
that the nature of the disease has come to light. 
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1.3.1 The molecular basis of cystic fibrosis 
The gene responsible for CF lies on chromosome 7cen-q22 and was the first human 
disease gene to be isolated by linkage analysis and positional cloning since there 
were no known chromosomal alterations in CF patients which could be used to 
accelerate its identification (Riordan et al., 1989). The gene was called the cystic 
fibrosis transmembrane conductance regulator (CFTR) and was predicted to code 
for a protein, 1480 amino acids long with a molecular mass of 169kd. The gene 
covers approximately 200 kilobase pairs (kb) of genomic DNA, is made up of 27 
exons and gives rise to a mRNA transcript of 6.5kb. The deduced protein had 
characteristics of a membrane bound protein containing two large hydrophobic 
repeated motifs, and showed similarity to a family of ATP-dependent transport 
proteins (Higgins, 1989). Initially it was thought that CFTR was not an ion channel 
itself since it was argued that the kinetics of chloride (CI -) conductance did not fit 
with the assumed characteristics of the CFTR protein (Hyde et al., 1990). Since then 
CFTR has been shown to function as a low conductance chloride specific pore (Rich 
et al., 1990) regulated by ATP interaction at nucleotide binding folds and by cyclic 
AMP mediated protein kinase A phosphorylation at multiple sites on a regulatory 
(R) çlornain (Gadsby and Nairn, 1994). It may also have other functions which are 
independent of, or secondary to, ion conductance. Alternative roles for CFTR 
include regulation of an outwardly regulating chloride channel (Schwiebert et al., 
1995), regulation of intracellular compartmental pH (Barasch et al., 1989), regulation 
of plasma membrane recycling (Bradbury et al., 1992), regulation of ATP transport 
(Sugita et al., 1998) and sodium channels (Stutts et al., 1995). 
Sequence analysis of DNA from CF patients has revealed that approximately 
70% of CF mutations resulted from a 3 base pair (bp) deletion removing a single 
amino acid (phenylalanine) from the protein at position 508 (tF508). However, 
there are now almost 800 known mutations for CFFR which display differing 
degrees of disease severity. These mutations can be classified into four different 
types based on the effect the mutation has on the translation, processing, regulation 
and function of the CFTR protein (Welsh and Smith, 1993). The AF508 mutation 
causes a deletion in the first nucleotide binding domain (NBD1) which binds ATP 
and is involved in channel activation (Nagel et al., 1992; Baukrowitz et al., 1994). It 
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has been shown that this mutated protein is not processed correctly, resulting in 
incomplete glycosylation (Gregory et al., 1991), and remains in the endoplasmic 
reticulum of the cell (Crawford et al., 1991), and is therefore unable to localise to the 
apical cell membrane and function as an ion channel. Experiments have 
demonstrated that the SF508 protein can function as an ion channel if correctly 
localised to the plasma membrane (Li et al., 1993; Pasyk and Foskett, 1995). 
The CFTR protein is expressed in a variety of epithelial cell types including 
those lining the lung, small pancreatic ducts, intestinal crypts, kidney tubules and 
sweat ducts (Crawford et al., 1991). The level of expression varies in different 
tissues with the lung showing surprisingly low levels of expression and the 
intestinal crypts and kidney tubule relatively high levels. 
1.3.2 Clinical aspects of Cystic Fibrosis 
Sufferers usually present early in life though some are not diagnosed until 
adulthood. The main clinical features associated with CF in the early stages are a 
failure. to thrive and grow, due in part to lack of pancreatic function, and 
progressive pulmonary disease. A cough may be present shortly after birth but is 
usually apparent in most patients before their first year. The cough eventually 
develops into spasms similar to bronchiolitis or pertussis. Gastrointestinal 
problems are also a feature at presentation, with 10-20 9/6 of all CF patients suffering 
from meconium ileus in the first few days of life. There is a tendency for meconium 
ileus to occur in some families with a greater than expected frequency (Allan et al., 
1981). This may be due to a particular genetic background or may be related to the 
particular mutations involved. Patients presenting with meconium ileus usually 
require a Gastrograffin enema. If successful the obstruction should be expelled in a 
few hours in approximately 50% of cases (Noblett, 1969). Patients who do not 
respond to this treatment will require surgical intervention to remove the blockage. 
This initially involved resection but improvements in surgical techniques now 
allow an ileostomy to be performed with removal of the meconium (Bishop and 
Koop, 1957). The recurrence of intestinal obstruction in older children and adults 
was originally termed "meconium ileus equivalent" (Jensen, 1962) but this has now 
been superseded by the term "distal intestinal obstruction syndrome" (Park and 
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Grand, 1981). The pathology manifests itself as a thick mucus layer covering the 
intestinal mucosa which blocks the opening of the intestinal crypts (Thomaidis and 
Arey, 1963). The syndrome is confined to patients with steatorrhoea and does not 
occur in other causes of pancreatic insufficiency. Treatment may be possible with 
simple laxatives or a Gastrografin enema but surgery may be neccessary (Docherty 
et al., 1992). Unfortunately surgical intervention is associated with high morbidity 
due to respiratory and surgical complications. 
Jnsufficent levels of pancreatic enzymes are present in approximately 80% of 
patients, the symptoms of which (bulky, soft and offensive stools) usually occur in 
the first months of life. The reduction in levels of pancreatic secretions are 
frequently a result of obstruction of the pancreatic ducts with inspissated mucus. 
This leads to destruction of the acinar cells which are replaced by fibrous scar 
tissue. Treatment is usually in the form of enzyme supplements given orally, but 
some patients have increased output of gastric acid combined with decreased 
production of pancreatic bicarbonate therefore reducing the pH and the 
effectiveness of the enzyme preparations. Patients may increase their enzyme 
intake,., but fail to improve alimentary symptoms, which may indicate fat 
malabsorption (Robinson and Sly, 1990). Supplementary feeding may become 
necessary and treatment can vary from simple diet adjustment to jejunostomy. 
allowing continuous feeding. 
The respiratory disease in CF progresses with increasing pulmonary damage 
leading eventually to respiratory failure. Bacterial infection is assumed to trigger 
the changes in the lung with Staphylococcus aureus considered the chief early 
pathogen. Supporting evidence for this comes from work by Davidson et al. (1995) 
on the CF mouse. Staph. aureus can usually be cultured from the respiratory tract of 
most CF patients. As symptoms develop, the cough becomes more productive and 
an associated infection with Pseudomonas aeruginosa usually occurs. Eventually 
Staph. aureus is no longer cultured from the sputum and after a time a progressive 
clinical deterioration occurs. Infection by Haemophilus influenzae, which was 
originally rarely mentioned in association with CF and Burkholderia cepacia are also 
of concern in CF. 
Antibiotic treatment is supplemented with chest physiotherapy to remove 
viscid secretions (Young, 1964), but attempts are also being made to reduce the 
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viscosity of secretions in order to improve clearance. The purulent secretions in the 
airways of CF patients have been shown to contain high concentrations of DNA 
(Chernick and Barbero, 1959; Potter et al., 1960). Aerosolised human 
deoxyribonuclease I has been used to degrade the DNA and so reduce the viscosity 
of the secretions (Hubbard et al., 1992; Shak, 1995). Pharmacologic approaches are 
also being investigated to correct the defective ion transport in CF. Aerosolised 
amiloride can be delivered to the respiratory epithelium to inhibit the excessive 
sodium ion absorption (App, et al., 1990; Knowles et al., 1990). Pharmacologic 
correction of the chloride transport has been attempted using triphosphate 
nucleotides (ATP and UTP) which have been shown to activate Cl - secretion in 
human airway epithelium via extracellular 5'-nucleotide receptors (Mason et al.; 
Knowles et al.; 1991). The Cl- secretory response results from activation not of the 
CFTR channel but an alternative population of Cl - channels that are activated by 
increases in cytosolic Ca 2,  (Clarke et al., 1992; Mason et al., 1991). 
None of the pharmacological approaches have shown particularly good 
efficacy and now the increase in understanding of the molecular basis for CF has 
led to attempts to correct the disease at its most fundamental level, the gene. 
1.4 Somatic Gene Therapy for CF 
Since the discovery of the CFT'R gene in 1989 there has been a great deal of interest 
in the potential of somatic gene therapy for cystic fibrosis. CF is thought to be 
particularly suitable for testing this type of therapeutic approach because it is a fatal 
disease caused by a recessive mutation in a single gene and the main tissue 
associated with the disease phenotype is relatively accessible. Somatic gene therapy 
for CF represents a novel problem in that the patients who will eventually receive 
the treatment are clinically well, unlike for example those suffering from terminal 
cancer. This means that the therapy must be seen to have some type of benefit for 
the patient. 
Almost all of the studies so far have concentrated on delivering DNA to the 
respiratory epithelium since morbidity is associated with this particular tissue. 
Curiously, CFTR is expressed at low levels in human airway epithelial cells at levels 
of only 1-2 copies per cell (Trapnell et al., 1991). It would appear therefore that only 
17 
Chapter One 	 Introduction 
low levels of expression may be required to correct chloride permeability in the 
lung. Work by Drumm et al. (1990) first showed that the transfer and expression of 
the wild type CFTR gene using a retroviral vector in a stable cell line derived from a 
CF patient, could correct the basic defect in chloride transport. At the same time 
Rich et al. (1990) used the vaccinia T7 hybrid expression system to transfer either 
wild type CFTR or mutant iF508 into an airway epithelial cell line from a CF 
patient. They showed that only the wild type gene could correct the defective C1 
transport. These experiments were able to provide the proof of principle that 
introduction of a functional copy of the CFTR gene could reverse the mutant 
phenotype, and so paved the way for serious attempts to make gene therapy for CF 
a reality. 
1.4.1 Gene delivery to the respiratory epithelium 
In 1991, Engelhardt et al. looked at the cellular targets of gene transfer to respiratory 
epithelium using a xenograft model to transfer the lacZ gene into rat tracheal 
epithelium. The cells were grown in primary culture and targeted before being 
seeded onto denuded trachea and grafted subcutaneously into nulnu mice. They 
found that all cell types present could be targeted and remain phenotypically, 
normal, but that not all cell lineages were present in this model. The presence of 
clonal, populations of lacZ expressing cells suggested the presence of a transduced 
cell capable of self renewal and pluripotent development which would be a 
desirable target for gene transfer. Olsen et al. (1992) used a retroviral vector to 
study the delivery of CFTR to a sheet of polarised airway epithelial cells in culture. 
The monolayer exhibited correction of the chloride transport which was 
maintained, at least partially, for up to 6 months. 
The efficiency of retroviral vector mediated gene transfer makes it an 
attractive choice for gene therapy but the limitation of delivery to actively dividing 
cells prohibits their use for correction of the lung defect in CF in vivo. The 
branching architecture of the lung (Weibel, 1991) creates problems for ex vivo gene 
therapy, and therefore DNA delivery will most likely have to take place in vivo, and 
not to dividing cells in culture. The lung has a relatively slow turnover of cells 
(approximately 120 days) and contains mostly terminally differentiated cells and 
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only a small number of cells undergoing mitosis (Evans and Shami, 1989). The 
most obvious choice of vector was the adenovirus since not only is it able to infect 
non-dividing cells, but it has a natural tropism for the respiratory and 
gastrointestinal tract. In 1992, Rosenfeld et al. used a replication deficient 
recombinant adenovirus carrying a normal CFTR cDNA to transfect the respiratory 
epithelium of the cotton rat in vivo. Expression of human CFTR protein was still 
detectable by immunohistochemistiy after 14 days and mRNA was detectable by 
reverse transcription PCR ( RT-PCR) 6 weeks after delivery. The transient nature of 
gene expression using adenoviral vectors will mean repeated gene delivery will be 
necessary. Any consequent immune response from the host is especially 
undesirable in CF patients who already have impaired lung function. This would 
clearly be undesirable were immunity to be acquired. Investigators therefore have 
looked at the possibility of using plasmid based vectors complexed with cationic 
liposomes which may be a safer approach. Yoshimura et al. '(1992) used a circular 
plasmid based expression vector complexed with cationic liposomes to deliver 
CFTR to the lungs of mice in vivo. RT-PCR performed on lung homogenates 
showed the presence of the mENA transcript for up to 4 weeks. The interest in the 
use of AAV based vectors for gene therapy led to Egan et al. (1992) transfecting a CF 
bronchial epithelial cell line with an AAV-CFTR vector. Electrophysiological 
evidence was found for correction of both the low-conductance Cl channel 
encoded by CFTR and a larger conductance, outwardly rectifying Cl - channel also 
abnormal in CF (Welsh et al., 1989). 
None of the studies so far had attempted to identify the important question 
of what level of gene transfer is required to correct the defect in Cl - transport. 
Johnson et al. (1992) set out to do just this using an in vitro model. They transfected 
an immortalised CF airway epithelial cell line with human CFTR cDNA using a 
retroviral vector. CFTR expressing cells were then mixed with non-CFTR 
expressing cells at defined percentages in a monolayer. The bioelectrical properties 
of these epithelial sheets were then characterised and the percentage of CFTR 
expressing cells required to correct Cl transport calculated. Initially they found 
that between 1-10% of CFTR expressing cells were required to give the same results 
as 100% cells. This figure was further refined to between 3-6%. It was suggested 
that movement of Cl between cells was responsible for this observation. It should 
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be noted however that the gene was under the control of an unidentified foreign 
promoter which may be grossly overexpressing the gene. However, Dorin et a! 
(1996) have shown using mouse models that gene expression at 5% of wild type 
levels is sufficient to rescue the intestinal phenotype of these animals, and total 
gene correction is not necessary. 
The important development of mouse models for CF in the early nineties 
(Snouwaert et al., 1992;.Dorin et al., 1992; Colledge et al., 1992, O'Neal et al., 1993) 
allowed for the first time the direct assessment of gene therapy approaches in vivo. 
Hyde et al. (1993) used a plasmid DNA/cationic liposome complex to deliver CFTR 
cDNA to the lungs of homozygous mutant CF mice. Expression of mRNA 
transcripts could be detected in all regions of the mouse lung (though not in every 
mouse) by in situ hybridisation. Electrophysiology showed not only correction of 
the primary defect in Cl - transport but also of the secondary alterations in sodium 
transport. 
In 1993, Engelhardt et al. used their xenograft model to investigate the safety 
and efficiency of gene transfer in different respiratory epithelial cell types. 
Xenografts of human bronchial epithelium were infected with various quantities of 
adenoviral vectors containing either the lacZ or CFTR coding sequence. Gene 
expression was detected up to 5 weeks after delivery in all cell types except basal 
cells. They also looked for the presence of extracellular recombinant and wild-type 
adenovirus at various time intervals after administration. No wild-type viral 
particles were found but recombinant adenovirus could be detected in diminishing 
amounts over a 21 day period. This persistence may be explained by residual 
adenovirus from the original application but the possibility exists that there was de 
novo virus production from either a small population of cells at high levels or from a 
large population at low levels. 
The increasing interest in gene therapy and the benefits it promises, along 
with the mass of data collected on the subject over a relatively short period, led to 
the first experiments using human patients. The results of the first experiments on 
human volunteers were published in 1993 (Zabner et al., 1993). In this study three 
CF patients received a different dose of adenoviral vector containing CFTR to the 
nasal epithelium. The nasal epithelium was chosen because it is easily accessible for 
vector administration and evaluation, any possible risk to an adverse reaction is 
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minimised, and the in vivo potential difference (PD) across the epithelial membrane 
can be readily assessed (Alton et al., 1987). The in viva nasal PD measurements 
suggested correction of the Cl - transport defect in all three patients and changes in 
basal voltage and response to cAMP agonists were detected for at least 3 weeks. 
One of the main concerns of this study was to look at the safety of using adenoviral 
vectors. Patients were examined closely for shedding of the virus and for signs of 
injury or trauma, either from the administration procedure or from the adenoviral 
vector. A mild inflammatory response was detected within 3 to 4 hours which was 
attributed to the application procedure. All three patients developed more severe 
symptoms over the next two months but these were considered to be episodes 
consistent with the disease status of each individual. This clearly demonstrates a 
problem in the assessment of clinical safety for CF gene therapy, where the 
population being tested are already susceptible to tissue trauma within the normal 
course of the disease. 
So far, any in vivo attempts at CF gene therapy had failed to show long term 
correction of the defect in Cl - transport. Practical therapeutic approaches will 
require sustained periods of correction. Flotte et al.. (1993) managed to show the 
presence of mRNA transcripts for CFTR by RT-PCR up to 6 months after the 
delivery of an AAV-CFTR vector to a single lobe of the rabbit lung. CFTR protein 
was detected in both large and small airways of the targeted lobe. Vector DNA was 
detected in -50% of the nuclei of cells in the proximal region of the lobe 10 days 
after delivery, showing a high efficiency of DNA transfer. In the more distal 
regions results were variable, with some regions showing 100% of cells positive for 
vector DNA while other areas had fewer or no positive cells. After 6 months only 
-5% of proximally located cells tested positive and very few positive cells were 
found distally. All animals were clinically healthy. 
The repetitive delivery of adenoviral DNA necessitates a study on the effects 
of such repeated doses. It may be that repeated delivery of adenoviral vectors 
produce no therapeutic effect if the patient has raised antibodies against the vector 
from previous administrations. Zabner et al. (1994) examined the antibody response 
of cotton rats after two applications of adenoviral vector to the lungs. Anti-
adenovirus antibodies were detected in serum and in bronchoalveolar lavage (BAL) 
fluid two weeks after the second administration. Neutralising antibodies could 
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only be found in the serum of some rats after the first delivery but none were 
detected after the second. No neutralizing antibodies were found in the BAL. 
Examination of tissue and body fluids showed no sign of systemic inflammatory 
response. PCR was used to check for the presence of adenoviral DNA in other body 
tissues. All organs tested negative except for the small intestine which was positive 
in some of the animals, although no clinical symptoms were associated. The cotton 
rats were chosen as a model because they are permissive for viral replication (Prince 
et al., 1993) and can mimic human pathology, but they have a very different 
anatomy and physiology to humans. Therefore repeated delivery of the same 
vector to Rhesus monkeys was also examined since the airway epithelium closely 
resembles that of humans (Harkema et al., 1987). Vector was administered three 
times to the nasal epithelium of three monkeys. CFTR vector specific transcripts 
could only be detected for 18 days although CFTR protein was found up to 6 weeks, 
and viral DNA up to 10 weeks, post application. All monkeys developed antibodies 
against adenovirus, levels of which rose sharply after each administration. 
Neutralising antibodies were found in their serum after the second administration 
but not in nasal washings, suggesting no interference of DNA transfer from 
secretory immunoglobulins. Virus could be cultured from nasal brushings and 
swabs on permissive cell lines up to 7 days after the first administration, though no 
mention was made of tests after subsequent administrations. No signs of infection 
or viral derived inflammation were detected, although slight erythema was found 
which was attributed to instrumentation. A similar study by Brody et al. (1994) 
found a dose dependent inflammatory response in the lung of the Rhesus monkey 
after intrabronchial delivery. This was found to persist for up to two months in 
some animals. 
The first attempt to deliver CFTR to human bronchial epithelium (Crystal et 
al., 1994) using an adenoviral vector had apparently little success. Four CF patients 
received a single dose to a single lobe of the lung. CFTR protein could only be 
detected in bronchial tissue from a single patient although no mRNA transcripts 
were found. Vector was thought to have spread beyond the site of application and 
frequent coughing was mentioned as a possible source of vector spread. A 
worrying observation from this study was the adverse reaction of one patient 
following administration. The patient showed what was described as mild to 
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moderate toxicity effects including tachycardia, hypotension and dyspnea. This 
again illustrates the importance of research into the development of safe non-viral 
methods for gene delivery. Alton et al. (1993) demonstrated correction of chloride 
transport in the CF mouse using a cocktail of human CFTR constructs driven by 
three different promoters which were complexed with a cationic liposome and 
delivered to the respiratory and intestinal tract. The degree of correction between 
mice was variable as was the level of CFTR transcript. Upon histological 
examination no differences were found between treated and untreated mice. The 
same group studied liposome-mediated delivery of an SV40 promoter driven 
human CFTR vector to humans (Caplen et al., 1994). This trial again used;the nasal 
epithelium as the target tissue. All patients tolerated delivery well with no clinical 
symptoms or histological evidence for any adverse effects. Nasal potential 
difference (PD) after administration showed a wide variation in measurements, but 
on average a 20% correction was seen in response to low Cl - perfusion which was 
no longer detected after 7 days. No obvious relationship could be seen between the 
dose of delivery and the electrophysiological effect. 
To date there have now been 5 published adenoviral clinical trials for CF 
(Zabner et al., 1993; Crystal et al., 1994; Knowles et al., 1995; Zabner et al., 1996; 
Bellon et al., 1997), 4 studies using DNA complexed with liposomes (Caplen et at., 
1995; Porteous et al., 1997; Gill et at., 1997; Zabner et al., 1997) and one report of an 
AAV based clinical trial (Wagner et al., 1998). The majority of these trials have used 
the nasal epithelium as the target tissue but both the lung (Crystal et al., 1994) and 
the nasal sinus (Wagner et al., 1998) have also been targeted. The results of these 
trials have shown that both adenoviral vectors and liposomes can deliver DNA to 
the respiratory epithelium at roughly equal efficiency but that there may be 
problems of potentially dangerous immune responses to adenoviral vectors. It 
should be noted however that in an as yet unpublished study of DNA/liposome 
delivery to the lungs of CF patients, a mild flu-like response was observed in all 
patients receiving DNA/lipid complexes which were not seen in patients treated 
- with lipid alone (Alton et al., 1998). Despite the ability to show the relative safety of 
CF gene therapy protocols, there has been as yet no clear evidence for efficient 
expression of the CFTR gene in any of the clinical trials so far. As work on gene 
therapy for the respiratory epithelium progresses, it has been realised that 
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successful treatment will require attention to be focused on the defects in the liver 
and gastrointestinal tract. 
1.5 Alternative Approach for CF Gene Therapy 
The strategies currently being tested for CF gene therapy possess a variety of 
problems including targeting gene delivery to the correct cell type, efficiency of 
gene transfer, immune response to and potential toxic effects of gene delivery 
vectors, and transgene expression profiles very different to that of wild type CFTR. 
These problems could potentially be overcome by specific correction of the 
mutation on the chromosome rather than the delivery of a functional cDNA to 
mutant cells. Currently, this could only be achieved using homologous 
recombination to remove mutant sequences and replace them with wild type. The 
corrected CFTR gene would then be expressed under its own endogenous promoter 
and enhancer sequences and would therefore be expressed at the correct levels in 
the correct cell types for the life of the cell. Unfortunately, homologous 
recombination is so rare using current techniques that this mutation correction 
strategy would have to be attempted ex vivo. This would be an invasive procedure 
and w, ?,,Wd only be feasible if the correction was life-long, therefore the correction of. 
mutations in epithelial stem cell populations of affected tissues is necessary. Such 
an approach requires that certain steps are possible; i. stem cells from the relevant 
tissue must be physically isolated; ii. stem cells must be maintained in culture 
without losing their stem cell properties; iii. the mutant CFTR allele must be 
targeted and corrected in vitro using homologous recombination; iv. the corrected 
stem cells must be grafted back into the host and regenerate a functionally 
competent epithelium. The target cells of choice are obviously those of the 
respiratory epithelium but the presence of an epithelial stem cell population in the 
respiratory epithelium has yet to be confirmed and therefore much work still has to 
be done before this potential cell population could be used as a target for mutation 
correction. 
The work described in this thesis is aimed towards correcting the Cftr 
mutation in intestinal epithelial stem cells of the CF mouse model using 
homologous recombination. The intestine was chosen for several reasons; it is a 
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relevant tissue which affects CF individuals, the CF mouse models all exhibit an 
intestinal phenotype to varying degrees which means they can be used as endpoints 
to assess the efficacy of this approach, the presence and location of stem cells is 
known and importantly, the stem cell population in the intestine is known to have a 
high regenerative capacity. The goal of this approach is to obtain functional wild 
type Cftr in intestinal tissue under the control of its endogenous promoter 
sequences. This would lead to effectively a heterozygous (symptomless) somatic 
state with correct spatial and temporal expression of Cftr. At the same time, by 
targeting the crypt stem cells the treatment should be life long. 
1.6 The Small Intestine 
The mouse small intestine (as does the human) develops from embryonic endoderm 
to form a tube lined by an undifferentiated stratified epithelium which lies over a 
layer of stromal cells. Two developmental processes convert the stratified 
epithelium into a columnar monolayer. The first step in this conversion is the 
breakdown of cell-cell junctions within the epithelium. This leads to the formation 
of microlumen (Mathan et al., 1976) which can be identified by electron microscopy. 
At the same time as epithelial junctions are being loosened, the underlying 
mesenchyme condenses at distinct regions adjacent to the epithelium and migrates 
up through the epithelial layers. This cell migration generates epithelial protrusions 
which point in towards the central lumen known as intestinal villi which are 
covered by a single layer of columnar epithelial cells. Regions of monolayered 
epithelium between the villi, known as the intervillous epithelium then migrate 
down into the underlying mesenchyme to form glandular structures called 
intestinal crypts. The small intestine develops into three segments called the 
duodenum, jejunum and ileum. These morphogenic developmental processes 
generate two sets of structures which are both physically and functionally distinct 
(figure 1.1), the villi which project out into the intestinal lumen, and the crypts 






Figure 1.1. Crypt and villus structures of the mouse small intestine. 
Schematic showing the gross morphology of the intestinal epithelium, arranged 
into protruding villus structures and hidden crypt pockets. 
nutrient absorption and therefore have a large surface area, while the crypts contain 
the intestinal epithelial stem cell population and are the sites of cell proliferation 
and fluid secretion. This secretion generates a flow of lumin.al contents away from 
the crypt towards the central intestinal lumen, a process which is mediated, at least 
in part by Cftr (Cohn, 1994). This means that the epithelial cells and therefore the 
stem cells are protected from close contact with the potentially toxic contents of the 
intestinal lumen. The primary crypts that are formed are polyclonal (Schmidt et al., 
1988) and are thought to contain multiple stem cells. However, the crypts then 
undergo a process termed "purification" which results in monoclonal crypts 
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As the site of food digestion, the intestinal epithelium is effectively in 
contact with the external environment and therefore is exposed to a wide variety of 
mutagens and toxins. In addition, the process of food digestion requires the 
presence of digestive enzymes which do not distinguish between host and ingested 
tissue. This environment is very toxic to cells and could lead to tissue damage or an 
accumulation of mutations resulting in neoplasia. Considering these potential 
dangers and the size of this tissue, the small intestine incurs very few growth 
abnormalities. This is at least in part, a result of the continual epithelial cell 
turnover in the intestine which is possible due to the presence of intestinal epithelial 
stem cells in the intestinal crypts. The stem cell population is thought to make up 
less than 0.1% of all crypt and villus cells (Evans et al., 1994). They reside near the 
crypt base (Potten and Loeffler, 1990) where they divide to produce daughter cells, 
some of which remain as stem cells while others go on to differentiate. The cells 
which differentiate are called the transit amplifying cell population. These are 
defined as cells which have a limited proliferative capacity and are ultimately 
destined to terminally differentiate into one of the four main intestinal epithelial cell 
types. As these cells proliferate and differentiate they migrate from the crypt base 
towards the crypt mouth. By the time they leave the safety of the crypt and enter 
the intestinal lumen at the base of the villi these cells are terminally differentiated. 
The cells continue to migrate up towards the villus tip until they reach the upper 
regions of the villus. It is at this point that the cells are removed from the intestinal 
surface either by exfoliation into the lumen (Shibahara et al., 1995) or by apoptosis 
(Hall et al., 1994). The continual, regulated production of daughter cells by the stem 
cell population ensures that there is a constant supply of newly differentiated 
epithelial cells to replace those lost and ensure that the integrity of the epithelial 
barrier remains intact. It also serves as an amplification process so that only one 
round of cell division by the stem cell can produce many daughter cells, and so 
protect it from the possibility of mutations arising from increased DNA replication. 
It may also increase the life span of the stem cell which might have only a limited 
number of cell divisions. The process of cell migration from the crypt base to the 
villus tip is extremely rapid and takes approximately 5 days in humans and 3 days 
in the mouse (Potten et al., 1979). This extremely rapid rate of cell turnover means 
that no epithelial cell remains in contact with the lumen for a prolonged period of 
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time and so is unlikely to acquire the multiple mutations which are believed to be 
necessary for intestinal carcinogenesis (Fearon and Vogeistein, 1990). 
The stem cells of the small intestine produce a variety of different 
differentiated cell types. The 4 main cell types are the absorptive enterocyte, the 
goblet cell, the enteroendocrine cell and the Paneth cell. Each cell type has its own 
distinctive role in the functioning of the small intestine. The absorptive enterocytes 
make up the majority (-80-90%) of epithelial cells and are involved in the 
absorption of nutrients from the intestinal lumen. These cells are therefore only 
found on the villus surface and can be identified by the presence of multiple apical 
microvilli which form what is known as a brush border. This structure serves to 
further increase the surface area available for nutrient absorption in the small 
intestine and is the localisation site of many intestinal digestive enzymes such as 
alkaline phosphatase, sucrose-isomaltase and maltase-glucoamylase (Henning, 
1981). Goblet cells make up -10% of epithelial cells in the small intestine and are 
responsible for the secretion of mucin. The mucin is required to line the epithelium 
to ease: the transport of food and waste products along the digestive tract and also 
to protect it against attack from digestive enzymes. Goblet cells are found both 
withiñ'•the crypt and on the villus surface. The enteroendocrine cells are an 
extremely heterogeneous population of cells which make up -1% of intestinal 
epithelial cells, (Hauft et al., 1989). There are at least 15 different enteroendocrine 
cell populations based upon the range of peptide hormones they secrete (Roth and 
Gordon, 1990). These cells are found in both the crypts and on the villus surface 
and are thought to be involved in regulating digestion, absorption and 
gastrointestinal motility. The fourth epithelial cell type is the Paneth cell which has 
different kinetics compared to the other epithelial cells. The Paneth cells are the 
only differentiated cells which do not migrate from the crypt base to the villus tip, 
instead immature but committed Paneth cells migrate downwards and are found at 
the very base of the small intestinal crypts, just below the presumed stem cell 
location. Unlike the other differentiated cells, Paneth cells are not removed from 
the intestine by apoptosis or exfoliation but remain at the crypt base for 
approximately 3 weeks where they are then removed by phagocytosis (Bry, et al., 
1994). Paneth cells contain many large secretory granules which contain lysozyme 
and other anti-microbial peptides such as cryptdins (Ouellette et al., 1994) and are 
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thought to contribute to mucosal barrier function, immunity and host defence 
(Geyer, 1973; Harwig et al., 1995). They also secrete growth factors and regulatory 
molecules which may play a role in controlling cell proliferation (Raaberg et al., 
1988; Mulherkar et al., 1993). However transgenic mice lacking Paneth cells were 
recently generated (Garabedian et al., 1997) using a cell specific ablation process to 
investigate the possible role of Paneth cell secretion on stem cell regulation, but no 
alterations in proliferation and differentiation were detected. 
Intestinal epithelial stem cells produce cell types other than the four just 
described. Sampling of antigens from the intestinal lumen occurs in regions of the 
intestine known as Peyer's patches. These are sites of specialised lymphoid tissue 
which are covered by equally specialised epithelium consisting of follicle-associated 
epithelial cells and M cells (Neutra and Kraehenbuhl, 1992). The M cells are a 
specialised group of epithelial cells which continually endocytose material from the 
lumen to present to lymphocytes and macrophages lying adjacent to their 
basolateral membrane. These cells are also produced from the multipotent stem 
cells which means that cells migrating from crypts which surround the Peyer's 
patches will differentiate into follicle-associated epithelium and M cells on one side, 
but into one of the four main lineages on the other. It is thought that the underlying 
lymphoid tissue is involved in the functional differentiation of follicle-associated 
epithelium and M cells. 
Directly underneath the intestinal epithelial monolayer lies a basement 
membrane made up of extracellular matrix (ECM) proteins which separates the 
luminal contents and epithelium from the underlying mesenchyme. The 
mesenchyme also differentiates during development, first into the outer muscle 
layers and later into cellular elements of the submucosal and mucosal connective 
tissue. The latter layer contains fibroblasts, myofibroblasts and muscle fibres. 
These mesenchymal cells are in turn surrounded by a layer of circular and a layer of 
longitudinal smooth muscle. 
1.7 Intestinal Epithelial Stem cells 
Stem cells are defined by their functional attributes (Potten and Loeffler, 1990; Hall 
and Watt, 1989) which creates a problem in that their function must be 
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experimentally proven involving manipulation of the cells. This manipulation 
process may alter the properties of the cells and therefore their identity as stem 
cells. A definition of a stem cell has been proposed by Potten and Loeffler (1990) 
based on their functional attributes. They define a stem cell as being an 
undifferentiated cell which is capable of; 
maintaining its own existence 
cellular proliferation 
producing a population of differentiated and functional progeny 
tissue regeneration following damage 
exerting adaptable control of the above properties 
Stem cells are thought to exist in all tissues which show cellular turnover, 
proliferation and regeneration and have been shown to exist in tissues such as the 
epidermis (Potten, 1983), epithelium of the small intestine (Leblond and Cheng 
1976), haematopoietic system (Till et al., 1978; Metcalf, 1984), corneal epithelium 
(Cotsarelis et al., 1989), bone (Beresford, 1989) and mesenchyme (Young et al., 1995). 
The stern cells of these different tissues must share certain properties so that they 
can be-defined as stem cells, but it is not known whether they share common 
molecqiar mechanisms for their regulation. Various growth factors have been 
shown to play a role in regulating stem cell activity, as have less well defined cell-
cell and cell-extracellular matrix (ECM) interactions. It is still unclear as to whether 
stem cells are merely undifferentiated cells responding to signals from their 
particular micro-environment which control lineage commitment and cell renewal, 
or whether they are an intrinsically separate population of cells which have some 
genetically predetermined functions that are permitted to be carried out within a 
distinct environment. 
Much work has been done on the stem cells of the haematopoietic system 
which has been made possible by the success of culture systems, permitting their 
study and manipulation. Consequently, by virtue of certain cell surface markers, 
cells which contain a high percentage of clonogenic and stem cells (Berardi et al., 
1995) can be enriched for. Similarly a great deal of work on epidermal cells, which 
are also capable of growth in culture has shown that integrins may be used to 
identify cell populations enriched for stem cells (Jones and Watt, 1993; Jones et al., 
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1995). Interestingly, integrins have also been implicated in the control of 
haematopoietic stem cells (Teixidó et al., 1992). Unfortunately, despite a large 
amount of work on the intestinal epithelium no markers yet exist specifically for the 
stem cell population and only a relatively small number of cell surface markers exist 
which could be used to enrich for proliferative cells (Schiechi, 1991, Beaulieu et al., 
1992). The situation is further complicated because unlike haematopoietic and 
epidermal cells, attempts to culture preparations of intestinal epithelial cells have 
proved extremely difficult (Flint et al., 1991). 
In the small intestine it has been proposed that the stem cells may be split 
into two different populations (Potten and Loeffler, 1990). These are termed "actual 
stem cells" which actually display all the characteristics of a stem cell, as given in 
the above definition, at a given instance, and "potential stem cells" which have the 
capability of exhibiting all these characteristics but are not expressing them all at a 
particular time (figure 1.2). 
The work described here is an attempt to determine whether intestinal 
epithelial stem cells from the mouse can be isolated and maintained in a viable state 
in culture. It also describes the establishment of a functional assay for murine small 
intestinal stem cells and begins to look at the possibility of using mutation 
correction by homologous recombination in somatic stem cells as an alternative to 
current gene therapy protocols for CF. 
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Figure 1.2. "The diminishing sternness spiral". 
This diagram represents the proliferation and differentiation pathways of the stem cell and 
its daughter cells in the intestine but it can probably be used as a basis for all stem cell 
populations. The top ring represents the cell cycle of the stem cell with the rings below 
representing the transit amplifying daughter cells which exhibit different levels of 
"sternness". The model shows a stem cell at one end and a fully differentiated cell at the 
other with the transit cells representing an intermediate population which display 
characteristics lying between stem cells and differentiated cells. The T1 transit population 
are the potential stem cells because under certain circumstances they are able to move 
"back" a level and become actual stem cells. According to this model, there are estimated 
to be between 4-16 stem cells and 30-40 clonogenic cells per mouse crypt (Potten et al., 
1987) constituting less than 0.1% of the entire intestinal epithelial population. This is based 
mainly on clonogenic assay systems and cell kinetic studies (Hendry et al., 1989). 











At present, precise correction of gene mutations on the chromosome itself is only 
feasible using homologous recombination. Homologous recombination is the 
exchange of DNA sequences between molecules which have a high degree of 
homology and is the basis of gene targeting in ES cells. Homologous recombination 
was identified in eukaryotic cells in the yeast Saccharomyces cerevisiae when a 
mutation in the LEU2 gene was corrected by introducing a plasmid carrying the 
wild type gene (Hinnen et al., 1978). Recombination between the plasmid and the 
chromosomal sequences resulted in the repair of the mutant LELI2 gene. 
Homologous recombination was confirmed in mammalian cells by restoration of 
thymidine kinase activity in mouse L cells carrying a mutation in the tk gene (Lin et 
al., 1984) by introduction of a different mutant tk gene. Recombination between the 
two mutant genes resulted in the generation of a wild type gene and restoration of 
thymidine kinase activity. Homologous recombination was shown to be possible in 
an endogenous gene when the -globin locus was successfully targeted in 
erythroleukaeniia cells (Smithies et al., 1985). Homologous recombination in 
mammalian cells however occurs at a much lower frequency than in yeast (Hinneñ 
et al., 1978) and DNA introduced into mammalian cells is much more likely to 
integrate randomly into the genome than into homologous sequences (Thomas and 
Capecchi, 1987; Mansour et al., 1988). In order to make identification of 
homologous recombinants easier, it is common to include some form of selection 
gene into the targeting construct to identify the cells which have taken up and 
inserted the construct into the host genome. The precise details concerning the 
mechanisms of homologous recombination in mammalian cells are not fully 
understood however several factors are known to affect the frequency. Increasing 
the size of the region of homology (Thomas and Capecchi, 1987; Hasty et al., 1992), 
the introduction of double stranded breaks in the DNA and the use of isogenic 
DNA (Riele et al., 1992) in generating the targeting constructs all increase the 
frequency of recombination. 
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Homologous recombination is commonly used to introduce mutations into 
the mouse genome and there is no reason why the same process cannot be used to 
correct mutations instead. Traditional gene targeting vectors are plasniid based and 
contain a region of DNA which is homologous to the locus to be targeted. 
Constructs usually also contain a dominant selectable marker gene which confers 
resistance to the drugs neomycin or hygromicin. Cells which are resistant to the 
selection process are then screened usually by PCR or by Southern blot to identify 
those clones which have undergone homologous recombination. The frequency of 
homologous recombination can vary greatly depending on many different factors. 
Previous attempts to target the Cftr locus has produced values ranging from 0.04% 
(Koller et al., 1991) to 10% (Dickinson et al., 1993). The different vector designs can 
be split into two main types. Insertional vectors are linearised within the region of 
homology so that they integrate into the chromosome via a reciprocal 
recombination event producing a duplication of the homologous sequences. 
Replacement vectors are frequently (though not always) linearised outside the 
region of homology so that homologous recombination requires a double crossover 
event between the homologous vector and chromosomal DNA. This results in the 
chromosomal DNA being replaced by that of the vector. The positive selection gene 
is inserted into the construct so that there are homologous sequences on either side. 
An alternative approach which could be used for mutation correction is the 'hit and 
run' strategy (Hasty et al., 1991a) but this is a two stage approach which uses an 
insertional type vector and requires two separate homologous recombination 
events. For the purpose of mutation correction in primary stem cells therefore the 
use of the replacement type vector to replace mutated DNA with wild type 
sequences is preferred. 
The strategy proposed for mutation correction in these experiments (figure 
2.1) is the correction of mutated Cftr sequence by homologous recombination using 
a replacement vector which also contains a positive selection gene to allow for 
detection of cells which had taken up the construct. Since many of the mutations 
generated in the mouse Cftr gene are found around exon 10 of the gene, and since 
this is the site of the majority of CFTR mutations in humans, this was the region that 
would be targeted. The positive selection gene would be inserted into intronic 
sequence so that coding sequence would not be affected. However, the ideal 
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strategy is to generate wild type sequence and so the presence of a foreign gene 
within the intron of the Cftr gene is not desirable and could potentially interfere 
with Cftr expression. This may be due to the disruption of regulatory elements, the 
induction of alternative splicing (Wassarman et al., 1997) or competition for 
endogenous 
allele 




exon9 	 exonlO 
1 	 targeted allele 
exon9 	 exonlO 






exon9 	 exonlO 
Figure 2.1 Mutation correction strategy. Homologous recombination between the targeting 
vector and the endogenous mutant allele will result in replacement of the mutant exon 10 
with wild type. At the same time the hyg/tk fusion gene will be incorporated into the 
chromosome. This can be removed using the Cre recombinase to promote recombination 
between the flanking IoxP sites which results in the loss of the hyg/tk gene and a single loxP 
sitel =IoxP site 
transcriptional regulators (Fiering et al., 1995). In order to circumvent this problem 
the positive selection gene would be flanked by 34bp loxP sites which will allow the 
gene to be removed upon addition of the Cre recombinase. The Cre recombinase 
originates from the bacteriophage P1 and catalyses specific recombination at loxP 
sites in both prokaryotic (Boyd, 1993) and eukaryotic cells (Sauer and Henderson, 
1988). Recombination would result in the loss of sequences between the two loxP 
sites and the retention of only a single 34bp loxP site. The insertion of a positive 
selection gene raised a further problem in that there would need to be selection for 
the correct removal of the selective gene. This problem can be overcome by using a 
hygltk fusion gene which has both positive and negative selective properties. The 
hyg portion of the gene can be used for positive selection as it confers resistance 
against hygromicin while the tk portion is used for negative selection as it confers 
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sensitivity to gancyclovir. Any cell which has taken up the construct will be 
sensitive to gancyclovir unless recombination between the two loxP sites occurs and 
so removes the hyg/tk gene and gancyclovir sensitivity. 
In this chapter I will present the construction of a targeting vector for 
homologous recombination at the Cftr locus and the attempts to use this vector to 
correct Cftr mutations in both ES cells and intestinal epithelial cells which carry 
specific mutations in the Cftr gene. 
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2.2 Results 
2.2.1 Restriction map of mouse genomic Cftr DNA 
In order to obtain a fragment of mouse genomic DNA which spans the mutated 
region in a CF mouse model, restriction sites were identified which could be used to 
isolate the DNA. Many of the mouse models, including the Cftr mouse contain 
mutations around exon 10 of the Cftr gene and so this was the region chosen for 
construction of the vector. It was decided that a fragment containing both exons 9 
and 10 would be preferable for targeting purposes. This would provide a large 
fragment of homologous DNA which should improve the frequency of homologous 
recombination. The use of isogenic DNA has been shown to increase the frequency 
of homologous recombination (Riele et al., 1992) and so this would require 129/Sv 
DNA. 
Within the laboratory I had access to three EcoRI fragments (pXTE1.8, pXTE2 and 
p)(TE4.5) which spanned exons 9 and 10 of the 129/Sv mouse Cftr gene (figure 2.2). 
These fragments had been cloned individually into the pBluescript II SK plasmid by 
Dr. Paul Dickinson. The presence of suitable sites was tested for by digestion of 
EcoRI digested plasmid. Table 2.1 shows a complete list of the restriction enzymes 
used to digest the pXTE1.8 and pXTE4.5 plasmids. 
pXTE4.5 	 pXTE2 	 pXTE1 .8 
Figure 2.2 Cloned EcoRl fragments spanning exons 9 and 10 of mouse Cftr. EcoRl 
fragments had previously been cloned into the pBluescript II SK plasmid. Clone pXTE4.5 
has a 4.5kb insert which contains exon 9 of mouse Cftr. Clone pXTE2 has a 2kb insert and 
contains exon 10 of mouse Cftr. Clone pXTE1 .8 contains a 1.8kb insert of intronic sequence 
downstream of exon 10. 
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Table 2.1 Restriction enzyme analysis of Cftr plasmids. - means no restriction site was 
detected. + means restriction site(s) was detected and the approximate size of bands given 
in brackets. 
Initial results identified a number of restriction sites present within the EcoRI 
fragments but it was not known where these sites were positioned in the insert. 
The position of some sites was resolved by double digests or by hybridisation of 
digested DNA to suitable labelled probes. Using this approach I was able to 
identify a BglI and SfiI site within the pXTE1.8 fragment which cut the insert 
approximately into 950bp and 850bp fragments. The recognition sequence for SfiI is 
GGCCN_NNN'NGGCC while the recognition sequence for BglI is 
GCCN_NNN'NGGC and so the BglI site actually lies within the SfiI site. I then 
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checked that the pXTE2 insert did not contain a Sf11 or Bgll site by restriction digest. 
This Sf11 site provided me with a unique restriction site downstream of exon 10. 
Further analysis with more restriction enzymes was unable to provide me with a 
unique site upstream of exon 9 and so I sequenced a region of the p)(TE4.5 insert. 
The first sequencing reaction was sufficient to identify a BstEfl site. I had 
previously checked for the presence of this site by digestion of the pXTE4.5 insert 
and had not been able to detect a change in the size of the fragment. The sequence 
data showed that the BstEll site was only 14 base pairs from one of the EcoRI sites 
and would not be detectable on a 0.7% agarose gel. The BstEll site was positioned 
at the 5' end of the insert and so was upstream of exon 9. The pXTE2 plasmid was 
checked for the presence of a BstEll site and found not to contain one. I now had 
unique restriction sites which could be used to isolate a 7.4kb genomic fragment of 
the mouse Cftr gene containing exons 9 and 10 along with some flanking intronic 
sequence. The collated data of restriction sites was used to generate a restriction 
map of this region (figure 2.3). 
- 	 HPB  
r 	ii 
- 
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Figure-2.3 Restriction map of mouse genomic DNA spanning exons 9 and 10 of the Cftr 
gene. The yellow box corresponds to the region of genomic DNA to be included in the 
targeting vector. The blue boxes represent coding exons and the red boxes represent 
flanking genomic DNA. Sizes are not to scale. Each letter represents a restriction site; A 
(Asp7181), B (BamHl), Bs (BstXl), Bt (BstEIl), H (Hindlil), Hp (Hpal), E (EcoRl), P (Pstl), S 
(Sfil), X (Xbal). 
2.2.2 Subcloning a genomic fragment from a lambda clone 
In the laboratory we had a small quantity of DNA from a lambda phage clone 
(XT2) which was known to contain both exon 9 and 10 sequences. The sample had 
been in the lab for several years and the quality was unknown. My approach was 
to digest the DNA with Bgll and BstEll and to purify the 7.4kb fragment. Initial 
attempts to digest the DNA and separate the DNA fragments on an agarose gel 
were unsuccessful and appeared to be due to a mixture of DNA degradation and a 
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high salt content of the DNA sample. Precipitated DNA was washed repeatedly in 
70% ethanol to try and remove the salt. The pellet was then resuspended in 
distilled water and microdialysed for 15 minutes. The volume of the sample had 
increased inferring that the sample still contained a large amount of salt. Digestion 
of this DNA sample was attempted but was unsuccessful. Several attempts were 
made to remove the salt but none were particularly successful. Two digests did 
resolve sufficiently on the gel to distinguish a 7.4kb band. This DNA fragment was 
cut out from the gel and purified. Several attempts were made to clone this 
fragment but none were successful. On the one occasion that sufficient salt was 
removed from the XXT2 sample, the DNA degraded. 
2.2.3 Plating and Screening of a Mouse Genomic Library 
The lack of success with the AXT2 DNA sample and the lack of remaining DNA 
meant an alternative approach had to be taken to clone this genomic fragment. I 
decided to screen a phage library to isolate a new clone containing exons 9 and 10 of 
the mouse Cftr gene. The X2001 library was generated from the 129 mouse strain 
and was estimated as having a titre of -4 x 109 plaque forming units (pfu)/ml. The 
titre value of the library was checked and found to be correct. I plated out a 
sufficient quantity of the library to obtain 600,000 plaques. This was based on the 
fact that an average ? phage insert would be -45kb, and the average haploid 
mammalian genome is 3 x 109bp. This means that 200,000 plaques would cover 3 x 
109bp of sequence but it is very unlikely that this amount of sequence would cover 
the entire genome and so a 3 times coverage was selected to be sufficient i.e. 9 x 
109bp or 600,000 plaques. 
The plaques were transferred onto filters and the filters were hybridised 
using a probe specific for mouse Cftr. This failed to identify any positive colonies 
and so the filters were again probed, this time using a different Cftr specific 
sequence. This again failed to identify any positive sequences. In order to ensure 
the validity of the library I probed the filters with a cDNA probe which should 
identify a gene family, thought to consist of approximately 12 members. This time I 
obtained approximately 85 clean positive signals which demonstrated that the 
filters did contain DNA and that the genomic coverage appeared to be sufficient. 
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The filters were probed once more this time using the entire mouse Cftr 
cDNA sequence, but again no positive signals were obtained. 
2.2.4 Regenerating A Large DNA Fragment from Three Subclones 
I decided to try and rebuild an -8.5kb fragment of DNA covering exons 9 and 10 of 
mouse Cftr using the three EcoRI subdones mentioned previously. The first step 
was to perform an Ecoffi partial digest on pXTE2 plasmid DNA and to gel purify 
the DNA which had been linearised. Next, the pXTE4.5 plasmid was digested with 
EcoRI and the 4.5kb insert was gel purified. The linearised pXTE2 fragment and the 
pXTE4.5 insert were then ligated. Colony hybridisation was used to identify clones 
containing the pXTE4.5 insert. DNA was prepared from each of these colonies and 
digested with EcoRI to ensure that the correct size fragments were present in these 
plasmids. To identify plasniids which contained the fragments in the correct 
orientation, they were cut with PstI. I identified 3 clones which appeared to have 
the two EcoRI fragments in the correct orientation. A partial EcoRI digest was set 
up on the DNA from two of these clones (19a and lb), and the DNA fragments 
separated on an agarose gel. Bands of 6.5kb corresponding to the two EcoRl 
fragments, and bands of 9.2kb corresponding to linearised plasmid were gel 
purified. The 9.2kb fragment was ligated to the 1.8kb gel purified EcoRI insert from 
pXTE1.8 and electroporated into a suitable bacterial host. Duplicate colony lifts 
were made and one set hybridised to the radiolabelled pXTE1.8 insert and the other 
set to the pXTE4.5 insert. Only colonies which were positive for both were analysed 
further. DNA was prepared from these double positive colonies and digested with 
EcolU, to ensure all the correct fragments were present and with Flindifi to 
determine the orientation of the inserts. This time two clones (7 and 15) were 
identified which contained all three EcoRI fragments in the correct orientation 
(figure 2.4). One was called pXTE8.3 and was used in all further experiments. 
2.2.5 Preparation of Biochemical Selection Cassette 
The selection cassette which I wished to use in the construction of my mutation 
correction vector consists of a hyg/tk fusion gene flanked by loxP sites. Such a 
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Figure 2.4. Restriction digests of religated mouse genomic subclones. 
Lanes 1-5, EcoRl digest. Lane 1, clone 2; lane 2, clone 4; lane 3, clone 7; lane 
4, clone 15; lane 5, clone 23A. Expected fragment sizes are shown on left hand 
side of the figure. Lane 6, XHindlll size marker. Lanes 7-11, Hindlll digests. 
Lane 7, clone 2; lane 8, clone 4; lane 9, clone 7; lane 10, clone 15; lane 11, 
clone 23A. Expected fragment sizes are shown on the right hand side of figure. 
cassette had already been created by Dr. Chris Boyd in the laboratory but some 
modification of the construct was required before it was suitable for me to use. 
The first step was to destroy an internal Hindifi site within the selection 
cassette which would then allow the cassette to be removed from the plasmid 
without including plasmid backbone sequences. This was achieved by partial 
digest of the CB524 plasmid with Hindifi and gel purification of linearised plasmid. 
The DNA was blunt-ended and then ligated to itself before being introduced back 
into bacterial hosts. Colony lifts were made and probed using a radiolabelled 
oligonucleotide corresponding to the novel sequence generated by the ablation of 
the internal Hindifi site within the selection cassette. This identified two positive 
clones which were analysed by restriction digest to determine the structure of this 
plasmid. These digests confirmed that both these clones no longer had an internal 
Hindffi site and instead had a newly generated NheI site. This altered plasmid was 
known as pUNLFS. 
The selection cassette had to be checked for the presence of Sf1 and BstEII 
sites since their presence would mean that the targeting construct could not be 
excised intact. The sequence of pUNLFS could be determined from the original 
CB524 plasmid. Analysis revealed a single BstEll site and a single Sf1 site. Instead 
of removing the BstEll and Sf1 sites separately by digestion and filling-in I decided 
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to remove them simultaneously because they were located only --400bp apart and 
were in a non-coding region of the plasmid. The plasmid was digested with BstEll 
and then SfiI and blunt-ended. The large DNA fragment was separated from the 
400bp fragment by gel electrophoresis and the larger fragment was gel purified. 
This fragment was ligated to itself, re-digested with Sfil to linearise any unmodified 
DNA and electroporated into bacterial hosts. A number of colonies were picked at 
random and plasmid DNA was digested with Bgll to look for a band shift caused 
by the loss of the 400bp fragment. Two clones were detected and one was analysed 
further (dUN7). This time the DNA was digested with BstEll and SfiI to make sure 
the enzymes no longer cut. Unfortunately, the plasmid was still found to be 
linearised by BstEH. Sequence analysis revealed that the new sequence generated 
by the re-ligation of the blunt-ended DNA fragment created a new BstEll site. 
1 	2 	3 	4 •5 
Figure 2.5. Confirmation by restriction digest of removal of BstElI site. 
Lane 1, ?.HindIlI size marker; lane 2, dUN7 uncut; lane 3, dUN7 x BstEIl; lane 4, 
mUN7 uncut; lane 5, mUN7 x BstEIl. These digests show that the BstEll site in 
mUN7 has successfully been removed. 
The BstEH site was removed from the dUN7 plasmid using the same 
approach to that used previously. The DNA was digested with BstEll, blunt-ended 
and re-ligated. The ligated DNA was digested again with BstEH to linearise any 
unmodified DNA, and transformed into a bacterial host. Two random colonies 
were picked and plasmid DNA prepared from overnight cultures. Restriction 
digests of the plasmid DNA from one of the clones (mUN7-1) revealed that the 
44 
Chapter Two 	 Targeting Vector 
BstEll site had been removed and the rest of the plasmid appeared intact (figure 
2.5). 
2.2.6 Insertion of selection cassette into genomic DNA 
In order to insert the selection cassette into the genomic DNA a suitable restriction 
site located in the intronic sequence between exons 9 and 10 had to be found. The 
restriction map I had generated previously did not identify any unique sites but 
previous work by Dr. Paul Dickinson had identified a unique Asp7181 site and 
possibly a unique HpaI within this intron. Using the Asp7181 site to insert the 
selection cassette would be problematic because although the site was unique in the 
genomic DNA there was another site in the plasmid backbone. I therefore decided 
to use the HpaI site. Unfortunately, test digests of the three EcoRI subclones and 
the pXTE8.3 plasmid revealed the presence of a previously undetected second HpaI 
site which lay upstream of exon 9. I decided to use the same partial digest approach 
I had used previously to clone the selection cassette into pXTE8.3. 
pXTE8.3 was partially digested with HpaI and linearised DNA was gel 
purified. The -5kb HindIll fragment from mUN7-1 containing the selection 
cassette was gel purified and blunt-ended. The two blunt ended fragments were 
ligated and electroporated into bacterial hosts. Test ligations indicated that the gel 
purification steps may be interfering with the ligation process and so pXTE8.3 DNA 
partially digested with HpaI was ligated to mUN7-1 DNA digested with HindIH 
and blunt-ended without any gel purification. Enrichment for the desired product 
could be achieved by plating out onto agar containing ampicilhin and 
chioramphenicol. The addition of both antibiotics will inhibit the growth of any 
bacteria which did not carry a plasmid containing the selection cassette DNA. 
Colony lifts were made and the filters probed with the 2.7kb HpaI fragment of 
pXTE8.3 to identify those colonies which contained both pXTE8.3 DNA and the 
selection cassette and at the same time eliminating any uncut mUN7-1 DNA or 
 --digested DNA which had -re-ligated; -Positive-colonies were picked -and gridded 
onto a fresh agar plate. Duplicate filters were made from these colonies and one set 
were probed with the pXTE1.8 insert and the other with the 2.7kb HpaI fragment to 
identify plasmids containing both ends of the pXTE8.3 genomic DNA. Double 
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positive colonies were analysed by restriction digest in order to determine the 
contents and orientation of the plasmids. This identified a clone (S70) which 
contains a single copy of the selection cassette inserted into the HpaI site of the 








Figure 2.6. Restriction digests of targeting vector. 
A. Colonies obtained from the ligation of the selection cassette into pXTE8.3 which 
were double positive by hybridisation were digested with Bgll to determine the 
orientation of the cloned fragments. Lane 1, 1-2; lane 2, M2; lane 3, S68; lane 4, S70; 
lane 5, S99; lane 6, size marker - AHindlll and X174Haelll. The expected fragment 
sizes are shown on the left hand edge of the picture. 
B!The same clones as in (A) digested with EcoRl. Lane 1, 1-2; lane 2,M2; lane 3, size 
marker - HindllI and 4X1741-laelll; lane 4, S68; lane 5, S70; lane 6, S99. The 
expected fragment sizes are shown on the right hand edge of the picture. 
2.2.7 Gene targeting in ES cells 
In order to test this targeting vector I wanted to use a mouse cell line which carried 
a mutation in the Cftr gene. No homozygous cell lines were available but I had 
access to an ES cell line (D18.2) which was heterozygous for a iF508 mutation in 
exon 10 generated by the 'hit and run' strategy. Gel purified targeting vector was 
electroporated into ES cells which gave rise to 23 hygromicin resistant colonies 
which were expanded and analysed. 
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Genomic DNA isolated from the 23 hygromicin resistant colonies was 
digested with Asp718I, electrophoresed and Southern blotted. The filters were 
hybridised using a 300bp EcoRE/DdeI fragment and a 200bp XbaI/DdeI fragment 
obtained from the remaining 700bp fragment of the Cftr gene which was not 
already included in the targeting construct (figure 2.7). 
XbaI DdeIE5oRI 
Asp718 	Asp718 	 Asp718 
I II 	I F508 allele 







AsL718 	 As0718 
I targeted 
9 	 10 
Figure 2.7. Detection of targeting event. The probe used to detect a homologous 
recombination event is composed of a Xbal/Ddel fragment and a EcoRl/Ddel 
fragment derived from genomic DNA which lies outside the region of the targeting 
construct. The D18.2 ES cell line contains a wild type allele and a mutant allele 
containing the iF508 mutation and a novel Asp7181 restriction site. Hybridisation 
of Asp7181 digested genomic DNA using this probe will detect a 3.2kb and a 6kb 
band. Correct targeting of either allele with the targeting vector will produce a band 
of 5.2kb. - non-vector genomic sequences; I exonic sequences; 
genomic vector sequences 
One clone was identified which contained both a mutant AF508 band and a targeted 
band (figure 2.8). This result confirmed that the vector was capable of targeting the 
Cftr locus at a reasonable frequency comparable to that achieved by Dickinson and 
colleagues of 1 in 6 (Dickinson et al., 1993). 
2.2.8 Gene Targeting in a Mutant Intestinal Epithelial Cell Line 
The IEC line CFMIE-G was derived from the small intestine of Cftrt" 1 homozgous 
mice (see chapter 4) and was used for targeting experiments using the S70 vector. 
Gel purified S70 DNA was transfected into CFMIE-G cells which were allowed to 
recover overnight. The cells were then trypsinised and mixed with non-transfected 
CFMIE-G cells and plated out into fresh culture dishes. Selection was applied to the 
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cells after 48 hours and the first resistant colonies began to appear a week later. 
Sufficiently discrete colonies were picked and plated into a single well of a 96 well 
4— 6.0kb wild type 
i— 5.2kb targeted 
- 3.0kb AF508 
Figure 2.8 Identification of correctly targeted ES cell clone. Hybridisation of genomic DNA 
isolated from G418 resistant colonies to probes derived from genomic DNA lying outside the 
targeting vector. The 6.0kb band corresponds to the wild type Cftr allele and the 3.0kb band 
corresponds to the AF508 allele. Track 2 contains a band of 5.2kb instead of a 6.0kb band 
which corresponds to the targeted allele. 
plate. Confluent cells were expanded then some were frozen in liquid nitrogen and 
others were used to isolate genomic DNA for restriction digest. The DNA was 
hybridised using the probe described earlier but analysis of the first 112 samples 
has so far failed to identify a targeted clone. 
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2.3 Discussion 
2.3.1 Screening of a dnomic Library 
The inability to successfully identify a genomic clone containing mouse Cftr 
sequences from a lambda zap library could be due to one of two main reasons. The 
first reason could simply be due to the use of poor quality probes. This is unlikely 
since three different probes were used to screen the library which had been used 
successfully as probes on other filters. Although a control probe appeared to prove 
that the library had sufficient coverage of the mouse genome, it may be that there 
simply was not a clone present in the library which contained Cftr sequences. In 
total I screened -6 x io plaques which would expect to give a 4 fold coverage of the 
mouse genome assuming a random distribution of cloned fragments and a haploid 
genome size of 2.7 x 109 base pairs. The number of independent clones which must 
be screened to ensure a 99% chance that a particular sequence with probability P is 
given by the equation; 
N=ln(1-P) /ln[1-(I/G)] 
where I is the size of the average cloned fragment in base pairs and G is the size of 
the target genome in base pairs (Moore, 1994). Therefore for a 99% chance of 
isolating a particular sequence in the mouse genome using a lambda phage vector 
with an average 20kb cloning capacity, this equation would predict the number of 
clones which requires to be screened to be; 
N=ln(1-0.99)/ln[1-(2 x 104  /2.7 x 10)] 
= 622,000 
This number is slightly higher than the number of clones screened and so the 
possibility that a clone containing Cftr sequences could have been found had -a 
greater number of clones been screened cannot be ruled out. However, one of the 
probes used to screen the library was a cDNA fragment which contained all exons 
of the Cftr gene. The exact size of the mouse genomic Cftr gene is unknown but is 
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likely to be similar in size to the human gene which is approximately 200kb. 
Therefore, this one probe is not going to simply detect a single fragment present 
within a single lambda clone, but can identify many different clones covering 
-200kb and so one would expect that the 6 x iø clones screened would have been 
sufficient. It may therefore be the case that for some reason, perhaps of cloning 
bias, there are no Cftr sequences present within this particular library. 
2.3.2 Gene Targeting in an Intestinal Epithelial Cell Line 
The inability to detect a homologous recombinant in mutant intestinal epithelial 
cells so far may be the result of a genuine low frequency of homologous 
recombination. Previous experiments in this laboratory have shown that the Cftr 
locus can be targeted at a frequency of 1 in 6 in mouse ES cells. However, the 
relevance of this figure in the experiments described here is questionable. The 
figure of 1 in 6 homologous recombinants is derived from targeting experiments in 
mouse ES cells (Dickinson et al., 1993) which are thought to be more 
recombinogenic compared to most immortalised cell lines (Jasin and Liang, 1991). 
Also, I showed that a homologous targeting event was obtained using ES cells 
which contained one wild type allele and one SF508 allele. This was detected after 
analysing only 23 ES cell clones. Secondly, frequency of homologous recombination 
vanesgreatly between different loci and different targeting vectors. Although the 
mouse Cftr gene has been targeted successfully in the region surrounding exon 10, it 
may be that the specific sequences used for homologous recombination is extremely 
important. Therefore, despite the fact that this particular locus has been 
successfully targeted previously does not mean that vectors containing overlapping 
homologous sequence will all be able to target at the same frequency. Thirdly and 
most importantly, the vector used in those previous experiments was an insertional 
vector whereas the vector I generated was a replacement vector. Targeting 
experiments using vectors containing the same homologous DNA but linearised 
within and outside the region of homology to generate insertional or replacement 
targeting vectors have shown that insertional vectors successfully target the locus at 
increased frequency (Hasty et al., 1991b). 
An alternative explanation may be that the targeting efficiency is not 
extremely low in these experiments but the method used to detect the targeting 
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event is unsuitable. The vector was originally designed to target a Cftr allele which 
had a mutation in exon 10 such that homologous recombination would take place 
between the sequences upstream of exon 9 and downstream of exon 10 so that both 
exons 9 and 10 are replaced by the wild type targeting DNA (figure 2.9). However, 
it was not possible to generate cell lines from mice carrying that specific mutation 
so cell lines were generated from the Cftrm homozygote animals which were 
created by insertional mutagenesis and carry a duplication of some sequences in 
exon 10 and flanking intronic sequence. The Cftrml  allele contains a deleted 
version of exon 10 as well as an intact version. This duplication of Cftr sequences 
creates two ways in which homologous recombination can take place and produce 
hygromicin resistant colonies. The first is the desired event I tested for using 
Southern blotting, in which homologous recombination takes places between the 
sequences flanking exons 9 and 10 of the targeting DNA (figure 2.9) and the 
homologous sequence on the chromosome. This event would cause a change in 
fragment size when DNA was digested with Asp7181 from 6.0kb to 5.2 kb using the 
probe chosen. Alternatively, homologous recombination could take place between 
sequences upstream of exon 9 and sequences within exon 10 such that the 
recombination event replaces the chromosomal DNA from upstream of exon 9 to 
the deleted exon 10. This would result in the loss of the targeting vector sequences 
downstream of this event and would still give rise to hygromicin resistant colonies. 
However, analysis by Southern blot would still show the 6.0kb band which when 
analysed would be presumed to be that of the non-targeted allele. It is possible 
therefore that homologous recombination at the correct locus has taken place but 
that the recombination event did not involve the entire Cftr sequence in the 
targeting vector. It should be possible to determine if this is indeed what has 
happened, either by finding other suitable restriction sites which he upstream of the 
selection cassette and downstream of the BglI site, or by designing suitable PCR 
primers to amplify from the selection cassette out to genomic sequences which he 
outside the targeting construct. This type of homologous recombination is similar 
to that seen in-the use of positive/negative selection-vectors (Mansour et al., 1988); 
These vectors are designed so that when linearised, a region of homology which 
contains a positive selection gene has a negative selection gene such as thymidine 
kinase (tk) either at one or both ends. The principle using these vectors is that a 
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random integration event will keep the targeting vector intact and therefore will 
retain the tk gene. Integration events that are mediated by homologous 
recombination however, will lose the tk gene. Therefore only homologous 
recombinants will survive gancyclovir selection. 
Asp7lBI 
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Figure 2.9. Homologous recombination events. A. The targeting vector was designed so 
that homologous recombination would take place between sequences upstream of exon 9 
and downstream of exon 10. This would result in the replacement of the endogenous exon 
9 and 10 with those of the targeting vector. This event can be detected by hybridisation of 
Asp7181 digested genomic DNA which would produce a 5.2kb band. B. An alternative 
targeting event which also employs homologous recombination is shown. Homologous 
recombination could take place between sequences upstream of exon 9 and sequences 
within the deleted exon 10. This would result in an allele which would be similar to the 
mutant allele except for the presence of the selection cassette. Hybridisation with genomic 
DNA containing this targeting event would produce a 6.0kb band as is normally found in 
the non-targeted allele. Digestion of the DNA with Asp71 81 and hybridisation with this 
particular probe is therefore unsuitable to detect such an event. Red boxes correspond to 
genomic DNA which lies outside the targeting construct, yellow boxes correspond to 
regions of DNA homologous between the targeting construct and the endogenous gene. 
The results presented here describe the generation of a targeting vector for 
mutation correction and demonstrate the ability of this vector to correctly target the 
Cftr locus in ES cells. The ability of this vector to successfully target a different Cftr 
allele in an immortalised intestinal epithelial cell line has yet to be demonstrated, 
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despite the analysis of many resistant clones. However, this may not be a problem 
of inefficient targeting but of efficient targeting in a manner not identified by the 
Southern blot and hybridisation procedures used here. Alternative approaches 
must be used to identify correctly targeted clones, either by identifying suitable 
restriction sites for Southern analysis or possibly by using PCR. 
The frequency of homologous recombination using this vector in ES cells 
(-4%) is similar to that achieved using other vectors to target the same locus. If a 
similar frequency could be obtained in epithelial stem cells, then this vector could 
be used for mutation correction. Further experiments will need to be carried out to 
ensure that the loxP/Cre system is effective and efficient in removing the selection 
cassette from the Cftr allele. 
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31 Introduction 
3.1.1 Vectors for Homologous Recombination 
Although plasmid based vectors such as those described previously are the most 
commonly used for gene targeting, there have also been reports of viral vectors 
being used for this purpose. Viral based vectors are commonly used for gene 
therapeutic purposes to deliver a cDNA into cells. These vectors are also being 
investigated for their ability to induce homologous recombination. Since one of the 
limitations of successful homologous recombination is the low level of DNA entry 
into the cells, the hope is that the relative increased efficiency of DNA transfer by 
viral vectors will result in an increase in the number of homologous recombinants. 
There have been reports of adenoviral (Wang and Taylor, 1993; Mitani et al., 1995; 
Fujita et al., 1995), retroviral (Ellis and Bernstein, 1989) and more recently adeno-
associated viral constructs (Russell and Hirata, 1998) being used successfully for 
gene targeting. 
3.1.2 Adenoviral Vectors 
Adenoviral DNA is normally maintained episomally in mammalian cells however it 
does integrate randomly to a limited extent (Doerfier, 1991). Wang and Taylor 
(1993) were able to show functional correction of the adenine 
phosphoribosyltransferase (APRT) gene in a Chinese hamster ovary cell line using 
an adenoviral construct designed to correct a mutant APRT gene which was a stable 
integrant into the cell's genome. However, they used two types of vector, those 
which4 did have a promoter and those which did not and found that homologous 
recombinants could only be obtained from vectors carrying a promoter. The 
authors claimed a frequency of APRT correction at between 1 in 10 5 and 1 in 106 
cells. This does not necessarily reflect the true targeting efficiency however because 
the adenoviral construct was E3-defective, El-nondefective and therefore 
replication competent. An endogenous Fg-r locus was targeted for homologous 
recombination using a replication incompetent (El and E3-defective) adenoviral 
vector by Mitani et al. (1995) into ES cells. This time there was no promoter attached 
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to the homologous DNA sequences. The adenoviral vector contained a neomycin 
phosphotransferase (neo) expression cassette which could be used to select for stable 
integrants. The vector was extremely efficient at reaching the nucleus (-30 copies of 
the viral genome per cell). The number of neo ES cell colonies obtained varied 
depending on the multiplicity of infection (MOl) used. The integration efficiency at 
an MOl of 100 was 2.5 x 10 5 whereas at an MOl of 1000 it was 2.1 x iø. However, 
further analysis revealed that the ratio of homologous recombinants to random 
integrants demonstrated the reverse relationship with a figure of 40% obtained at 
MOl 100 and only 6% at an MOl of 1000. While a figure of 40% of G418 resistant 
colonies being homologous recombinants is impressive, the absolute targeting 
efficiency (1.0 x 10 5) was similar to that obtained using a plasmid based vector 
introduced by electroporation (Hasty et al., 1994). 
Fujita et al. (1995) also used an El, E3 deleted replication incompetent 
adenoviral vector for homologous recombination. This group used a plasmid 
which could be maintained episomaly in mouse C127 cells as the target for 
homologous recombination. The recombination event was designed to generate an 
intact neo gene which could be selected for. The plasmids were then transferred to 
and recovered in E.Coli for precise molecular characterisation of the recombination 
events. G418r  colonies were obtained at high numbers due to the very high 
efficiency of adenoviral infection, and again the number was dependent on the MOl 
used, with the number increasing (in a non-linear manner) as the MOl was 
increased. Analysis of the recovered plasmids revealed that adenoviral integration 
was extremely low and that the majority of recombination events resulting in G418 
resistance had been homologous recombination events. The authors claim an 
absolute targeting efficiency of between 1 x 1W and 8 x 10 depending on the MOl 
used. They also claim this to be between 100 and 1000 times more efficient than 
targeting using a similar plasmid introduce by calcium phosphate precipitation or 
electroporation. 
3.1.3 Retroviral Vectors 
Retroviral vectors normally integrate their DNA randomly into the genome of their 
host cell. However, mutants can be generated which are defective in integration 
(Panganiban and Temin, 1983; Schwartzberg et al., 1984) and so, can in theory be 
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used to deliver DNA with high efficiency into cells for-homologous recombination. 
The use of retroviral vectors has long been thought of as the most appropriate 
vehicle for gene delivery into the epithelial cells of the intestine. The rate of cell 
turnover in the intestine is such that delivery of DNA to stem cells is the only 
feasible approach. Since this would require integration of the DNA into the host 
genome to be effective, the retroviral vector understandably was the vector of 
choice. Ellis and Bernstein (1989) used an integration defective retroviral construct 
carrying a 3' deleted neor gene to test for homologous recombination in mammalian 
cell lines carrying a different 5' deletion neor  gene. Homologous recombination 
between the two mutants can be selected for because it can give rise to a functional 
copy of the gene. Neor colonies were obtained at a frequency of 1 in 1-5 x 106 cells. 
Analysis of the target locus by Southern blot analysis however, revealed that none 
of the target loci had been corrected by a simple homologous recombination event 
and analysis of the mechanism involved was complicated and presumed to involve 
both homologous and non-homologous recombination. The authors did suggest 
however that the region of homology was extremely small and that perhaps a 
longer stretch of homologous DNA was required. 
3.1.4 Adeno-associated Viral Vectors 
Wild type adeno-associated virus (AAV) contains a single stranded DNA genome 
which integrates safely at a specific site on chromosome 19 in human cells, 
however, recombinant AAV vectors lose the ability to specifically integrate at this 
site. Recently, the first published attempts using AAV vectors for homologous 
recombination in mammalian cells (Russell and Hirata, 1998) suggested this may be 
a suitable vector. Using a similar approach to that described above, a recombinant 
AAV vector containing a mutant neor gene was delivered to HeLa cells containing a 
two gene with a different mutation and homologous recombinants were detected by 
selecting for G418 resistance. Up to 0.1% of cells were G418 resistant depending on 
the MOl used. Restriction analysis of the resistant clones revealed that 6 out of 11 
clones tested contained the correctly targeted bands. However, 3 out of the 6 clones 
had extra bands suggesting that random integration had taken place as well as 
homologous recombination. Since random integration occurs in approximately 1% 
of all cells, it would appear there is an unexplained increase in random integration 
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in cells that have undergone homologous recombination. In a second experiment 
which was carried out to target a truly endogenous locus, the human X-linked 
hypoxanthine phosphoribosyltransferase (HPRT) gene was targeted in male HT-
1080 cells. Successful targeting of the locus would generate a mutant gene which 
confers resistance to 6-thioguanine (6TG). Between 0.02 and 0.05% of total cells 
were 6TG resistant. Out of 13 clones which were picked at random and analysed, 
10 contained the mutation carried on the AAV vector in the chromosome, although 
5 out of the 13 had some form of random integration as well. In order to see if this 
was directly comparable to normal cells, targeting experiments were carried out on 
the HPRT locus of normal male fibroblasts. This time the number of 6TG resistant 
colonies increased to between 0.06 and 0.42% of cells depending on the MOl used. 
PCR analysis confirmed that 11 out of 13 clones tested contained the vector 
mutation on the chromosome. Southern analysis revealed that one out of four 
clones tested contained a random integrant. 
Targeting experiments were repeated using a plasmid which contained the 
AAV vector for comparison and this time the efficiency was more than 1000-fold 
less and was in fact no different to background mutation rates. The reason for 
increased homologous recombinants using AAV is unclear. It was suggested that it 
may be to do with the single stranded DNA AAV genome promoting homologous 
pairing. However, previous studies using single stranded substrates did not 
observe higher recombination frequencies (Fujioka et al., 1993). 
3.1.5 Small Fragment Homologous Replacement 
Despite the fact that the length of homology between the endogenous and 
exogenous DNA has been shown to be important in homologous recombination, 
attempts have been made to target genomic loci using short fragments of DNA. 
These fragments are only a few hundred base pairs in size and therefore do not 
contain any biochemical selection cassette. Initial experiments by Hunger-Bertling 
- 	et al. (1990) - showed that a DNA -fragment of only 165bp -could be delivered- to - - 
lymphoid cells either by electroporation or using polyoma capsids and successfully 
correct a point mutation in the HPRT gene. Moreover, they showed that using 
double stranded DNA or either single DNA strand alone appeared to have no effect 
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on the targeting frequency which were crudely estimated at between 1 in iø and 1 
in iø. 
Small fragment homologous replacement (SFHR) was used to attempt to 
correct the SF508 CFTR mutation in various cell lines (Kunzelmarin et al., 1996). A 
fragment of 491 base pairs was delivered to cells homozygous for the mutation 
either by complexing with lipids or dendrimers, or by electroporation. Evidence for 
homologous recombination was achieved using PCR oligonudeotides (oligos) 
which lie outside the region of homology to amplify the target locus. Corrected 
alleles would produce a fragment slightly larger (3bp) than non-corrected. Further 
confirmation was obtained by hybridisation using allele specific oligos. 
Determination of the allele correction frequency was achieved by densitometric 
analysis of the allele specific hybridisations, and the authors claimed a figure of —3-
10%. Expression of the corrected allele was confirmed by RT-PCR and patch clamp 
analysis. However, no attempts were made to determine the frequency of random 
integration which must be addressed to assess the value of this approach. 
The mechanism of SFHR is unclear and it not known why the constraint of 
homology length, which has been noted by several other groups using plasmid 
based targeting vectors, does not seem to apply here and may even result in an 
increased targeting efficiency. '. 
3.1.6 RNA-DNA Chimaeric Oligonucleotides 
The use of chimaeric oligonudeotides consisting of both RNA and DNA bases is a 
relatively recent and extremely promising method for precise mutation correction. 
Original experiments, using either the Llstilago maydis Rec2 or the E.Coli RecA 
protein (Kmiec et al., 1994) showed that homologous pairing was more efficient 
between single stranded DNA and a RNA-DNA hybrid molecule compared to an 
all DNA duplex. This led to attempts using a RNA-DNA hybrid molecule to correct 
a point mutation in an alkaline phosphatase gene which was contained on an 
episomal vector in CHO cells (Yoon et al., 1996). The chimaeric molecule was 
constructed so that a 5bp DNA sequence which spanned the point mutation but 
contained the wild type DNA sequence was flanked on either side by a lObp 
sequence of RNA complementary to the flanking DNA chromosomal sequence. 
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The RNA sequences were then flanked by short DNA sequences which allowed the 
single-stranded molecule to form a hairpin structure. This structure was thought to 
increase the stability of the molecule. Inhibition of degradation by RNase H was 
achieved by modifying the RNA residues by 2'-O-methylation of the ribose sugar. 
The target vector was first delivered to CHO cells using lipofection and then the 
chimaeric oligo was also delivered by lipofection 6 hours later. Targeting efficiency 
was estimated by enzymatic activity of alkaline phosphatase which was detected 
using a colorimetric assay. Approximately 30% of cells appeared coloured after 
staining for enzyme activity. Control experiments using an oligo with the same 
sequence but consisting entirely of DNA bases did not cause any increase in 
alkaline phosphatase activity. To ensure the enzyme activity was due to a 
correction of the alkaline phosphatase gene, DNA from the CHO cells was 
transformed into E.Coli and the resulting colonies were hybridised to allele specific 
probes. This also gave a figure of approximately 30% correction. Plasmid DNA 
was also isolated from the bacteria and sequenced to confirm the results. It is 
difficult to derive the true figure for targeting efficiency in these experiments since 
neither the number of CHO cells containing the alkaline phosphatase vector, nor 
the number of vector molecules per cell is known. 
The same group also published an attempt to target an endogenous gene in 
mammalian cells (Cole-Strauss et al., 1996). The f-globin gene was chosen as a 
target in lymphoblastoid cells (B cells) that were homozygous for the sickle cell 
allele Ps. This allele is responsible for sickle cell anaemia and is the result of a single, 
base change in the f-globin gene. A chimaeric oligo was constructed based on the 
previous design. The oligo was delivered to B cells using lipofection and the cells 
were harvested for analysis after 6 hours. In this experiment, the correct targeting 
of the 3-globin gene could be assessed using restriction fragment length 
polymorphisms (RFLPs) because the correction of the allele to the I allele 
introduces a Bsu 361 restriction site. Restriction digest followed by Southern 
blotting and hybridisation showed that the intensity of the Ps allele band decreased 
as the intensity of the allele increased in a dose dependent manner. Further 
analysis using PCR to amplify across the mutant locus also showed the presence of 
the Bsu 361 restriction site which was confirmed by sequencing of the product. In 
these experiments, the rate of random integration was assessed by looking for 
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mutations in the HPRT gene but no increase above background was observed. 
Interestingly however, they did look for recombination in the &globin gene since it 
has more than 90% homology to the 0-globin gene and in particular has complete 
homology over the 5bp DNA-core sequence of the oligo and only two separate base 
pair differences over the flanking RNA sequence. Direct sequencing failed to detect 
any base changes over this region of the gene. One note of caution from this work 
came from a note added in proof which stated that the same locus was not able to 
be targeted in a different cell line, despite efficient uptake of the oligo suggesting 
that this technique may not be applicable to all loci or cell types. 
More recently, Kren et al. (1998) used a similar approach to introduce 
mutations into the rat factor IX gene. Significantly, this work was the first report by 
a separate group using the chimaeric oligo technology successfully, and it was 
achieved using both primary hepatocytes in culture and hepatocytes in vivo. The 
oligos were not delivered by lipofection this time, but using lactosylated 
polyethylenimine (PEI) as the carrier. Although a precise figure for gene targeting 
frequency is difficult to ascertain from these experiments, a range of 11.9 to 22.3% 
was given for primary cultured hepatocytes, and a figure of 13.9 to 18.4% was 
obtained from liver tissue harvested after tail vein injection. This in vivo figure was 
increased to 40% after two injections. In order to confirm this gene conversioiin-
hepatocytes, factor IX coagulation activity was measured and found to be reduced 
to approximately 50%, and was associated with an increased partial thromboplastin 
time. In these experiments, no attempt was made to determine the frequency of 
random integration. 
The precise mechanism of gene correction using a RNA-DNA chimaeric 
oligonudeotide is not known, however, it has been suggested that a joint molecule 
is formed between the complementary genomic DNA strand and the 
oligonudeotide, inducing a mismatch repair mechanism. They also suggest that the 
RNA-DNA hybrid, as well as stabilising homologous pairing, may promote rapid 
repair activity by mimicking transcriptionally active DNA. 
In the experiments described above it is extremely difficult to determine the 
rate of random integration into the host cell's genome due to the lack of a selectable 
marker. The methods used to assess the frequency of random integration were 
sequencing a few hundred base pairs immediately surrounding the targeting locus, 
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hybridising a Southern blot containing genomic DNA from the targeted cells with 
an allele specific oligo and looking for mutations in either a highly homologous 
gene (&-globin), or a random gene (HPRT). These methods do not sufficiently rule 
out the possibility that random integration of oligonucleotide sequences occurs in 
the genome of host cells. 
In this chapter I shall describe the preliminary attempts made to introduce 
DNA reporter constructs into primary intestinal epithelial cells by a variety of 
different methods. 
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3.2 Results 
3.2.1 DNA Delivery into Intestinal Organoids 
Preliminary experiments to deliver DNA to primary intestinal epithelial cells by 
four different methods was undertaken. I attempted to deliver DNA to intact 
intestinal organoids (see chapter 5 for description) in suspension and to adherent 
organoids in culture. In all the experiments described negative controls were set up 
which involved treating organoids in the same manner but without DNA vector 
present. A positive control was also included in the DNA/liposome and adenoviral 
experiments using the vector to deliver the f3-galactosidase gene to control cell lines. 
3.2.1A DNA/liposomes 
Organoids were isolated as described in chapter 8 (section 8.1.6) and resuspended 
in serum free medium. The plasmid construct CMV 13-gal which expresses the 13-
galactosidase gene under the control of the CMV promoter was complexed with the 
lipid DOSPER at a weight ratio of 3:1. Organoids were then mixed with DNA/lipid 
complex and incubated at either 4°C, :'00m  temperature or 37°C. Aliquots of 
organoids were removed from each of the three experiments after 1, 2, 3 and 4 
hours incubation, washed and cultured. Organoids incubated at room temperature 
and 37°C appeared to start dissociating after 1 hour and only a small number of 
organoids from these experiments were able to be cultured successfully. After 5 
days in culture the cells were fixed and stained for 13-galactosidase activity. Not a 
single cell stained positive in any of the organoid cultures from these experiments. 
In a second experiment, I delivered DNA to organoids already established in 
culture. Organoids were cultured for 48 hours and the medium was removed and 
DNA/lipid complexes were added to duplicate wells at a constant DNA:liposome 
ratio of 3:1 but using increasing concentrations of DNA. DNA concentrations of 
18ng, 37ng, 73ng, 147ng and 460 ng (6 well equivalent of bong, 200ng, 400ng, 
800ng and 2.5jig) were complexed to DOSPER and added to each well. The 
organoids were cultured for a further 2 days after transfection then were fixed and 
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stained for 13-galactosidase activity. No positively stained cells were detected in any 
wells except for those organoids transfected with the highest concentration of DNA. 
However, only 3 individual cells were positive for 3-galactosidase activity (data not 
shown). 
3.2.113 Retrovirus 
The retrovirus RV-BAG was used to infect intestinal organoids. This vector is 
replication deficient and carries the 3-galactosidase gene under the control of the 
viral long terminal repeat (LTR) enhancer-promoter. This was supplied (as a kind 
gift from Dr. David Kipling) in the form of tissue culture medium supernatant from 
producer cell lines. The number of plaque forming units (pfu) in the supernatant 
aliquots was unknown to me and since the experiments were very preliminary and 
the aliquots extremely limited, I did not determine the number of pfu in the 
supernatant. 
The first experiment was set up to determine if it was possible to infect 
epithelial cells when the organoids were intact and in suspension prior to culturing. 
The organoids were isolated and incubated with culture medium and polybrene 
before being split into three samples each of which was incubated with the 
retrovirus for 1 hour at 4°C, room temperature or 37°C. A similar dissociation of 
organoids which were incubated at room temperature and 37°C was seen to those 
in the DNA/liposome experiment. Fresh culture medium was added to the 
organoids and they were plated and cultured as normal. After 10 days, the cells 
were fixed and stained for 3-galactosidase activity. No positively stained cells were 
detected from all 3 samples. 
In a second experiment, the organoids were isolated and processed as in the 
previous experiment, however this time polybrene was added to the culture 
medium used in the final stage of organoid isolation so that the organoids were in 
contact with the polybrene for at least 30 minutes before exposure to retrovirus. In 
- this experiment all organoids were -incubated With the efrOvitus for 1 hour at 37°C. 
Fresh culture medium was added to the organoids before they were cultured. The 
organoids were cultured for 48 hours, then were fixed and stained for 13-
galactosidase activity. Again, not a single positively stained cell could be detected. 
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Figure 3.1. Retroviral infection of mouse intestinal 
organoids. Intestinal organoids were cultured for 24 hours and 
then incubated with the retroviral vector RV-BAG which carries 
the IacZ gene. Cells were fixed and stained for f3-galactosidase 
activity after 7 days in culture. Only a small number of positive, 
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In the third experiment, 7 x 10 3 organoids were isolated and. cultured for 24 
hours. The organoids were then incubated with retroviral supernatant. The 
organoids were cultured for a further 6 days and then fixed and stained for I-
galactosidase activity. Only 4 epithelial colonies contained any positive staining 
cells (figure 3.1). 
3.2.1C Adenovirus 
An adenoviral vector (AdCMV-lacZ) containing the J3-galactosidase gene was used 
in these experiments and was a kind gift from Dr. Malcolm Dunlop. Freshly 
isolated organoids (6 x 10) were resuspended in serum free medium and mixed 
with -4.8 x 109 adenovirus particles to give a particle:cell ratio of approximately 
100:1 if it is assumed there are approximately 800 cells per organoid (Patel et al., 
1996). The organoid/adenovirus mix was split into three and each sample 
incubated for 30 minutes at 4°C, room temperature or 37°C with mixing every 10 
minutes. The organoids were plated out and cultured for 5 days before being fixed 
and stained for 3-ga1actosidase activity. 
The majority of epithelial colonies contained a number of positive staining 
cells scattered throughout the colony (figure 3.2A). However, in these experiments, 
the organoids which had been incubated at 37°C produced a larger number of 
colonies compared to those incubated at lower temperatures. Many of the 
fibroblast-like cells stained positive for 3-galactosidase activity (figure 3.2B). The 
experiment was repeated again, this time using a particle:cell ratio of 60:1 and 
incubating the organoids at 37°C for 1 hour with mixing every 10 minutes. 
Organoids were cultured for 2, 3, 6 or 10 days before being fixed and stained for 
enzyme activity. A similar result was obtained to the previous experiment in that 
occasional positive cells were seen in epithelial colonies scattered throughout the 
central dome of the colony as well as in the surrounding cells. 
In a third and final experiment, freshly isolated organoids were resuspended 
in serum free medium and incubated with adenoviral particles, this time at a higher 
particle:cell ratio of -240:1 at 37°C for 30 minutes with mixing every 10 minutes. 
Organoids were cultured for 6 days then fixed and stained for enzyme activity. 
Chapter 7Wree 	 Gene Delivery to Organoids 
Rather than individual scattered positive cells throughout the colonies, positive 
cells were abundant in the central region of the colonies reaching close to 100% of 
all surface cells (figure 3.2C). However, the surrounding cells which are 
presumably the cells produced by cell division in culture still contained only a 
number of scattered positive cells. 
3.2.1D Electroporation 
The use of an ex vivo approach to gene delivery allows using electroporation as a 
means to introduce DNA into cells. This is the preferred method to introduce DNA 
into mouse ES cells when generating transgenic or knockout animals .and is 
therefore' theoretically a good approach for mutation correction in somatic stem 
cells. 
The protocol used for introduction of CMV-13 gal plasnild DNA (50ig) into 
organoids by electroporation was essentially the same as that used for introducing 
DNA into mouse ES cells. After electroporation the organoids were resuspended in 
medium and cultured for 3 days then fixed and stained for enzyme activity. 
Control electroporation of organoids without DNA showed that electroporation 
itself did not appear to have a damaging effect on the organoids (figure 3.3A) 
although there was a reduction in the number of colonies obtained. This is also 
seen in ES cell electroporation where the conditions for optimal DNA transfer 
typically result in 50% cell death. Electroporation of DNA into the organoids did 
result in a very small number of cells exhibiting enzyme activity (figure 33B) 
however there was also a more pronounced reduction in colony size. 
The experiment was repeated, this time using 100xg of the CMV$ gal 
plasmid. The increase in the amount of DNA electroporated resulted in an increase 
in the number of cells displaying enzyme activity per organoid but there was no 
sign of epithelial proliferation. The few organoids which did adhere to the culture 
dish had not increased in size or produced migrating cells on to the culture 
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Figure 3.2. Adenoviral infection of mouse intestinal 
organoids. (A). AdCMV-lacZ infected organoids at a particle to 
cell ratio of 100:1. A small number of positive cells can be seen 
scattered throughout the colony. (X50) (B). Colonies infected 
with AdCMV-lacZ at a particle to cell ratio of 100:1 showing 
preferential lacZ expression in mesenchymal cells on the 
periphery of the epithelial colonies (arrows point to the central 
organoid of the epithelial colonies). (X50) (C). AdCMV-lacZ 
infected organoids at a particle to cell ratio of 240:1. The majority 
of the epithelial cells at the centre of the colony are expressing 
lacZ, as are the mesenchymal cells round the colony edge. 
However, only a small number of positvely stained cells can be 
seen in the regions in between. (X50) 
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Figure 3.3. Electroporation of mouse intestinal 
organoids. (A). Mouse intestinal organoids electroporated 
and cultured for 4 days. Organoids fixed and stained for 
alkaline phosphatase activity. (X50) (B). Mouse intestinal 
organoids electroporated with 504g of pCMV-gal plasmid 
DNA and stained for f—galactosidase activity after 4 days in 
culture. Only a very small number of positively stained cells 
can be identified. (X50) (C). Mouse intestinal organoids 
electroporated with 1 OO1g of pCMV-3gal plasmid DNA and 
stained for 3—galactosidase activity after 4 days in culture. 
The number of positively stained cells is increased but there 
is no sign of proliferation from the cells in the organoid. (X50) 
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3.3 Discussion 
Although gene targeting has almost always been carried out using plasmid based 
vectors introduced into cells either by electroporation or calcium phosphate 
precipitation, some groups have also looked at the possibility of using viral based 
vectors which can take advantage of their increased efficiency of DNA transfer into 
cells. However, for the purposes of mutation correction, the best vector to use to 
deliver the DNA construct is not necessarily the most efficient vector. Although 
viral vectors can be used to deliver DNA into cultured cells with an extremely high 
efficiency, it has to be remembered that the DNA is not only required to enter the 
cell but to undergo homologous recombination once inside. 
The amount of useful information to be gleaned from these experiments on 
DNA delivery into primary intestinal epithelial cells is somewhat limited because of 
their very preliminary nature. Sufficient viral vectors were only available to carry 
out 2 or 3 experiments so none of the conditions were able to be optimised. Also, 
the viral stocks used were of unknown litre and quality and so I am unable to 
generate accurate figures for infection efficiency. However, some potentially useful 
information can still be obtained from the limited data. 
3.3.1 Liposome Mediated Delivery, to Organoids 
The inability of DNA/lipid complexes to deliver reporter constructs and drive lacZ 
expression is disappointing. The rate limiting step is most likely the transfer of 
DNA across the cell membrane and delivery of DNA to the nucleus rather than 
gene expression since the cytomegalovirus (CMV) promoter used to drive lacZ 
expression has been shown to work in intestinal epithelial cells in situ and in cell 
lines (Westbrook et al., 1994; Lozier et al., 1997). Primary cells are notoriously 
difficult to transfect using liposome mediated gene transfer compared to established 
cell lines (Kofler et al., 1998). Several groups have attempted gene delivery into 
intestinal cells using liposome complexes. Westbrook et al. (1994) used plasmid 
DNA complexed with Lipofectin to deliver the lacZ gene in vivo to colonic epithelial 
cells in the rat. Examination after 48 hours revealed almost 100% blue staining 
absorptive epithelial cells present on the surface cuffs of the epithelial lining but no 
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staining was seen 'within goblet cells and almost no staining whatsoever was seen 
in the crypts. The latter observation was attributed to cell division and turnover in 
the intestinal epithelium however, since they did not look earlier that 48 hours to 
confirm this, it is impossible to say if the plasmid was delivered to crypt epithelial 
cells. No staining could be detected 4 days after gene delivery. Positive staining 
cells were never detected in the underlying mucosa. The experiments were 
repeated using a plasmid carrying the APC gene and expression was confirmed in 
colonic epithelial cells by RT-PCR up to 48 hours after delivery. Unfortunately, RT-
PCR does not allow any quantification as to the number of cells successfully 
transfected with the plasmid. Using a similar approach of colonic enema todeliver 
DNA/liposome complexes to rat intestinal epithelia, Schmid et al. (1994) also found 
that 3-galactosidase activity could be detected up to 48 hours after delivery, 
however their results conflicted with those of Westbrook et al. in that not only were 
they able to detect reporter activity in surface absorptive cells but they also reported 
activity in goblet cells, crypt cells and in the underlying mesenchyme down to the 
muscularis mucosae. These experiments used LipofectAMlNE as the delivery lipid 
and the reporter gene was under the control of the Rous sarcoma virus (RSV) 
promoter which may explain some of the differences in gene expression between 
these two sets of experiments. Both of these groups used rat colonic epithelium as a 
target because of the relative ease of delivery, however the results may not 
necessarily be applicable to the small intestine of the mouse. Alton et al. (1993) used 
liposomes to deliver a human CFTR construct driven by the CMV promoter to the 
large intestine of the Cftrmouse. Preliminary experiments using a dye 
delivered to the colon had shown that colonic delivery resulted in the staining of 
ileal epithelial cells as well as those of the colon and rectum. After delivery of the 
CFTR construct using the lipid DC-Chol/DOPE, no CFIR mENA could be detected 
in colonic epithelium however the forskolin response in the ileum and rectum 
which is used as a measure of CFFR function showed a —20% response compared to 
heterozygote untreated animals. This result suggests that liposomes can be used to 
- -- - - - -_ - deliver--DNA-to small-intestinal epithelial cells but the-efficiency oithisapproach is - --
unknown. 
Previous experiments in this and other laboratories have shown that the 
efficiency with which plasmid constructs can be delivered to different cell types can 
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be dramatically affected by the total amount of DNA used, the ratio of DNA to lipid 
and the type of lipid used in the experiments (Lozier et al., 1997; El Ouahabi et al., 
1997; Zhao et al., 1997, and data not shown). These are factors which require to be 
optimised for each experimental system, therefore it may be that by varying these 
parameters, efficient DNA delivery could be achieved in intestinal organoids. 
3.3.2 Retroviral Delivery of DNA to Organoids 
The results from the retroviral experiments were also disappointing. It was 
unsurprising that no lacZ expressing cells could be detected following incubation 
with retrovirus particles in suspension. Retroviral vectors require actively dividing 
cells to be able to integrate their genome into host cells and it is unlikely that the 
freshly isolated organoids contain actively proliferating cells. However, it is 
possible that the virus could gain entry into the cells while in suspension and 
integrate into the genome once proliferation starts in vitro. The biggest problem 
with incubating the organoids in suspension prior to cell culture is that the majority 
of cells in suspension are terminally differentiated cells and will not survive cell 
culture so that in effect these cells are competing out the number of retroviral 
constructs available to gain entry into proliferative cells. 
It might have been expected that a greater number of transfected cells would 
have been obtained from transfection of cultured cells. The application of 
retrovirus after only 24 hours in culture should have meant that the maximum 
number of proliferating cells would be present in the culture and therefore the 
maximum number of target cells for retroviral infection, however the number of 
positively stained cells was extremely low. The viral titre used in these experiments 
is important in optimising the infection efficiency. In vitro experiments using an 
intestinal epithelial cell line have shown that viral gene delivery is inhibited at high 
retroviral concentrations (Noel et al., 1994). These experiments also looked at the 
effect of cell density on the efficiency of gene delivery in vitro and found a large 
degree of variation in transduction efficiency over a range of different densities. 
This was thought to be due to the balance between the number of cells available for 
infection and the number of actively proliferating cells in the culture. Also it has 
been shown that the expression of the retroviral receptor in this and other cell lines 
72 
Chapter Three 	 Gene Delivery to Organoids 
is decreased at high cell conuluency (Puppi and Henning, 1995). The limited 
amount of viral supernatant available for the experiments described here meant 
that there was insufficient to establish an accurate figure for the litre so the exact 
pfu used is unknown. Future experiments would require this to be calculated and 
optimised to ensure that the apparent low efficiency was not due to inhibition by a 
high viral litre or a sub-optimal cell density. In vivo experiments (Lau et al., 1995) 
have provided some unconvincing evidence of retroviral mediated gene transfer 
into the intestinal epithelial cells of adult rats and mice which even the authors 
consider to be extremely inefficient (approximately 0.15%). Problems with non-
specific background staining and questionable positive staining of 13-galactosidase 
activity in the gut make interpretation of these results difficult. No conclusive 
evidence of successful delivery into intestinal epithelial stem cells was obtained. 
Similarly, in a second publication from the same group, a retroviral construct 
containing the lacZ gene was used to infect segments of foetal rat intestine ex vivo 
which were then grafted subcutaneously into nu/nu mice (Jacomino et al., 1996). 
Due to problems with background 0-galactosidase, the efficiency of vector delivery 
was assayed by PCR analysis of geñomic DNA isolated from the grafts for 
recombinant retroviral sequences. The efficiency of gene delivery which could only 
be estimated by a somewhat circuitous route was again found to be extremely low. 
These results suggest that retroviral gene delivery may not be the best approach for 
efficient gene delivery to intestinal epithelial cells. 
3.3.3 Electroporation of DNA into Organoids 
The use of electroporation to get DNA into the intestinal epithelial cells was more 
successful than the liposome or retroviral attempts, in terms of the number of lacZ 
expressing cells per organoid. The number of cells expressing lacZ per organoid 
increased when the amount of DNA was increased. However, while 
electroporation of the organoids without any DNA still resulted in viable 
proliferation of intestinal epithelial cells, the addition of DNA severely impaired 
both the number of surviving adherent organoids and the proliferative capacity of 
the adherent cells. This appeared to be related to the quantity of DNA used and 
was more severe using lOOj.tg of DNA compared to 50pg. The efficiency of 
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electroporation depends upon electric field strength, temperature, capacitance, 
medium and cell condition (Chu et al., 1987; Andreason and Evans, 1989). The 
conditions used for organoid electroporation were the same as used in the lab to 
introduce targeting constructs into mouse ES cells. It may be that optimisation of 
these conditions specifically for organoids could prevent this inhibition of cell 
survival and proliferation. Previously, investigators reported attempts to introduce 
DNA into primary macrophages (Stacey et al., 1993) using conditions optimised for 
a macrophage cell line. in a similar manner to that seen in the experiments 
described here, the primary macrophages survived electroporation without DNA 
but showed large scale death over a 12 hour period if DNA was included in the 
electroporation. Moreover, the toxicity was DNA concentration dependent and 
DNA sequence and source independent. The authors suggest this may be part of an 
antiviral host defence programme which is sensitive to cytoplasmic accumulation of 
double-stranded DNA though no evidence for this is provided. It may be possible 
to use significantly less DNA in the electroporation and so reduce the level of cell 
death. Experiments using mouse ES cells have shown that gene targeting can be 
carried, out at a much higher absolute frequency than standard protocols 
(Templeton et al., 1997). The improvements were a result of optimising and scaling 
down the electroporation process itself and altering the plating density following 
electroporation. The conditions for electroporation were adjusted so that only a 
limited number of DNA molecules were delivered to the nucleus. This was thought 
to reduce the level of random integration. An absolute targeting efficiency of 1 in 
10 was claimed for the Hprt locus in ES cells compared to a value of between 1 in 10 5 
and 1 in 106  claimed by other groups. As a result of the optimisation procedure, 
only 5run of targeting. DNA was used in each electroporation experiment, compared 
to —20pM normally used in gene targeting experiments. If this technique could also 
be optimised for intestinal organoids then the deleterious effect of large quantities 
of DNA on the survival and proliferation of intestinal cells may be abrogated. 
3.3.4 Adenoviral Delivery of DNA into Organoids 
The greatest success with gene transfer into intestinal epithelial cells was obtained 
using an adenoviral vector. Adenoviral vectors have the advantage of being able to 
74 
Chapter Three 	 Gene Delive!y to Organoids 
infect non-dividing cells although these are receptor mediated processes and so the 
cells must express the appropriate cell surface receptors for binding and 
internalising the vector. The attachment receptor for Ad2 has recently been 
identified as CAR, a transmembrane protein of unknown function (Bergelson et al., 
1997), and it has been shown that the alphabeta 3 and a1phabeta5 integrin receptors 
mediate adenoviral (Ad2) internalisation (Wickham et al., 1993). These integrin 
receptors are known to be expressed in both neonatal and adult mouse small 
intestine (Hamilton et al., 1997) but the expression pattern of the CAR protein has 
yet to be determined. 
The epithelial cells which surround the organoid in the type 2 colonies were 
predominantly negative for lacZ expression whereas the majority of the cells of the 
central core were positive as were a large majority of the fibroblast-like cells 
surrounding the epithelial colony. Both the epithelial cells at the centre of the 
colony and the surrounding fibroblast-like cells are made up of either cells from the 
original organoid and therefore were in direct contact with the adenoviral vector, or 
are the first few generations of daughter cells produced by the surviving 
proliferating epithelial cells. As a result there is a high probability that these cells 
could contain adenoviral vector and are capable of expressing the lacZ gene. The 
epithelial cells on the periphery of the colony however are more likely to be late 
generation daughter cells which are the product of several rounds of cell division. 
It is possible therefore that the adenoviral vector has been diluted out after several 
rounds of cell division which explains the lack of lacZ expression. The question of 
whether or not these cells express the correct receptors for adenoviral binding and 
entry is not an issue since they are never exposed directly to the vector and can only 
contain it by having it passed on from the parent cell during cell division. 
Adenoviral vectors have been used by others to deliver DNA into intestinal 
epithelial cells. Cheng et al. (1997) used an El-deficient adenoviral vector carrying 
the -galactosidase gene to infect intestinal epithelial cell lines and were able to 
show efficient gene expression in -95% of cells using a relatively high MOl of 5 x 
- 	The same vector was used in in vivo experiments, where the vector was - - 
delivered by means of an oral duodenal tube directly into the duodenum of adult 
rats. The animals were sacrificed at 3, 7 and 14 days after administration and gene 
transfer was assessed using antibodies against bacterial 3-galactosidase. After 3 
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days, positive staining was found along the apical membrane of enterocytes 
covering the upper half of viii but no staining was seen in the crypts. Although no 
data is shown, the authors claim that positive cells were present both at 7 and 14 
days but in much smaller numbers. Again, this evidence is not convincing. 
Bacteria present in the intestine will also be positive using this particular antibody. 
The staining pattern showed apical localisation of 3-galactosidase which is the site 
of bacterial adhesion in the small intestine and this apical localisation is not 
consistent with various transgenic animals which express f3-galactosidase in the 
intestinal epithelium and show an even cytosolic distribution. Also, the authors 
claim that the positive staining cells in the upper regions of the viii are the result of 
crypt cells which have been infected and then migrated up on to the villus during 
the three days between delivery and analysis. However, they do not look at any 
time point earlier than the three days to confirm this. The fact that positive cells are 
still seen at 7 and 14 days is also confusing since all the epithelial cells present at the 
time of administration should be completely replaced after this period of time. For 
positive cells to be found on villi after this time would mean that crypt cells must be 
positive at earlier time points yet no positive staining cells were ever found in the 
crypts.-Further controls are necessary to exclude the possibility that -galactosidase 
activity is not due to bacteria in the gut. Delivery of an adenoviral construct 
carrying the green fluorescent protein (GFP) gene to intestinal loops of jejunum and 
ileum (Croyle et al., 1998) resulted in gene transfer to Heal epithelial cells but not 
jejunalepithelial cells. In these experiments gene expression was analysed 24 hours 
after adenoviral administration but cells expressing GFP were only found on vifius 
cells and not in the crypts suggesting that the epithelial cells of the crypt may be 
inaccessible to adenoviral vector. 
The adenoviral vectors most commonly used for gene therapeutic purposes 
are respiratory viruses which bind to receptors expressed on the surface of 
respiratory epithelial cells. In an effort to increase the affinity of adenoviral vectors 
for the intestinal epithelium Croyle et al. (1998) have investigated the delivery 
potential of adenovirus strain 41. This particular strain was discovered in stool 
samples of infants with diarrhoea as was strain 40 and these are known as enteric 
adenoviruses. It is likely that Ad41 binds to cell surface receptors expressed on 
intestinal epithelial cells. Studies using human and rat cell lines which are capable 
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of some degree of differentiation in culture were used to compare binding and 
internalisation of the Ad41 and the Ad5 strain of adenovirus. Their results 
suggested that the Ad41 was more efficient at binding and internalising the cells in 
both their undifferentiated and in particular their differentiated state. 
3.3.5 DNA Delivery to The Intestinal Epithelium 
The data available so far from various groups attempting gene delivery to the 
intestinal epithelium would appear to demonstrate great difficulty in obtaining 
efficient DNA delivery. The accessibility of the intestinal lumen raised great hopes 
that the intestine could be used as an easy efficient target for gene transfer but 
perhaps the intestinal environment of assorted digestive enzymes, proteases and 
lipases is not a convivial environment for most gene therapy vectors. Alternatively, 
or coincidentally it may be that intestinal cells are not suited to the uptake and 
expression of foreign DNA, or even are specifically designed not to. The intestinal 
mucosa is essentially exposed to the outside environment and therefore all kinds of 
foreign matter such as bacteria, viruses and toxins. As a result, just 1-2metres of the 
human intestinal mucosa contains more antibody secreting cells than do all other 
tissue combined (Brandtzaeg et al., 1987). It would make sense that either the cells 
of the intestinal mucosa do not willingly take up any passing particle or, as is more 
likely the case, are extremely efficient at taking up particles with the intention of 
degrading them. 
In vivo attempts at gene delivery have not only revealed the inefficiency of 
this process but also the inability to deliver DNA to crypt and specifically stem 
cells. It is unclear from the available data whether this is a limitation of the crypt 
cells to take up the vectors or whether it is a physical problem of obtaining access to 
the crypts. The crypts are designed as a protective environment for the stem cells 
and are also the site of fluid secretion as well as mucin secretion. As a result, the 
net movement of fluid and particles trapped within it, is from the crypt towards the 
-- - - intestinal lumen, thus making vector entry into-the-crypt extremely difficult. Also, 
the intestinal epithelium, and in particular the crypt epithelium is lined with a layer 
of mucus, designed to protect the epithelium from the toxic environment which will 
also serve as a barrier to gene delivery. This demonstrates the preference for an ex 
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vivo approach to intestinal gene therapy which would bypass some of these 
endogenous barriers to efficient gene delivery. 
The preliminary results described here appear to confirm the great difficulty 
in successfully delivering DNA into primary intestinal epithelial cells. The delivery 
systems used here will require greater optimisation if they are to be of any 
therapeutic use, however it may be that other delivery systems not tested here will 
be much more efficient. 
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4.1 Introduction 
Results from the preliminary attempts to introduce DNA into IEC of organoids 
were relatively unsuccessful and so made it difficult to use this system to assess the 
efficiency of the mutation correction construct. I decided it would be more 
appropriate to use a model system to ensure that the targeting vector was both 
capable of mutation correction and was able to be manipulated in situ by means of 
the lox-Cre recombinase system. The obvious choice for a model system was an 
immortalised cell line, which would provide a more robust system than primary 
cultured organoids. Another benefit of using a cell line, is the efficiency of 
introducing DNA. 
In order to assess my targeting vector I could, in theory use any murine cell 
line. Correct targeting in a murine cell line which contained two non-mutated 
copies of the Cftr gene could still be identified by a combination of biochemical 
selection and DNA analysis. However, if a cell line was used which carried a 
homozygous Cftr mutation, then it might be possible to show not only gene 
targeting and mutation correction, but functional correction as well by looking for 
correction of chloride ion transport using patch clamp and fluorescent imaging 
techniques. This would however rely on the cell line actually expressing Cftr. 
Unfortunately, to date there have been no reports of cell lines generated from any of 
the Cftr mutant mice which I could use. I therefore decided to generate 
immortalised cell lines from the small intestine of Cftr homozygote mutant mice. 
The generation of immortalised cell lines from the mammalian small 
intestine has proved to be a relatively difficult task compared to other tissues. The 
reasons for this are discussed in chapter 5 in relation to the establishment of 
primary cultures from the small intestine. It is because of these difficulties that the 
majority of intestinal cell lines in use are derived from human colorectal carcinomas 
(Fogh et al., 1977; Reid et al., 1978; Kirkland, 1985; Kirkland and Bailey, 1986). 
Apparently normal cell lines have been generated from mammalian small intestinal 
epithelium as mentioned previously, but these cell lines are relatively difficult to 
generate and have a limited life span. I decided to generate immortalised cell lines 
from the mouse small intestine by inserting a viral oncogene into primary IEC. 
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There are a number of different viral oncogenes which can be used to 
immortalise cells, such as the human papilloma virus type 16 (HPV-16) E7 protein 
(Miinger et al., 1989), adenovirus type 5 (Ad5) E1A polypeptides (Lillie et al., 1986), 
polyoma virus large T antigen (PyLT) (Asselin and Bastin, 1985) and simian virus 40 
(SV40) large T antigen (SV4OTag) (DeCaprio et aL, 1988). These viral proteins use 
similar mechanisms to achieve cellular immortalisation, by interacting with the 
retinoblastoma gene product (pRB) which is coded for by the retinoblastoma gene 
(RB-1) (Lee et al., 1987). RB-i is a tumour suppressor gene, deleted or mutated with 
high frequency in retinoblastomas, as well as a variety of other tumours and 
tumour cell lines (Friend et al., 1986; Harbour et al., 1988). pRB normally inhibits 
cell proliferation by binding to the E2F family of transcription factors (Nevins, 1992) 
and consequently repressing a subset of genes involved in progression from the Gi 
to the S phase of the cell cycle. This repression is thought to be achieved by 
masking the transactivation domain of E2F1 thereby repressing its function and by 
actively repressing surrounding cis-acting elements or basal promoters, possibly by 
recruitment of a histone deacetylase which may act to modulate the local structure 
of the chromatin (Magnaghi-Jaulin et al., 1998). The binding of the viral oncogenes 
to pRB appear to inhibit the normal function of pRB and so has the' same effect as a 
deletion or mutation (Nevins, 1992). 
Two possible approaches to generating immortalised cell lines were readily 
available to me. Firstly, I had access to an amphotropic retroviral vector (psiCRW-
SVU19) (Bond et al., 1996) which expresses SV40TAg and also confers resistance to 
the aminoglycoside G418 and can be used as a positive selection for the presence 
and expression of the vector. Secondly, I had access to transgenic mice which carry 
the polyoma large T antigen (Paquis-Flucklinger et al., 1993) and could in theory be 
used to generate immortalised cell lines. Despite a common mode of action through 
pRB, these two viral oncogenes are thought to produce different effects. While 
PyLT can cause immortalisation of cells retaining some of their differentiated 
characteristics (Galiana et al., 1990), SV40TAg expressing cells are reported to de- 
- - differentiate and possibly go on to become transformed Jat et al., 1991), although - , - 
this may not always be the case. This may be due to SV40TAg binding to and 
sequestering both pRB and p53 simultaneously, rendering them inactive resulting 
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in unlimited growth potential of the cells (McLean, 1993). Both approaches have 
their own advantages and disadvantages and so I decided to use both systems. 
SV40TAg is extremely efficient in immortalising cells but there is a problem 
in getting the oncogene into the cells in the first place. Many different cell types 
which have proved resistant to DNA transfer using chemical techniques have been 
transformed successfully using retroviral constructs carrying a variety of different 
oncogenes, for example smooth muscle cells (Perez-Reyes et al., 1992), and intestinal 
epithelial cells (Vincentini et al., 1996; Vidal et al., 1993). Previous experiments 
described in chapter 3 demonstrated the very low efficiency of retroviral 
transfection of mouse intestinal organoids which suggests it may be difficult to 
immortalise IEC in organoid culture using this approach. 
An alternative approach was to use the PyLT transgenic mice to generate 
cell lines. In theory this could be a relatively simple procedure since expression of 
PyLT in mouse cells has been shown to be sufficient for immortalisation 
(Rassoulzadegan et al., 1983; Kaplan et al., 1989). Therefore primary cultures of 
intestinal organoids from PyLT transgenic mice should be able to produce 
immortalised cell lines as long as the PyLT transgene is expressed in the intestinal 
epithelium. One added complication with this approach is that the generation of 
cell lines from mice carrying a mutated Cftr gene would require crossing the P'yLT. 
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4.2 Results 
4.2.1 Primary Culture of Organoids Derived from PyLT Transgenic Mice 
Intestinal organoids were isolated and cultured from neonatal PyLT transgenic mice 
as described in chapter 8 (section 8.1.6). Although organoids adhered to the culture 
dish as normal, the majority of cells surrounding the organoids had a fibroblast-like 
morphology. However there were many small colonies of epithelial-like cells 
which did not appear to be associated with any organoid structure. The culture 
medium was changed after 24 hours and at this point many of the organoids 
detached from the culture dish leaving flat monolayers of cells behind. The 
majority of these cells had a fibroblast-like appearance. After 1 week in culture only 
a small number of colonies with an epithelial-like morphology could be detected. 
There was no biochemical selection procedure to ensure the expression of the PyLT 
gene and so the continued proliferation and survival of cells was taken as the 
selection criteria. After 11 days no increase in cellular proliferation could be seen. 
In an attempt to determine whether any of the cells present in the culture 
were immortalised, the cultures were treated with trypsin and replated into a fresh 
culture dish. This resulted in a number of fibroblast-like cells adhering to the dish 
but no cells with an epithelial-like morphology could be observed. This was also 
the case with the CBA derived control cultures. There was only a very small 
increase in the number of cells in the cultures over the next 7 days. Trypsinisation 
of these cells, followed by replating resulted in even fewer surviving cells which 
again had a fibroblast-like appearance. The cultures from the PyLT transgenic cells. 
were similar to those derived from CBA cells, and no immortalised cells could be 
generated. 
4.2.2 Infection of Mouse Intestinal Organoids with psiCRIP-SVU19 
Although .a cell line derived from .Cftr homozygous mutantanimalswas required. --
for my purposes, I initially tested out a protocol for SV40TAg immortalisation using 
cells from control CBA and transgenic ROSA 26 (Friedrich and Soriano, 1991) 
animals. This was necessary due to the limited supply of homozygous mutant 
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animals which meant that protocols had to be optimised to increase the chances of 
success. Intestinal organoids from CBA and ROSA 26 neonatal mice were isolated 
and cultured as described, except cells were grown in a T25 flask instead of a. 2cm 
dish in order to increase the number of cells available for infection. The cultures 
were grown for 8 days and all 3 epithelial colony types were observed. By day 8 
there were many large type 3 colonies present in the culture flask. 
The cells were maintained in culture for a further 72 hours in normal culture 
medium without selection. The cells showed no obvious deleterious effects from 
the transfection protocol. After 72 hours the cells were trypsinised and replated in 
fresh culture medium, still without selection. After 24 hours, a large majority of the 
cells had stuck down on to the culture flask, but even after a further 24 hours, there 
was still no sign of cells with an epithelial-like morphology. After 72 hours, the 
culture medium was removed from both flasks and replaced with fresh normal 
culture medium in one instance and medium containing G418 at the relatively low 
concentration of 100pg/ml in the other. After 24 hours, the flask containing the 
selective medium contained colonies which appeared to have a "cobblestone" 
appearance which is frequently associated with epithelial cells in culture. The other 
flask. contained only one such colony. Three days after the addition of selective 
medium, cells in both flasks were again trypsinised and replated into selective. 
medium. 18 days after the initial transfection the cell number was still increasing 
but cells from uninfected cultures did not survive the repeated trypsinisation and 
replating. 
The cells from one flask were trypsinised and replated at a low dilution into 
96 well plates in order to obtain wells with different proportions of epithelial to 
non-epithelial cell types in order to increase the proportion of epithelial cells. At 
this point the cells were tested for SV40TAg expression and their epithelial origins. 
SV40TAg expression was identified in the nucleus of 100% of cells by 
immunohisotchemistry (figure 4.1A). A monoclonal antibody directed against 
cytokeratin 18, was used to confirm the epithelial origin of these cells. Antibody 
staining clearly showed distinct colonies of cytokeratin 18 positive and negative 
cells (figure 4.1B) demonstrating that proliferating IEC had been infected by the 
retroviral vector using this approach. There was an approximately equal number of 
positive and negative staining cells in the flask. 
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The cells in the 96 well plate were grown to confluency and wells which contained 
at least 80% cells with an epithelial-like morphology were trypsinised and these 
replated into fresh 96 well plates in order to enrich for epithelial-like cells. To try 
and obtain clonal cell lines, cells were also plated out at low density into 96 well 
plates so that each well typically contained between 0 and 3 cells. The wells were 
examined microscopically and those that appeared to contain a single cell were 
marked and examined every day to ensure that any forming colonies arose from a 
single cell. Several epithelial cell lines were generated using this protocol and 
frozen in liquid nitrogen but only a selection were characterised further. Several 
non-epithelial cell lines were also generated in this way and one cell line with a 
fibroblast-like phenotype (MIF-1) was also characterised. 
4.2.3 Preliminary Characterisation of SV40TAg Immortalised Cells 
All cell lines with an epithelial-like morphology were tested for cytokeratin 18 
expression using the monoclonal antibody and results showed that more than 95% 
of cells in each line were cytokeratin 18 positive (figure 4.1C) demonstrating they 
were of epithelial origin and suggesting they originated from undifferentiated crypt 
epithelium. In each well tested there were occasional cells which were negative for 
cytokeratin 18. The M1F-1 cell line which had a fibroblast-like morphology was 
completely negative for cytokeratin 18 expression (figure 4.1D) and was also 
negative using the pool of anti-cytokeratin antibodies, demonstrating that these 
cells were not epithelial in origin. The cytokeratin positive cell lines had the 
'cobblestone' appearance associated with many epithelial cell types in culture, but 
there was also a small number of large pleomorphic cells dispersed throughout the 
culture (data not shown). 
Expression of the intermediate filament, vimentin which is found in cells of 
mesenchymal origin was identified using a monoclonal antibody and was detected 
in all cell lines tested. This is in keeping with the results obtained from the 
organoid primary cultures which showed that all cells were vimentin positive after 
5 days in culture. 
Staining using a monoclonal antibody directed against a-smooth muscle 
actin which is normally expressed in intestinal smooth muscle cells and intestinal 
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myofibroblasts revealed that approximately 30% of the 2.9.1 cells were positive for 
a-smooth muscle actin. Similarly, the MIF-1 cell line contained approximately 15% 
a-smooth muscle actin positive cells while the remainder were negative. One 
interpretation of these results is that these cell lines were made up of a mixed 
population and were not clonal in origin. In order to try and ensure the clonality of 
the cell lines they were again plated out into 96 well plates at limiting dilutions and 
examined daily under the microscope. The cell lines were re-derived and again 
characterised using antibody staining. The results obtained were identical to those 
obtained previously. 
Cytokeratin positive cell lines were also stained for markers of intestinal 
epithelial differentiation. Cells were stained for alkaline phosphatase activity either 
at subconfluency or at 100% confluency to identify any cells with an absorptive 
enterocyte phenotype. Low levels of activity could be detected in the occasional cell 
of subconfluent cultures as judged by the intensity of coloured reaction product. 
Confluent cells showed much more intense staining but only in distinct patches of 
cells (figure 4.2A). Cells derived from CBA animals were also stained using 
Periodic Acid Schiff (PAS) to try and identify goblet cells. In approximately 10-20% 
of cells magenta staining dots could be seen in the cytoplasm. In some cells these 
dots had the appearance of large vesicles, while in other the staining was more 
punctate (figure 4.2B). These results suggest that some of the cells may be mucin 
producing goblet cells. 
Expression of Cftr was also analysed by reverse transcriptase polymerase 
chain reaction (RT-PCR). Cells were grown to confluency and total RNA was 
isolated. The RNA was reversed transcribed then amplified using primers 9A1 and 
11B which are specific for mouse Cftr. Figure 4.2C shows that the predicted 437bp 
product could be detected in all the lines tested while minus RT controls were 
negative. These results are summarised in Table 4.1. 
4.2.4 Effect of Matrigel on Cell Cultures 
The epithelial cell lines 2.9.1 and 2.6.1 were grown on a thin layer of Matrigel to see 
what effect the presence of basement membrane proteins had on the cultured cells. 





1 	2345 67 8 
437bp 
- 	 , 
Figure 4.2 Characterisation of Intestinal Epithelial Cell Lines. 
(A). MIE 2.9.1 cells grown to confluency on plastic and stained for 
alkaline phosphatase activity (red). (X50) (B). MIE 2.6.1 cells grown on 
plastic and stained with PAS. Positive staining granules (mauve) can be 
detected in a subset of cells. (X200) (C). RT-PCR of RNA prepared 
from intestinal epithelial cell lines using primers specific for mouse Cftr. 
PCR primers amplify from exon 9 to exon 11 sequences to give a 
product of 437 bp. Lane 1, size marker OX174 digested with Haelll ; lane 
2, cell line TRE1; lane 3, RT control; lane 4, cell line TRQ1 ; lane 5, -RT 
control; lane 6, cell line MIE 2.9.1; lane 7, -RT control; lane 8, positive 
PCR control plasmid. (D). MIE 2.9.1 cells grown within a thick layer of 
Matrigel for 7 days showing a 'rose stem' appearance. (X150) 
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3-dimensional aggregates rather than the monolayer obtained when grown on 
plastic. Since basement membranes are known to regulate the differentiation status 
of some cell types, the aggregates were stained for alkaline phosphatase activity to 
determine any change in their differentiation status. Unlike the cells grown on 
tissue culture plastic, the cells grown on Matrigel stained positive for enzyme 
activity suggesting that the effect of basement membrane proteins was to induce 
differentiation. 
The cell lines were also grown within a thick layer of Matrigel. The effect of 
completely surrounding the cells with basement membrane protein was the 
formation of complex branching structures which had a 'rose stem' appearance 
(figure 4.2D). Hepatocyte Growth Factor (HGF) was also added to' the culture 
medium to determine whether supplying potential morphogenic, mitogenic and/or 
motogenic signals may produce the formation of cyst-like structure seen in 
intestinal organoid primary culture. However, the addition of HGF had no 
discernible effect the morphology of the branching structures (data not shown). 
In order to assess the tumourigenic potential of these cells and to determine 
whether they were immortalised or transformed, 5 x 106  cells from three of the lines 
(2.9.1, TRE1 and TRQ1) were embedded in Matrigel and grafted subcutaneously 
into immunocompromised scid mice. These grafts were performed in duplicate. At 
graft retrieval after 12 weeks there was no evidence for the formation of any 
tumours or epithelial structures of any kind. 
Cell cytokeratin vimentin a smooth alkaline PAS Cftr 
Line 18 muscle phosphatase 
actin 
MIE + + 30% low-high 10- + 
2.9.1 20% 
TRE-1 + + ND low ND + 
MIF-1 - + 15% - ND - 
Table 4.1 Preliminary characterisation of intestinal epithelial cell lines. Expression of 
cytokeratin 18, vimentin and a smooth muscle actin identified using monoclonal antibodies. A 
+ denotes 100% of cells were positive and - denotes 100% of cells were negative. A 
percentage denotes the percentage of cells which expressed the antigen. Alkaline 
phosphatase activity determined using a chromogenic substrate and the Periodic Acid Schiff 
(PAS) stain used to identify mucin. ND, not done. 
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4.2.5 Generation of Intestinal Epithelial Cell Lines from Cfti "ru mice 
Using the same approach as described above, cell lines were generated from 
neonatal Cftr tmIHGU/ tmlHGU mice. The epithelial cell lines obtained from these 
experiments were similar to those derived from CBA and ROSA26 mice and were 
positive for cytokeratin expression. However, the level of alkaline phosphatase 
activity appeared to be greater in this cell line and appeared before the cells reached 
confluency. 
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4.3 Discussion 
The main aim of this particular piece of work was not to characterise intestinal 
epithelial cell lines in detail but to generate a resource which provide a model for 
assessing mutation correction strategies. Therefore the characterisation of the lines 
generated was by no means exhaustive. 
4.3.1 Generation of Immortalised Intestinal Epithelial Cell Lines 
Immortalisation of IEC using SV40TAg appears to have been relatively successful 
given that it has generally proved difficult to generate epithelial cell lines from the 
small intestine. Results from retroviral infection of intestinal organoids 
demonstrated an extremely low efficiency of gene transfer. It is therefore unlikely 
that there were a large number of individual immortalising events in the 
experiments and the number of clonal immortalised cell lines is probably very 
small. 
4.3.2 Phenotype of Intestinal Epithelial Cell Lines 
4.3.2A Epithelial Origin of Cell Lines 
The epithelial cell lines generated from CBA (2.9.1) and transgenic ROSA26 (TRE1 
and TRQ1) mice appear to have a relatively undifferentiated phenotype. All cell 
lines expressed cytokeratin 18 which is normally expressed in the undifferentiated 
proliferative cells of the intestinal crypts. In addition, they express Cftr which has 
also been shown to be preferentially expressed in the crypts. This phenotype might 
be expected since retroviral infection relies on proliferating cells to allow integration 
of the viral gene into the genome. Proliferating intestinal epithelial cells are 
restricted to the crypt and are relatively undifferentiated in comparison to the villus 
epithelium. Also, the primary cultures which were infected had been growing for 8 
days before the retrovirus was applied. At this time point only type 3 colonies are 
capable of epithelial proliferation. The phenotype of these colonies are described in 
chapter five, section 5.2. Approximately 95% of cells in the epithelial lines 
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described expressed cytokeratin 18 confirming their epithelial nature. In cell lines 
generated from the intestine of the 'immortomouse' which carries a temperature 
sensitive SV40TAg transgene in every cell, only 10% of cells were found to express 
cytokeratin as judged by immunohistochemistry using a polyclonal anti-keratin 
antibody. Further analysis of these cells using monoclonal antibodies specific to 
cytokeratins 8, 18 and 19 which all have their own expression pattern in the 
intestinal epithelium revealed that only cytokeratin 18 could be detected but in only 
5% of cells, suggesting that the remaining 5% of cytokeratin positive cells expressed 
another cytokeratin, possibly cytokeratin 20 which is also thought to be expressed 
in the intestinal epithelium (Calnek and Quaroni, 1993; Flint et al., 1994). However, 
the addition of the protein kinase-C activator, phorbol 12-myristate 13-acetate 
(PMA) to the culture medium induced cytokeratin expression in 100% of cells. The 
mechanism of this induction of cytokeratin expression is unclear. 
4.3.2B Differentiation Status of Cell Lines 
Expression of alkaline phosphatase, normally expressed in differentiated IEC was 
determined by a colourometric substrate assay. There was little evidence for 
expression when cells were subconfluent, although some foci of expression did 
develop in small groups of cells after reaching confluency. The human colon 
carcinoma cell lines HT-29 and Caco-2 have an undifferentiated phenotype but both 
can be induced to differentiate under certain conditions. Confluent HT-29 cells can 
be induced to differentiate by changing the carbon source in the culture medium 
from glucose to galactose (Pinto et al., 1982) or if the cells are grown in the presence 
of sodium butyrate (Barnard and Warwick, 1993). Caco-2 cells on the other hand 
spontaneously differentiate after reaching confluency over a period of 10-14 days 
(Pinto et al., 1983). The mechanism of these differentiation processes are not fully 
understood but it is interesting to note that confluency of the cells is required in 
both cases as is the case for 2.9.1 cells described here. Culture of the 2.9.1 cell line 
on top of a layer of -Matrigel induced alkaline phosphatase expression in the 
majority of cells and the formation of large cellular aggregates. This is similar to the 
effect of basement membrane proteins on the 'normal' rat intestinal cell line IEC-6 
(Carroll et al., 1988). 
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PAS staining was used to try and identify mucin expressing goblet cells and 
PAS positive material was found in 10-20% of cells in the 2.9.1 line. As well as 
mucin, the PAS stain also stains up glycogen and Paneth cell granules (Bancroft and 
Cook, 1994) and further analysis is needed to determine the nature of this staining. 
Treatment of the cells with diastase prior to PAS will inhibit glycogen staining and 
antibodies could be used to identify the contents of Paneth cell granules. 
4.3.2C Clonality of Cell Lines 
The fact that these cells have an undifferentiated phenotype and yet alkaline 
phosphatase activity and possibly mucin expression can be detected, suggests that 
these cells may represent a progenitor population which is capable of 
differentiating given the correct culture conditions. This has also been found in cell 
lines other than the HT-29 and Caco-2 cells mentioned previously (Haittunen et al., 
1996: Henderson and Kirkland, 1996). Another possibility is that these cell lines are 
not clonal. This was also suggested by the cytokeratin 18 and cc-smooth muscle 
actin expression pattern which demonstrated some heterogeneity within the 
cultures. However, this heterogeneity was still present even after two successive 
roundsof dilution plating. Each well was examined under the microscope after 
plating to identify wells which contained only a single cell. These wells were then 
examined daily to ensure that there was only a single colony present. At this stage 
a small number of wells were found to contain two growing colonies demonstrating 
that the initial judgement was not always correct, however it also demonstrates that 
daily examination was useful in identifying such wells. The possibility cannot be 
ruled out that more than one cell was present within the wells and that they were 
attached or lying sufficiently dose to one another that the resulting colony appeared 
as only a single entity. It is also possible that the a-smooth muscle actin positive 
cells represent a sub-population which are necessary for epithelial survival and 
therefore the generation of epithelial cell lines is actively selecting for wells 
contaminated with this non-epithelial cell type. In the small intestine, a-smooth 
muscle actin is not only found in smooth muscle cells but also in myofibroblasts 
which closely associate with the proliferative epithelium and have been suggested 
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1997; Ratineau et al., 1997). A similar result was obtained by investigators 
generating testicular cell lines from mice (Paquis-Flucidinger et al., 1993). Their 
initial lines contained distinct cell populations which displayed either germinal or 
Sertoli cell characteristics. Despite isolating individual colonies, lines which 
displayed onlygerminal or Sertoli cell characteristics could not be obtained and 
both cell types were always found together. 
4.3.2D Effect of Basement Membrane Proteins on Cell Culture 
Basement membrane proteins had a marked effect on cells in culture. The 
differentiated cellular aggregates formed on thin layers of Matrigel are not seen 
when grown within thick Matrigel layers where the cells are surrounded by 
basement membrane proteins. Instead, the cells form branching structures with a 
'rose stem' appearance. Branching morphogenesis is a vital process during lung 
(Thomas and Dziadek, 1994; Miettinen et al., 1997) and mammary gland 
development (Sympson et al., 1994) and has been shown to be regulated by the 
ECM. However branching morphogenesis is not a function of intestinal epithelial 
cells in vivo. 
4.3.2E Tumourigenic Potential of Cell Lines 
Some cell lines are capable of unlimited proliferation but maintain some degree of 
growth regulation and maintain some of the characteristics of their normal 
differentiated phenotype. These are referred to as immortalised cells, whereas cell 
lines which have lost these differentiated characteristics altogether and are no 
longer under the same growth restraints are said to be transformed. The acquisition 
of transformed characteristics is sometimes associated with the ability to form 
tumours when grafted into animals. These cell lines have been continually 
passaged for up to 10 months and would appear to be immortalised cell lines, 
- - -- 	however preliminary analysis suggests ihat the cells havienot been -transformed. - 
This also appears to be the case with many other reported SV40TAg immortalised 
intestinal epithelial cell lines (Emami et al., 1989; Vincentini et al., 1996; Whitehead 
and Watson, 1997). 
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4.3.3 PyLT Transgenic Mice 
Theoretically it should have been easier to generate cell lines from the PyLT 
transgenic mice than from retroviral transfection of organoids because every single 
cell will contain the transgene. The fact that I was unable to extend the life-span of 
any cells in the organoid primary cultures suggests that the transgene is not active 
or at least not sufficiently active to allow successful immortalisation, however it 
may be that polyoma large T antigen is unable to immortalise murine intestinal 
epithelial cells. The latter option is unlikely since polyoma large T antigen has been 
used to immortalise a variety of cell types. Also, the organoid primary cultures 
contain a heterogeneous mix of cells which would mean that PyLT was also unable 
to immortalise other intestinal cell types such as fibroblasts and smooth muscle 
cells. There is in fact considerable evidence to suggest that transgene expression is 
insufficient or indeed completely lacking. Firstly, the wild type polyoma virus 
when injected into newborn mice is capable of forming tumours in a wide range of 
tissues(for review see Gross, 1983; Eddy, 1969) demonstrating that gene expression 
is possible in a wide range of tissues. However, in previous experiments transgenic 
mice carrying either the large T or middle T gene under the control of polyôma 
early region regulatory sequences (Bautch et al., 1987) only expressed the transgene 
in the testes and in the hemangiomas which developed in these animals. The 
transgenic animals used in this experiment use the polyoma complete enhancer-
promoter region to drive transgene expression and are essentially normal except for 
the late development of testicular tumours (Paquis-Flucklinger et al., 1993). Indeed 
it was found that polyoma RNA could only be detected in the testes of these mice 
using Northern blot analysis, although lower levels could also be detected in the 
kidneys using more sensitive techniques. This suggests that the lower levels were 
insufficient to induce abnormal growth patterns in these cells. Secondly, it has also 
been shown in transgenic mice carrying the wild type polyoma early enhancer 
attached to the chioramphenicol acetyl transferase (CAT) reporter gene that this 
enhancer exhibits only very low activity in the mouse intestine (Krippl et al., 1988), 
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4.3.4 Immortalisation of Intestinal Epithelial Cells 
Another approach to generate cell lines would have been to use the so-called 
'immortomouse' which is a transgenic animal carrying a temperature sensitive 
mutant of the SV40TAg gene under the control of the H-2k" promoter (Jat et al., 
1991). The H2kb  gene is a member of the major histocompatibility complex and is 
expressed by most cell types but at a very low level. The activity of this promoter 
however can be increased by ?-interferon. The immortomouse is therefore perfectly 
viable because the mutation in the SV40TAg gene results in a protein which is 
optimally active at 33°C and relatively inactive at 37°C. This system would be 
extremely beneficial because there is no need to introduce the immortalising gene 
into the cells. It should therefore be possible to isolate cells from these mice and 
grow them at the permissive temperature of 33°C in the presence of y-interferon to 
generate cell lines. This approach has been used successfully to generate epithelial 
cell lines from both the small and large intestine of these mice (Whitehead et al., 
1993). However, in order to generate cell lines from mice carrying this transgene as 
well as a Cftr mutation the transgene would have to be bred onto one of the Cftr 
mutant lines. 
There have been several attempts to generate cell lines by introducing viral 
oncogenes into intestinal epithelial cells (Moyer and Aust, 1984; Emami et al., 1989; 
Chastre et al., 1991). SV40 large T antigen was found to be capable of generating 
immortalised cell lines as was the early gene E1A from adenovirus (Emami et al., 
1989). As in primary cultures of IEC, the ability to immortalise IEC with SV40TAg 
was successful only when using cell isolation techniques which resulted in the 
culture of cell aggregates rather than single cells. Also, there has been a tendency to 
use foetal tissue presumably due to the increased ability to survive in culture. It 
could be argued that the success of these attempts to immortalise IEC relies on the 
proliferative nature of these cells which is necessary for the viral DNA to integrate. 
- - 
 
However,-- it may -be - that-- -successful immortalisation- -not- only requires -cell ----- --- --
proliferation, but also requires that SV40TAg is active in early undifferentiated cells. 
There are several pieces of support for this. Firstly, the culture techniques used in 
these experiments either used undifferentiated foetal cells or culture systems, such 
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as the one used in the experiments described here, which contain cells with a large 
proliferative capacity indicative of an undifferentiated progenitor population. 
Secondly, in the generation of immortalised IEC lines from the H-2K'-tsA58 
'immortomouse', intact crypts were cultured in which every single cell carries and 
is capable of expressing the SV40TAg gene. When these crypts are cultured at the 
permissive temperature of 33°C in the presence of interferon-y, the crypts adhere to 
the culture dish and form small epithelial islands. Despite the expression of 
SV40TAg in all the cells, the vast majority of cells die until only a small number of 
cells remain in the centre of each island. The cell lines obtained are derived from 
these small number of proliferating cells. Therefore in each crypt which contains 
many proliferating cells with gradations in their degree of differentiation there is 
only a small number of cells capable of immortalisation. It may be that this 
corresponds to the small number of stem cells which exist in each intestinal crypt. 
The third piece of evidence comes from the analysis of transgenic mice which carry 
an SV40TAg transgene under the control of a region of the rat intestinal fatty acid 
binding protein gene (Hauft et al., 1992). The transgene is active only in the 
uppermost portion of the small intestinal crypts and along the entire length of the 
villus and therefore not active in stem cells or their immediate progeny. These mice 
show no evidence of immortalisation of IEC and the only reported phenotypic 
difference between these transgenic animals and their wild-type littermates was 
increased crypt cell proliferation and the re-entry of differentiated vilus associated 
enterocytes into the cell cycle. 
It has long been presumed that intestinal tumourigenesis results from an 
accumulation of damaging mutations in the epithelial stem cell population (Fearon 
and Vogelstein, 1990) since these are the only cells which are physically present 
long enough in the intestine to accumulate such mutations. However, it may be 
that not only are these cells present for a sufficient time, but they are the only 
epithelial cells in the intestine which are capable of immortalisation and therefore of 
ultimately becoming tumourigenic. 
The cell lines generated in these experiments appear to have been 
successfully immortalised by SV40TAg. The epithelial lines display a relatively 
undifferentiated phenotype based on the expression of various markers, which is 
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unsurprising given the use of a retroviral vector to deliver the immortalising gene. 
These cell lines provide a potentially useful system to study the regulation of 
intestinal epithelium while the generation of cell lines from CF mutant mice 
provides a useful resource to test mutation correction strategies in a relevant cell 
type. 
Chapter Five 
Primary Culture of Mouse Intestinal Organoids 
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5.1 Introduction 
An ex vivo approach to somatic gene therapy requires the removal of the host's cells 
from the tissue of interest and their successful maintenance in culture so that DNA 
can be delivered to the cells. The cells must not only remain viable in culture but 
must retain their ability to carry out their normal function when grafted back into 
the host. This is particularly important when using a stem cell population since 
they must be able to function as pluripotent progenitor cells capable of tissue 
regeneration following grafting. 
Normal mammalian cells when removed from their natural environment 
and placed into a laboratory environment do not survive for long. The provision of 
appropriate nutrients can support the viability of normal cells for a considerable 
length of time but their phenotype can change dramatically. Many problems exist 
in determining the correct requirements of different cell types for successful culture. 
The constituents of the tissue culture medium used is very important and the 
addition of serum, hormones and growth factors to basic culture medium, as well as 
the extracellular environment can have a major effect on cultured cells. A primary 
culture is defined as the culture of freshly isolated cells from the original soiirce, 
without further subculturing. Depending on the method used for tissue isolation, 
these may be a heterogeneous or homogeneous population of cells. These cells are 
not immortalised and so tend to reflect the normal characteristics of the original 
tissue. There are many cell types which can be grown successfully in primary 
culture, but changes may occur during the culture period, such as de-differentiation 
(Jamous et al., 1993; Negoescu et al., 1995; Walter and Miller, 1996; Benardeau et al., 
1997). The majority of primary cultures are established for the purpose of studying 
normal cell function in vitro and so requires that a normal differentiated phenotype 
is maintained. Careful use of cell isolation procedures and suitable culture 
conditions has made this possible for a number of different cell types such as 
hepatocytes (Isom et al., 1985), neurons (Ray et al., 1993), airway epithelium 
(Chevillard et al., 1993), proximal tubule cells (Courjault-Gautier et al., 1995) and 
pneumonocytes (Alcorn et al., 1997). However, attempts to grow intestinal 
epithelial cells (IEC) in culture have met with limited success. The majority of small 
100 
Organoid Primary Culture 	 Chapter Five 
intestinal epithelial cells in the mouse have an extremely short life-span of 
approximately 2-3 days (Wright and Alison, 1984). The extreme brevity of their 
existence in vivo does not make them particularly amenable to long term culture in 
vitro. The intestinal epithelium of the adult mouse is in a steady state condition 
which means that as a consequence of active cellular proliferation there must be an 
equally high level of cell loss. The method by which cells are removed from the 
intestinal epithelium is still unclear. In most text books it is stated that epithelial 
cells are removed from the intestine by extrusion of cells into the lumen once the 
cells had reached the upper regions of the villi (Alberts et al., 1994; Morson and 
Dawson, 1979; Segal and Petras, 1992). This is based on cytological examination 
and DNA content of washings from the small intestine (Pink et al., 1970) as well as 
inference from the kinetics of the intestinal epithelium. This view is now being 
challenged with evidence that apoptosis may play a critical role in controlling 
epithelial cell turnover in the small intestine. Spontaneous apoptosis occurs in the 
stem cell zone of the small intestine but not in the colon, conversely bcl-2 (a gene 
involved in the suppression of apoptosis) expression is found in the stem cell zone 
of the colon but not the small intestine (Merritt et al., 1995). Spontaneous apoptosis 
may be a method of regulating (stem) cell number in small intestinal crypts, and 
may account for the low rate of tumour formation in this tissue. The role of 
apoptosis at the villus tip is more controversial (Jones and Gores, 1997). Hall et al. 
(1994) studied the level of apoptosis at the villus tip of both mouse and human 
tissue using a mixture of in situ end labelling (ISEL) and histology. They concluded 
that the level of apoptosis at the distal end of the viffi is sufficient to account for 
most, if not all of the intestinal epithelial cell loss. It could be argued that the end 
labelling technique (also known as TUNEL) will overestimate the number of 
apoptotic cells because it has been reported that it cannot distinguish between 
necrotic and apoptotic cells (Grasl-Kraupp et al., 1995). However, apoptotic cells 
have been described at the villus tip by electron microscopy (Shibahara et al., 1995), 
and expression of the apoptosis associated gene bax is detected in this region of the 
- villus (Krajewski et al., 1994; Potten et al., 1997), suggesting that. apoptosisis - - 
triggered in at least some cells. It is likely that removal of cells from the villus tip 
involves both apoptosis and extrusion. Apoptosis in the small intestine can be 
readily induced by even small amounts of ionising radiation (Potten, 1977) and the 
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level is greatest in the stem cell zone, suggesting that these cells are extremely 
sensitive to cell/DNA damage. These facts and the short life span of JEC in vivo 
may explain why it has proven so difficult to culture these cells in vitro. Removal of 
JEC from the intestine and placing them in culture is undoubtedly a stressful 
procedure for the cells, and may well induce apoptosis in the stem cell population. 
The remaining differentiating IEC are destined to terminally differentiate after only 
a few days, and may be programmed to eventually undergo apoptosis or may 
require special signals to inhibit apoptosis. 
The successful maintenance of intestinal epithelial stem cells in vitro per se 
does not appear to have been the specific aim of any published attempts at JEC 
culture. Most, if not all attempts have been for the purpose of studying the function 
of differentiated epithelial cells in a controlled environment. Isolated individual 
intestinal epithelial cells will only last 2-3 hours before viability is lost in culture, 
therefore other methods of culturing these cells have been developed. 
5.1.1 Organ Cultures 
In organ cultures, pieces of intact tissue are removed and placed in culture so that 
the correct tissue architecture and cellular associations are maintained. Some early 
approaches were relatively simple and involved immersing small fragments of 
intact intestine in oxygenated buffer solutions (Deschner et al., 1963). However, 
cells were only capable of surviving for a matter of hours before rapid degeneration 
took place. Other systems did actually involve culturing tissue explants (such as 
human biopsies of rectal (Eastwood and Trier, 1973) or small intestinal mucosa 
(Browning and Trier, 1969) in culture medium in order to provide nutrients to 
maintain cell viability and function for longer periods of time. Attempts at organ 
culture using post natal rodent intestine were also able to maintain the viability and 
function of intestinal cells for a period of up to 48 hours before rapid tissue 
degeneration occurred (Kedinger et al., 1980). 
Greater success was achieved using embryonic rodent intestinal fragments 
for organ culture (DeRitis et al., 1975; Calvert and Micheletti, 1981). It was shown 
that not only could the tissue be maintained in culture for at least 72 hours, but that 
the embryonic tissue was able to continue normal development from a stratified 
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multilayered epithelium to a cuboidal monolayered epithelium covering intestinal 
villi. Fine structural analysis however revealed that although 3 intestinal epithelial 
cell types could be identified, full differentiation was never achieved. 
Experiments using intestinal fragments isolated from various regions of the 
GI tract of rats at different stages of development (Kondo et al., 1984; 1985) revealed 
some interesting results. It was found that culturing GI tissues such as the 
oesophagus and the forestomach which are lined with squamous epithelium, 
readily produced monolayers of epithelial cells which form cornified envelopes. 
These cultures could be maintained for 2-6 months during which time confluency 
was reached. Moreover, the cultures were just as successful when derivedfrornE13 
foetal tissue as they were from P21 postnatal tissue. In contrast however, attempts 
to culture epithelium isolated from the glandular stomach and the small and large 
intestine showed that although tissue fragments could be cultured and epithelial 
monolayers obtained, proliferation ceased after 10-14 days. Interestingly, tissue 
obtained from rat jejunum and ileum were only able to produce monolayers of cells 
when derived from embryonic tissue. Unlike the oesophagus and forestomach, no 
monolayers were obtained from small and large intestinal fragments derived from 
newborn or neonatal animals. They also showed that the ability of explants to 
support epithelial proliferation in vitro increased as the age of the tissue increased 
from E13 to E17. This ability then decreased as older tissue was used until, using 
tissue from newborns, no proliferation was detected. This maximal proliferation at 
E17 coincides with the beginning of intestinal differentiation where the stratified 
epithelium is converted into a columnar monolayer covering the newly formed villi. 
Experiments by Quaroni (1985) showed that E18 rat intestine could be cultured for 
up to a month in suspension cultures. However, intestinal cells inside the tissue 
explant die rapidly and only cells at the ends of fragments are viable and proliferate 
to cover the tissue fragment with an epithelial monolayer. Tissue derived from 
animals older than E19 showed a progressively smaller yield of cultured tissue with 
less morphologically preserved cells. This provides further evidence that after the 
intestinal endoderm differentiates into a columnar intestinal epithelial monolayer, 
the ability of these cells to proliferate in culture becomes increasingly difficult. 
Organ culture is unlikely to prove useful for ex vivo gene therapy for several 
reasons; 1. there is little evidence to believe that stem cell viability and function is 
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maintained during organ culture. This may be due to unsuitable culture conditions 
or it may be a result of insufficient oxygenation and nutrient supply to intact pieces 
of tissue while in culture; 2. delivery of DNA into the stem cell population will most 
likely be problematic because of their location near the base of the intestinal crypts 
which remain intact; 3. the tissue fragment maintained in culture will have to be 
removed from the animal and, even if DNA can be successfully delivered into the 
stem cell population and can correct the Cftr mutation, this piece of tissue must be 
returned to the intestine of the original animal which would be an extremely 
complicated surgical procedure; 4. success with intestinal organ culture for more 
that 48 hours has so far only been possible with foetal intestine and more work 
must be done before post natal -tissue could be used. 
5.1.2 Primary Cultures 
Intestinal primary cultures have been used in a similar manner to organ cultures, 
i.e. as a way to obtain and study differentiated intestinal epithelial cells in vitro. 
Indeed many primary cultures are derived from the proliferating cells of tissue 
exp1ans (for review see Evans et al., 1994). The main advantage of primary cultures 
over organ cultures is that characterisation of IEC proliferation and differentiation 
can be studied at a more detailed level, even down to individual cells. One of the 
disadvantages is that the cultures usually contain a disorganised heterogeneous mix 
of epithelial and non-epithelial cell types which may complicate the interpretation 
of some results. 
Tsuchiya and Okada (1982) showed thatvilus fragments of newborn rat could be 
cultured with epithelia remaining viable for up to 4 weeks although deterioration 
was apparent after 2 weeks. Tissue fragments from the villus tip did not adhere to 
the culture dish and despite remaining viable, showed no evidence of cell mitosis 
while in culture. Intestinal fragments from the base of the villi contained cells from 
the developing crypts. These fragments did adhere to the culture dish and an 
expanding monolayer of cells grew out from the original piece of tissue where 
mitotic figures could be identified. 
Montgomery (1986) isolated a heterogeneous mix of intestinal cells by 
trypsinisation of E18 rat intestine. These cells grown in culture on plastic for 6 days 
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formed cell mounds which consisted of an epithelial monolayer covering a dome of 
mesenchymal cells. Small epithelial covered protrusions could be identified from 
the cell mound which contained at least 2 differentiated epithelial cell types. 
Culturing these cells on top of a collagen gel gave the same result but if a further 
layer of collagen gel was applied on top of the mounds, large vesicle were formed 
which were stable for up to 14 days in culture. The vesicles were lined with 
epithelia, the majority of which, after 7 days in culture, were mitotically active. The 
same cells cultured within a collagen matrix (Montgomery et al., 1983) were unable 
to form any 3-dimensional structures and after 7 days in culture, the cells were 
found throughout the matrix only as single cells or small aggregates. HOwever, 
these cells were able to form differentiated intestinal structures when - grafted 
subcutaneously into syngeneic hosts. This suggested that stem cells derived from 
embryonic tissue could be grown in culture and maintain their stem cell properties. 
Attempts to culture pure populations of IEC have met with varied success. 
A mixture of collagenase and dispase was used to digest adult human colonic 
mucosa (Gibson et al., 1989). This resulted in the isolation of colonic epithelial 
crypts which were reported to have no basement membrane supporting them or 
any mesenchymal contamination. Culture of these crypts produced limited 
epithelial proliferation for approximately 3 days but the majority of cells are dead 
by 7 days. - A similar approach using adult mouse colonic tissue (Booth et al., 1995) 
showed an increase in cell number up to 9 days in culture, and viability was 
maintained for up to 35 days. Although precise numbers are not given there is a 
level of mesenchymal contamination within these primary cultures. The 
contribution of these cells to the success of the cultures is not clear. Attempts to 
passage the cultured cells on to secondary cultures were unsuccessful. 
The importance of supporting mesenchymal cells in regulating JEC function 
in vivo is well known but their importance for successful in vitro epithelial survival 
was not known. In order to-resolve this issue, Fukamachi (1992) isolated an almost 
pure intestinal epithelial population of cells from E16.5 foetal rats and cultured 
- them on a collagen gel in serum free medium. Single cells were unable to be grown 
in culture but cell aggregates adhered quickly and proliferated rapidly. Cells 
survived up to 4 weeks in culture but secondary cultures were unsuccessful. The 
cells maintained their epithelial phenotype during culture but were unable to 
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differentiate. The conclusion from this work was that mesenchymal cells are not 
required for IEC proliferation but that they may be necessary for differentiation. 
The small proportion of contaminating mesenchymal cells however, mean that this 
question has not been fully answered. Some apparently normal epithelial cell lines 
have been generated from intestinal explants (Quaroni et al., 1979) which retain an 
undifferentiated phenotype and are uncontaminated with mesenchymal cells. 
Using similar isolation techniques, Haffen et al. (1981) generated an epithelial cell 
line from neonatal rat intestine which were able to generate an intestinal 
architecture upon association with chick embryonic intestinal mesenchyme in vivo. 
Summing up the results from a large number of experiments by a large 
number of different groups indicates that human intestinal tissue is easier to culture 
than rodent tissue, the small intestine is the most difficult tissue to culture 
compared to the other regions of the CI tract and embryonic tissue was much easier 
to maintain in culture than post natal tissue. This means that attempts to culture 
post natal mouse small intestinal cells for gene therapeutic purposes coud prove 
difficult. It was decided to use a cell isolation technique published by Evans et al. 
2.  (1992) for several reasons. The success of this technique appears to he with the 
relatively gentle manipulation procedures used, and the maintenance of cell-cell 
and cell-ECM communication. The isolation procedure produces aggregates of sells 
containing both epithelial and mesenchymal populations. Culture of these 
aggregates from the rat gives rise to both epithelial and mesenchymal proliferation. 
Moreover, the cells can be maintained in culture for up to a month, which is a 
significant improvement on other systems using post natal tissue. Most 
importantly, Tait et al. (1994b) had shown that using this same technique, the 
isolated cells could be grafted into denuded rat colonic muscle in situ and were able 
to generate a small intestinal mucosa. This shows that the isolation procedure as 
well as maintaining the capacity for epithelial proliferation, also maintains 
intestinal epithelial stem cell properties. I therefore decided to try this isolation 
technique on neonatal mouse small intestine and attempt to culture the resulting 
cellular aggregates. 
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5.2 Results 
5.2.1 Establishment and Characterisation of Organoid Primary Cultures 
Intestinal tissue used in these experiments was obtained from neonatal mice aged 
between 5-7 days. At this stage of intestinal development in the mouse the 
intestinal epithelium contains villus and early crypt structures covered by a 
monolayer of polarised cells. Epithelial cell proliferation is already restricted to 
these early crypts (O'Connor, 1966; Al-Nafussi and Wright, 1982). The small 
intestine is removed from the mouse and subjected to digestion with a mixture of 
dispase and collagenase as described in 8.1.6 to produce a collection of cellular 
aggregates (figure 5.1). These aggregates, or intestinal organoids as they have been 
called, are then plated onto plastic coated tissue culture dishes in DMEM growth 
medium supplemented with 10% FCS and antibiotics. After assessing the culture of 
intestinal organoids at a variety of densities, a concentration of -1 x 10 4 per 60 x 
15mm culture dish was regularly used. Organoids plated at this density gave a 
sufficient number of colonies per plate to allow identification and characterisation 
of individual colonies. 
After 24 hours only a small percentage of the organoids have stuck down 
onto the culture dish. The vast majority (-90-95%) of organoids have either 
dissociated into single cells or are still present as intact aggregates but are floating 
in the growth medium. At this point the growth medium is changed and any non-
adherent organoids are removed. Over the next 48 hours, the majority of colonies 
show an increase in cell number with cells proliferating out from the organoid. 
Most of the cells proliferating from the organoids had an epithelial morphology, 
although some colonies did appear to consist of fibroblasts or smooth muscle-like 
cells. However, not all organoids produced a sheet of cells and these organoids 
remained as isolated mounds of cells. After 48 hours the majority of epithelial cell 
sheets had ceased to increase in size and any increase in cell number was restricted 
to cells of a fibroblast and smooth muscle-like morphology. The central organoid in-
these colonies was larger than at the time of plating but by this time, the structure 
had altered so that it appeared to have collapsed. Certain organoids in culture 
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Figure 5.1. Intestinal organoids. 
Isolated organoids from neonatal mouse small intestine. Organoids 
are cellular aggregates, the majority of which consist of an outer 
layer of epithelial cells surrounding an inner core of mesenchymal 
derived cells. (X75) 
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exhibited rhythmic contractions which were presumably due to functional activity 
of smooth muscle cells lying below the epithelium. 
Approximately 1-2% of colonies which contained epithelial-like sheets did 
not stop proliferating after 48 hours and continued to increase in size for up to 2 
weeks, producing large sheets of epithelial cells surrounding a small central 
organoid. In contrast to the other colonies, the organoids at their centre still had the 
appearance of a small dome of cells and appeared relatively unchanged from the 
time of plating. 
The primary cultures were characterised by studying firstly the size and 
morphology of the colonies along with their proliferative capabilities. Secondly, 
more detailed information was obtained using histological stains, 
immunohistochemistry and detection of alkaline phosphatase activity. Colonies 
consisting of cytokeratin negative, vimentin positive cells with a distinct fibroblastic 
or smooth muscle morphology were not analysed further. The data obtained from 
the primary cultures revealed that each epithelial colony could be categorised into 
one of 3 distinct types. 
Type 1. Approximately 1-5% of 'colonies' are composed essentially of the original 
organoid and show little or no increase in size, however some vimentin positive 
mesenchymal cells can be seen proliferating out from the base of the organoid (data 
not shown). Alkaline phosphatase activity (a marker of differentiated epithelium) 
could be detected only in the cells covering the organoid, reflecting their 
differentiated status, and not in the surrounding mesenchymal cells (figure 5.2A). 
All cells appeared negative for cytokeratin 18 which is expressed in the 
undifferentiated crypt epithelium of the rodent intestine (Calnek and Quaroni, 
1993). These results are consistent with the original organoid containing villus 
derived epithelial cells which have a differentiated phenotype with little or no 
proliferative capacity. 
Type 2. These made up the vast majority of epithelial colonies in which cells 
proliferated rapidly for -2 days before proliferation ceased. The colonies were 
positive for alkaline phosphatase activity (figure 5.213) and negative for cytokeratin 
18. Surrounding the colonies were a number of mesenchymal cells negative for 





Figure 5.2. Primary culture of intestinal organoids. 
(A). Type I colony stained for alkaline phosphatase activity (red) after 5 days in 
culture. Cells which make up the original organoid (arrow) stain positive reflecting 
their differentiated epithelial phenotype, but surrounding fibroblast-like cells are 
negative. Little or no epithelial proliferation is seen from these colonies. (X70) (B). 
Type II colony stained for alkaline phosphatase activity after 4 days in culture. Cells of 
the original organoid (arrow) and the newly generated surrounding epithelial cells are 
positive reflecting their differentiated phenotype. These cells are negative for 
cytokeratin 18 and proliferation within these colonies ceases after approximately 48 
hours. (X70) (C). Type Ill colony stained for cytokeratin 18 (brown), a marker for 
undifferentiated crypt epithelium, after 8 days in culture. All cells including those of the 
original organoid (arrow) are positive. Proliferation within these colonies continues for 
up to 2 weeks in culture. These cells are negative for alkaline phosphatase activity 
confirming their undifferentiated phenotype. (x50) (D). Edge of a type Ill colony 
showing the difference between the cytokeratin 18 positve (brown) epithelial cells and 
the negatively staining mesenchymal cells which surround all epithelial colonies 
(arrowheads) (X60) 
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amplifying cells which are destined to terminally differentiate after a limited 
number of cell divisions. 
Type 3. Approximately 1% of colonies exhibited a large capacity for proliferation 
which was sustained for up to 2 weeks producing a large sheet of epithelial cells. 
These cells were found to be negative for alkaline phosphatase activity but positive 
for cytokeratin 18 (figure 5.2C, and D). Again, these colonies were surrounded by a 
number of mesenchymal cells. This is consistent with the original organoid 
containing at least one undifferentiated epithelial cell with a large proliferative 
capacity suggesting either a stem cell or at least an early daughter cell. 
Immunohistochemistry performed on the cultures using an antibody 
directed against the intermediate filament vimentin which is specific to cells of 
mesenchymal origin (Nagle, 1994) demonstrated that vimentin expression could be 
identified in all cells after 5 days in culture (figure 53A). This result suggests that 
the epithelial cells in culture are undergoing a change in their differentiation status 
more reminiscent of mesenchymal cells. Despite this, the cells of type 2 colonies are 
still positive for alkaline phosphatase activity and the cells of type 3 colonies are 
still positive for cytokeratin 18 suggesting a phenotype between that of epithelial 
and mesenchymal cells. This may simply be a change in the differentiation status of 
the epithelium due to the effects of primary culture. A similar phenotype has been 
seen in certain cancers and has been referred to as an interconverted phenotype 
(Hendrix et al., 1996), and is associated with increased invasiveness and metastasis. 
Cytokeratin expression, as shown by immunohistochemistry using a pan-
cytokeratin antibody revealed some interesting differences between the 3 types of 
epithelial colonies. While the non-proliferative type 1 colonies which are essentially 
single organoids were positive (data not shown), the type 2 colonies showed a 
gradation of cytokeratin expression. The central region of the colony which 
contains the remnants of the organoid always stained strongly positive, while the 
cells surrounding the organoid showed a gradual decline in cytokeratin levels as 
their distance from the original organoid increased (figure 5.313). Type 3 colonies on 
the other hand were always strongly positive no matter how far away they were 
from the original organoid (figure 53C). 
Type 3 colonies would appear to consist of undifferentiated intestinal 






Figure 5.3. Expression of epithelial and 
mesenchymal markers. 
(A). Vimentin expression of type II epithelial colony and 
surrounding mesenchymal cells after 5 days in culture. 
(X60) (B). Cytokeratin expression as detected by a pan-
cytokeratin antibody in a type II colony after 4 days in 
culture. Cytokeratin expression is strongest in cells of 
the original organoid (arrow) and the immediate 
surrounding cells. Staining intensity decrease as 
distance from the organoid increases. (X75) (C). 
Cytokeratin expression as detected by the pan-
cytokeratin antibody in a type II colony adjacent to a 
type Ill colony (*). While the staining decreases in the 
epithelial cells at the edge of the type II colony, the 
intensity of staining of cells in the type Ill colony 
remains constant. (X75) 
Organoid Primar3, Culture 	 Chapter Five 
phosphatase activity. It might be expected that during their time in culture this 
phenotype would change and that these cells might differentiate. However, even 
after one month in culture these colonies retained their original phenotype 
suggesting that in vitro differentiation of these cells was not taking place. 
5.2.2 Effect of Substratum on Organoid Cultures 
To assess the effect of the substratum on epithelial proliferation, differentiation and 
survival, organoids were cultured on a variety of different surfaces. Organoids 
were cultured on non-tissue culture plastic, tissue culture plastic alone, or tissue 
culture plastic coated with collagen IV, laminin, gelatin or a commercially available 
complex mixture of ECM proteins (Matrigel or ECM gel). The organoids were 
cultured on the various substrata and compared at a gross level to organoids 
cultured on tissue culture plastic alone. 
Organoids cultured on collagen IV, laminin or gelatin coated tissue culture 
plastic showed no gross differences to those grown on tissue culture plastic alone. 
However, organoids cultured on non-tissue culture plastic or grown on 
Matrigel/ECM gel showed significant differences. Initially, organoids grown on 
non-tissue culture plastic behaved in a similar manner to those grown on tissue 
culture plastic (figure 5.4A). The number of organoids which adhered to the culture 
dish remained the same and all 3 types of epithelial colony could be identified 
within the cultures. Changes in the morphology of the colonies became apparent 
after 4 or 5 days. The epithelial cells began to retract in towards the central 
organoid source so that they appeared as much tighter colonies without the 
intercellular spaces commonly found within colonies grown on tissue culture 
plastic (figure 5.413). Contraction of the colonies continued until the cells of each 
colony formed a large single mass (figure 5.4C). This cell mass remained adherent 
to the culture dish for the duration of the culture and no other gross changes were 
noted. This effect was seen in both type 2 and type 3 colonies. 
Intestinal organoids cultured with Matrigel were grown either on top of a thin layer 
of Matrigel or embedded within a thick layer. Organoid adhesion to Matrigel was 
greatly increased compared to any other substratum with almost all intact 
organoids attaching after overnight incubation. Despite the increase in adhesion, 
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Figure 5.4. Substratum effects on organoid primary culture. 
A-C Organoids cultured on top of non-tissue culture plastic (A). After 3 days in 
culture, organoids appear similar to those grown on normal tissue culture dishes. 
(X100) (B). After 4-5 days in culture the colonies begin to contract and the colonies 
become more compacted. (X100) (C). After 7 days in culture the epithelial cells have 
contracted into a large ball of cells and only fibroblast-like cells remain attached to the 
plastic surface. (X100) D-E Organoids cultured in the presence of Matrigel. (D). 
Organoids grown on top of a thin layer of Matrigel produce a confluent sheet of tightly 
packed epithelial cells which proliferate out from the original organoid (arrow). (X100) 
(E). Organoids grown within a thick layer of Matrigel generate cyst-like structures (*) 
composed of a central lumen lined by a layer of epithelial cells (arrow). (X70) 
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organoids remained as relatively intact structures and no cell proliferation could be 
detected even after 5 days. This effect may have been due to the presence of TGFt3 
within the Matrigel (Vukicevic et al., 1992) which has been shown to have a growth 
inhibitory effect on intestinal epithelium (Barnard et al., 1989). The experiment was 
repeated, this time adding hepatocyte growth factor (HGF) at 20ng/ml to the tissue 
culture medium. This growth factor has a wide range of mitogenic, motogenic and 
morphogenic effects on different epithelial cell types (for review see Rosen et al., 
1994) and has been shown to counteract the inhibitory effects of TGFf. on epithelial 
morphogenesis (Santos and Nigam, 1993). Organoids grown on top of a Matrigel 
layer were now able to proliferate and produced similar colonies to those described 
previously although the epithelial cell contacts appeared much tighter than when 
grown on plastic (figure 5.413). The non-proliferative organoids which normally 
remain in suspension, stay attached to the Matrigel. After the first 24 hours, a 
transparent ring could be seen in the Matrigel surrounding these organoids. The 
size of this ring increased over the following 24 hours until the organoids were 
removed when the culture medium was changed. The ring surrounding these 
organoids appeared to be degradation of the Matrigel and may have been due to 
the release of proteolytic enzymes from the particular organoids. The most 
dramatic effect was seen with organoids cultured within a thick layer of Matrigel. 
which appeared to form cyst structures composed of an epithelial layer 
surrounding a central lumen (figure 5.4E). These structures were positive for 
alkaline phosphatase activity (data not shown) demonstrating a differentiated 
phenotype. 
5.2.3 Effect of different culture media on primary cultures 
The composition of culture medium can have a large effect on cell proliferation, 
differentiation and survival. Evans et al. (1992) in their original rat primary culture 
paper examined the effects of epidermal growth factor (EGF), transferrin and 
insulin on rat intestinal organoid cultures. They were able to optimise the culture 
medium to give maximal epithelial proliferation with minimal mesenchymal 
growth. In an attempt to specifically improve stem cell survival, mouse intestinal 
organoids were cultured in medium already known for its ability to support the 
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proliferation and maintenance of undifferentiated pluripotential cells. Conditioned 
medium from Buffalo rat liver cell (BRL) cultures was used to maintain the 
undifferentiated state of mouse derived ES cells before the discovery of Leukaemia 
Inhibitory Factor (LIF), the factor responsible for the maintenance of ES cells in vitro. 
Since this discovery, ES cells can now be cultured in commercial culture medium 
supplemented with LIF. In this laboratory we use Glasgow Minimal Essential 
Medium (GMEM) with added supplements for ES cell culture. The culture of 
mouse intestinal organoids in either BRL conditioned medium or LIF containing ES 
cell medium did not appear to have any gross effect on organoid culture and no 
difference in the number of type 3colonies obtained. 
Glutamine is the principal energy source for small intestinal enterocytes. In 
conjunction with this role, glutamine has also been shown to increase DNA 
synthesis and cell number as well as induce villus formation of embryonic 
endoderm in culture (Beaulieu and Calvert, 1985). Although these results suggest a 
role for glutamine in promoting IEC differentiation, it has also been shown that 
glutamine can inhibit the differentiation and increase the proliferation rate of two 
different intestinal epithelial cell lines (Turowski et al., 1994). Glutamine has also 
been shown to stimulate growth of intestinal mucosa in vivo, a process which is 
mediated by EGF (Ko et al., 1993). There has also been some evidence that insulin-
like growth factor-il (IGF-II) inhibits the differentiation of IEC in culture (Zarrili et 
al., 1996). Addition of either IGF-H (0-20ng/ml) or glutamine (0.3-1.5mg/ml) to the 
primary culture medium had no gross effect on the intestinal epithelium. 
In primary cultures of rat intestinal organoids it was previously shown that 
addition of exogenous heparin to the cultures resulted in an increase in epithelial 
proliferation (Flint et al., 1994). However, the addition of heparin at various 
concentrations to mouse organoid cultures did not result in any significant 
alteration in cell number or proliferation at a gross level. In order to confirm the 
proliferative effect in rat organoid cultures, I performed the organoid isolation 
procedure using 6 day old rat small intestine. Addition of heparin at 50 jig/ml to 
the organoid- cultures resulted -in the generation of large epithelial sheets which - - 	- 
were not seen at the same time intervals in cultures without heparin (data not 
shown), thus confirming the observations of Flint and colleagues. Therefore it 
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would appear that the effects of heparin on IEC proliferation are subject to some 
degree of species specificity. 
Culture Conditions 
} 	
Effect on Primary Cultures 
gelatin coated culture dish no gross effect 
collagen N coated culture dish no gross effect 
laminin coated culture dish no gross effect 
non-tissue culture coated dish colonies grow as normal for the first 2 or 3 
days then colonies begin to contract until 
they form an apparently disorganised cell 
mass. 
Matrigel/ECM coated culture dish organoids 	show 	no 	evidence 	of 	cell 
proliferation unless HGF is added to the 
culture medium. 
addition 	of HGF 	at 	20ng/ml 	allows 
epithelial proliferation and the formation 
of colonies with much tighter cell-cell 
contacts. 
3-D Matrigel/ECM gel organoids 	show 	no 	evidence 	of 	cell 
proliferation unless HGF is added to the 
culture medium. 
addition 	of 	HGF 	at 	20ng/ml 	allows 
epithelial proliferation and the formation 
of 	differentiated 	epithelial 	cyst-like 
structures. 
- 	 BRL conditioned medium no gross effect 
LIF containing ES cell medium no gross effect 
addition of excess glutamine to basic culture no gross effect 
medium 
addition of IGF-ll to basic culture medium no gross effect 
addition of heparin to basic culture medium no gross effect 
Table 5.1. Effect of altering the culture conditions of mouse intestinal organoids. 
This table summarises the effect on mouse intestinal organoids of a variety of alterations to 
the basic culture conditions, by the addition of growth factors to the basic culture medium, the 
use of different culture medium known to support the undifferentiated state of mouse ES 
cells, or by altering the culture substratum. 
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5.3 Discussion 
There are several reasons which may contribute to the success of these intestinal 
primary cultures. The cells are isolated from 6 day old mice which have already 
started to form distinct crypt structures. However, these crypts are still relatively 
immature in terms of size and organisation of their stem cell hierarchy (O'Connor, 
1966). Cell proliferation is already restricted to the crypts by this time (Calvert and 
Pothier, 1990) but they are not yet clonal (Schmidt et al., 1988). Tait and colleagues 
have been unable to successfully culture organoids from adult rats (personal 
communication) which may be related to increased differentiation of the adult 
intestinal crypts. 
The majority of IEC are post-mitotic, terminally differentiated cells that only 
have a short lifespan of between zero and 72 hours. A limited viability of these cells 
in culture would therefore be expected. The majority of organoids in primary 
culture after 24 hours are found floating in the culture medium rather than adhered 
to the culture dish. The experiments by Tsuchiya and Okada (1982) in which they 
attempted to culture finely chopped fragments of P1 rat intestine resulted in two 
types of 'organoid'. One was adherent epithelial lined structures which showed 
epithelial proliferation and corresponded to cells from the base of the villi and 
developing crypt regions. The other was rounded fragments which were found to 
float in the culture medium and appeared to consist of vifius tips containing 
differentiated epithelial cells. The fact that the floating organoids consisted of 
terminally differentiated cells while adherent fragments contained proliferative 
cells supports the hypothesis that the mouse organoids found floating after 24 hours 
in culture consist of terminally differentiated cells of the intestinal villi. In support 
of this is the observation by Patnaik et al. (1981) while attempting to culture 
epithelial cells from the rat colon that the proliferative cells adhered to the culture 
dish much more readily than differentiated non-proliferative cells. The reason why 
proliferative cells might adhere more readily than non-proliferative cells is unclear. 
It may be that these cells display a different set of cell-surface adhesion molecules. - - - 
The integrin family of cell adhesion molecules have restricted expression patterns in 
the intestine and some have been shown to be restricted to the proliferative 
epithelium (Beaulieu, 1997). Alternatively, it may be that the method by which 
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organoids are isolated is the cause of this phenomenon. The fragmentation of 
intestinal villi by either physical or enzymatic means will produce cell aggregates 
from the lamina propria which are covered in a layer of epithelial cells except at 
either one or both ends. Examination of these fragments suggests that the epithelial 
cells at the open ends adhere to each other and so seal the openings to leave an 
intact epithelial monolayer. These epithelial cells will be polarised and will still be 
attached to intact basement membrane at their basal membrane which may make 
adhesion to the culture dish problematic since the apical membrane is the only free 
surface with which to attach. Organoids originating from the crypt regions 
however will not have an outer layer composed of mainly epithelial cells because of 
the architecture of the tissue at these regions. The cell aggregates will have a large 
part of their surface covered with mesenchymal cells including fibroblasts, which 
adhere readily to culture dishes. The large gaps in the epithelium may not be able 
to be sealed and therefore fragments could adhere readily by way of the 
mesenchymal fibroblasts. This could also explain why adherent organoids always 
have a layer of epithelial cells on their upper surface and not mesenchymal cells. 
5.31 Maintenance of Cell-Cell and Cell-ECM Contacts 
Part of the success of this primary culture method is the maintenance of epithelial-
mesenchymal and epithelial-ECM contacts. It is interesting to note that in almost 
all the reported cases of successful IEC cultures there is at least a small number of 
contaminating mesenchymal cells present. In cases where a population of 
reportedly pure epithelial cells have been successfully maintained in culture, the 
cells have originated from foetal intestinal tissue. The stratified nature of the 
epithelium before E15 means that unlike mature intestine, direct epithelial-
mesenchymal contact is not possible for the majority of epithelial cells. This lack of 
epithelial-mesenchymal contact in the foetal intestine may mean that at this stage in 
development at least, a proportion of epithelial cells do not require direct contact 
with mesenchymal cells for continued survival. 
It is widely believed that a stem cell population can only maintain their stem 
cell qualities when located within a particular microenvironment or niche 
(Schofield, 1978; Hall and Watt, 1989; Potten and Loeffler, 1990; Williams et al., 
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1992). The long term culture of stem cells will therefore require the provision and 
maintenance of this environment. Haematopoetic (Dexter and Lajtha, 1974) and 
keratinocyte (Barrandon and Green 1987; Jones et al., 1995) stem cells can be 
successfully cultured in vitro. The successful culture of both these stem cell 
populations relies on the presence of a supporting cell line to provide the correct 
environment for stem cell survival. Bone marrow stromal cells are required for 
haematopoietic stem cell survival and keratinocyte stem cells are usually grown on 
a layer of embryonic fibroblasts. These experiments demonstrate that the qualities 
of 'sternness' are not cell autonomous but are maintained by extracellular signals 
that may be derived from other cells or from the extracellular environment. Most 
procedures used so far to isolate and culture IEC result in the purification of 
individual cells which are cultured without stromal support and therefore disrupt 
any special microenvironment. This environment must therefore be recapitulated 
in the culture system if the stem cells are to survive. Unfortunately little is known 
about the factors which make up the stem cell environment in the intestine, but it is 
likely that access to various growth factors, and the maintenance of cell-cell and 
cell-ECM communication is important. Patel et al. (1996) have shown using rat 
intestinal organoids that if the aggregates are further dissociated into single cell 
suspensions, epithelial proliferation no longer occurs. Epithelial proliferation in the 
mouse cultures is also only seen from intact organoids and not dissociated cells. It 
would therefore appear that only when the IEC are kept in a 3-dimensional 
conformation, in association with neighbouring epithelial cells and mesenchymal 
cells, are they capable of surviving in vitro. 
5.3.2 Classification of Epithelial Colonies 
In theory the organoids can contain only two types of proliferative epithelial cell, 
the TA cell and the stern cell. Individual organoids may contain a mixed 
population of both proliferative cell types, one proliferative type only, or only 
- - - differentiated cells. The results-from the primary-culture -experiments-support-this-
idea as some organoids demonstrate a large proliferative capacity as would be 
expected of stem cells, some a limited proliferative capacity as would be found in 
the TA cells, whilst others show no proliferation. A number of cultured organoids 
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produce large sheets of undifferentiated cells on one side as well as smaller 
numbers of differentiated cells on the other, suggesting cells of both proliferative 
capacities were present within the same organoid. Further support comes from the 
differentiated phenotype of cells from the type 2 colonies, whereas the type 3 
colonies contain undifferentiated epithelial cells. The cells of type 3 colonies remain 
undifferentiated for the life of the culture. Two possible explanations are that the 
culture conditions allow only new stem cells to be produced, or more likely, that the 
daughter cells cannot differentiate correctly because they lack the necessary signals 
to do so. Intestinal epithelial cells require mesenchyme to correctly differentiate 
(Kedinger et al., 1987; Haffen et al., 1987) however in our cultures, the daughter cells 
migrate out from the organoid and away from underlying mesenchyme on to tissue 
culture plastic, and therefore may not receive important signals required for correct 
differentiation. The differentiated phenotype of many normal cell types is difficult 
to maintain in vitro most likely due to a lack of correct growth and environmental 
factors. This distinction between the different colony types is similar to that 
exhibited by keratinocytes in culture (Watt, 1988). These colonies can be divided 
into holoclones, meroclones and paraclones based on their proliferative capacity 
and differentiation status. The holoclones have a high proliferative capacity in the 
absence of differentiation, whereas paraclones have a limited proliferative capacity 
and undergo terminal differentiation. These characteristics are similar to the type 3 
and type 2 colonies present in the intestinal organoid cultures. The meroclones 
however are colonies which display properties that are a mixture of holo- and 
paraclones. It should not be assumed that stem cells can necessarily be identified 
by their large proliferative capacity. Despite this capacity for large or unlimited 
proliferation, they are thought to have a long cell cycle in vivo due to time spent in 
the G0 resting state. Successful isolation and culture of stem cells which mimicked 
their in vivo activity would therefore not give rise to a rapidly proliferating 
population of cells. It is likely however, that the act of culturing stem cells, induces 
a regenerative response, and as a result increased proliferation. 
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5.3.3 Intestinal Epithelial Proliferation in vitro 
It is interesting to note that in both explant culture experiments (Kondo et al., 1985) 
and in the highly proliferative type 3 colonies, proliferation ceases after 10-14 days. 
Does the cessation of proliferation mean that organoids do not in fact contain stem 
cells but contain early daughter cells instead which retain a large but finite 
proliferative capacity? Alternatively, it may be that stem cells are present within 
the organoids but the culture conditions are such that the stem cells are induced to 
differentiate. It may also be the case that stem cells are viable in culture but that 
they are induced into a resting state. It had long beeti proposed that regulation of 
intestinal stem cell proliferation was in part, mediated by the number of 
differentiated epithelial cells on the viii (Galjaard et al., 1972; Rijke et al., 1976). This 
would involve some sort of feedback mechanism possibly via a secreted factor 
which would allow the stem cells in the crypt to determine the number of 
differentiated cells present on the villi, and so regulate the production of daughter 
cells accordingly. Indeed, a mitotic inhibitor was extracted from rat intestinal 
villous cells which appeared to specifically inhibit proliferation of intestinal crypt 
cells and had no effect on a variety of cell lines derived from other tissues (May et 
al., 1981). It may be therefore that the differentiated epithelia in the primary 
cultures secrete such a factor and so inhibit stem cell proliferation. This appears 
unlikely however since the culture medium is changed every 48 hours and so there 
should be no build up of a secreted inhibitor. It is also possible that inhibition could 
be mediated by a non-secretory mechanism such as a relay system between adjacent 
cells. In future experiments it would be interesting to address this question by 
either removing differentiated cells from the culture while leaving the organoids 
intact, or by removing intact organoids and placing them in secondary culture to 
see if proliferation can be induced. 
5.3.4 Cell Turnover in Primary Cultures 
The continued presence of type 2 cells in the primary cultures suggests that these 
differentiated, non-proliferative cells are not subject to the same fate as their in vivo 
counterparts. Such cells are normally removed from the intestinal mucosa through 
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apoptosis and/or extrusion into the lumen. The small number of rounded cells on 
the surface of the type 2 colonies may be apoptotic cells or cells which are being 
extruded. However, only a small number of cells are ever noted while the 
remainder of the cells appear healthy and remain adherent to the culture dish. If 
this was the fate of all terminally differentiated cells the type 2 colonies would be 
expected to decrease in size. One possible explanation for the lack of shedding and 
apoptosis may be that this process is somehow linked to cell migration. Possibly 
the process of migration itself or changes in signals from the surrounding 
environment may be responsible for this effect since the composition of the 
basement membrane is known to change along the crypt villus axis (Beaulieu, 1997). 
The results from transgenic mice which over express E-cadherin in intestinal 
epithelial cells (Hermiston et al., 1996) show that despite the slowed migration time, 
there was no increase in cell loss from lower regions of the villus and that cell loss 
still occurred at the normal position along the crypt-villus axis. This lends further 
support to the idea that extracellular signals play a role in removal of IEC from the 
mucosa, and that this is not entirely a cell autonomous process. 
It is unknown if the proliferative epithelial cells remain on the organoid or 
migrat,e out onto the culture dish during culture. The identification of proliferative 
cells would be possible by BrdU labelling. This would have to be performed within 
a relatiyely small time frame for type 2 colonies because of their limited 
proliferation. Another possible method to identify the location of proliferating cells 
from type 3 colonies would be to remove either the central organoid or the 
surrounding cells at a point when epithelial proliferation was still active, and 
replate the cells onto a fresh culture dish. It would be hoped that proliferating cells 
would still be capable of proliferating when replated. 
5.3.5 Phenotype of Epithelial Cells in Culture 
The expression of cytokeratins in the cultures raised some interesting questions. 
Type 1 colonies maintained their expression of cytokeratins throughout their time 
in culture. Type 2 colonies however, displayed a gradated pattern of expression 
such that cells on the central organoid and immediate surrounding area were 
strongly positive for cytokeratin expression but expression decreased as the 
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distance from the organoid increased. This result is similar to results obtained by 
Quaroni (1985) using rat intestinal explant cultures. In these cultures, small tissue 
fragments adhered to the culture dish and cellular outgrowths were obtained. The 
differentiation status of the explant cultures was studied using a panel of antibodies 
directed against cell surface components and digestive enzymes. 
Immunofluorescence and radioimmunobinding results showed that the cells 
covering and immediately surrounding the original tissue fragment displayed a 
differentiated phenotype whereas cells further away from the explant appeared 
undifferentiated. The requirement of mesenchymal derived signals for correct 
epithelial differentiation was proposed as the explanation for these results It may 
be that mesenchymal signals are also required for appropriate cytokeratin 
expression. Cytokeratin expression in the explant cultures was also studied by 
Quaroni using a monoclonal antibody directed against an unidentified epitope 
which is described in the paper as being specific for intestinal cytokeratin. Their 
results show strong staining of cells covering the explant and weaker staining of the 
cells in the outgrowths, although the staining does not completely disappear. It 
should be noted however that detection of their antibodies is by 
immunofluorescence which is much more sensitive than the peroxidase/DAB 
procedure used here. Also, the exact nature of the cytokeratin epitope is unknown 
and it may be that it identifies a different epitope to those recognised by the pool of 
antibodies I used. This commercial pool contains antibodies directed against 
various cytokeratins including 8, 18 and 19 which are all expressed in the small 
intestinal epithelium. It does not however recognise cytokeratin 20 which is also 
expressed in the intestinal epithelium and this may explain the difference between 
cytokeratin levels in these two culture systems. 
It is interesting that while cytokeratin expression in general appears to be 
lost in IEC with a differentiated phenotype in primary culture, expression is 
maintained in type 3 colonies with an undifferentiated phenotype. Levels of 
cytokeratins appear unchanged no matter how far the cells have migrated from the 
original organoid and this is true using both the pan-cytokeratin and the --
cytokeratin 18 specific antibodies. This observation is difficult to explain but it may 
be that undifferentiated epithelium does not require mesenchymal signals to 
maintain cytokeratin levels unlike their differentiated counterparts. 
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The induction of vimentin expression in epithelial cells suggests some 
degree of de/re-differentiation as a result of in vitro culture. This may be important 
for any attempts to use these cells to regenerate small intestinal epithelium in vivo. 
It is unclear if this change in gene expression represents a permanent change in 
differentiation of these cells so that prolonged culture may inhibit the ability of 
these cells to regenerate a neomucosa. Tait and colleagues found that foetal rat 
intestinal epithelium could be cultured for up to 3 days without inhibiting the 
ability of these cells to regenerate (Tait et al., 1994a). However, these foetal cells had 
to be incubated overnight with foetal intestinal mesenchyme and the entire 
recombinant, grafted to achieve this. There is also the possibility that the actual 
stem cells are not expressing vimentin, but the small number that potentially exist 
in culture can not be identified. 
5.3.6 Effect of Basement Membrane Proteins on Primary Cultures 
The majority of epithelial cells when grown in culture on normal tissue culture 
plastic, ,grow as a monolayer of poorly or non-polarised cells. Epithelia in vivo sit on 
a basement membrane (BM) composed of extracellular matrix proteins which are 
thought not only to physically separate the epithelium from the underlying strornal 
cells but to provide the correct signals to regulate polarisation, growth and 
differentiation. In vitro studies have shown that ECM proteins can have a varied 
effect on intestinal epithelial proliferation and differentiation (Basson et al., 1996; 
Sanderson et al., 1996; Wolpert et al., 1996; Lorentz et al., 1997; Beaulieu, 1997). The 
removal of these signals in tissue culture will therefore alter epithelial regulation. 
The localisation of various basement membrane proteins has been shown to be 
greatly restricted along the crypt-villus axis, as have their epithelial integrin 
receptors (Beaulieu, 1997). This differential localisation, in some cases correlates 
with epithelial proliferation or differentiation, and has led to the hypothesis that 
these ECM proteins may play a role in these processes. Laminins are a group of 
trimeric ECM proteins, and at least 7 different isoforms have been described in 
different tissues. Members are expressed in the BM of many tissues including both 
the mouse and human intestinal epithelium (Simonassmann et al., 1994; Hashimoto 
and Kusakabe, 1997). In the intestinal epithelial BM, laminin 1 and 2 have 
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reciprocal expression patterns with laminin 1 restricted to the differentiated villus 
region and laminin 2 restricted to the proliferative crypt region (Beaulieu, 1997). 
Laminin has been shown to induce differentiation (Hahn et al., 1990; Vachon and 
Beaulieu, 1995; Basson et al., 1996) and reduce the proliferative response to certain 
growth factors (Wolpert et al., 1996) in intestinal epithelial cell lines. It has also been 
shown to be upregulated in in vitro models of intestinal epithelial wound repair 
(Lotz et al., 1997; Goke et al., 1996). Collagen IV is a structural protein and a major 
component of epithelial BM. It is found in the BM along the entire length of the 
crypt-villus axis (Beaulieu, 1997). Collagen IV has also been suggested to play a role 
in promoting intestinal epithelial restitution (Coke et al., 1996) and was shown to 
promote JEC attachment and spreading in vitro (Moore et al., 1994). Coating-culture 
dishes with either of these proteins did not appear to have any gross affect on 
primary cultured cells, although it may be that these ECM proteins did have an 
effect, but a subtle one. It is possible that no effect was seen on epithelial 
proliferation because it is likely that the proliferative cells themselves remain 
localised to the organoid. Therefore, they may not come into contact with these 
exogenous ECM proteins. The migrating cells however, are in contact with these 
proteins but no gross differences in their proliferation or differentiation was 
observed, suggesting that laminin and collagen IV, at least on their own have no 
effect on these cells. 
The addition of Matrigel or ECM gel to the primary cultures was an attempt 
to supply the intestinal epithelium with a more complex set of ECM-mediated 
signals. Matrigel has been used in vitro by others for a variety of purposes, such as 
cell attachment (Santos et al., 1997) and cell invasion (Noel et al., 1991) assays, and to 
study the effects of basement membrane on gene expression (He et al., 1995), cell 
proliferation (Fukamachi and McLachlan, 1991) and differentiation (Lein and 
Higgins, 1989). Matrigel has been shown to induce morphological changes in many 
different cultured cell types including mammary epithelium (Barcellos-Hoff et al., 
1989), oviduct epithelium (Joshi, 1991) and endothelial cells (Zimrin et al., 1995) 
where it induces- the formation of 3-dimensional structures. The nature of these 
structures in some cases is reminiscent of the tissue of origin (Barcellos-Hoff et al., 
1989), but novel structures may also form, not usually associated with the original 
tissue (Bao and Hughes, 1995). In the experiments described here the organoids 
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were unable to form any new structures and cell proliferation was inhibited in the 
presence of Matrigel. As previously mentioned this may have been due to the 
presence of TGFI3 in the Matrigel preparation. Growth factor depleted preparations 
of Matrigel can be purchased but the levels of TGFI3 remain unchanged because it 
binds tightly in an inactive form to collagen IV. The ECM proteins which constitute 
the Matrigel preparations are laminin (56%), collagen IV (31%), entactin (8%) and 
heparan sulfate proteoglycan (5%). The inhibition of epithelial proliferation and 
migration may be a result of signals derived from the ECM proteins. Altmann and 
Quaroni (1990) using Matrigel in intestinal organ culture experiments, obtained a 
similar growth inhibitory effect. They were able to overcome this inhibition by 
altering the constituents of the Matrigel with the addition of a minimum 20% 
collagen type I. Similarly, the rat crypt derived cell line IEC-6 when plated on a 
similar basement membrane extract also underwent growth arrest (Carroll et al., 
1988). 
5.3.7 Effect of HGF on Primary Cultures 
The addition of HGF to the tissue culture medium was not only able to overcome 
these growth inhibitory effects but also induced changes in the morphology of the 
proliferating epithelia. HGF, also known as Scatter Factor is produced by cells of 
mesenchymal origin and is a ligand for the tyrosine kinase proto-oncogene receptor 
c-met. . During development HGF and c-met are expressed in the developing 
mesenchyme and epithelium respectively of tissues such as the liver, lung, kidney 
and intestine. The localisation ofHGF and c-met expression suggested that HGF 
was one of the long sought after regulators of epithelial-mesenchymal interactions 
which are so important during organogenesis and regeneration. HGF has been 
implicated in many morphogenic events during organogenesis such as branching 
morphogenesis in the lung (Ohmichi et al., 1998), metanephros development in the 
kidney (Woolf et al., 1995), and sensory neuron development (Mama et al., 1997). 
Signalling by HGF is also thought to play a role in the morphogenesis of the 
developing intestine. This hypothesis is based on the pattern of HGF and c-met 
expression during intestinal organogenesis rather than on functional data. In the 
mouse, expression of the c-met receptor is found in the intestinal epithelium of both 
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undifferentiated endoderm and differentiated crypt and villi (Sonnenberg et al., 
1993). However, HGF expression changes throughout development from low 
expression in a narrow layer surrounding the undifferentiated epithelium at E14 to 
strong expression in distinct regions of the mesenchyme at E15 when villus 
morphogenesis is taking place. HGF expression is localised to the mesenchymal 
cells which migrate up through the epithelium to form the viii. By E17 when the 
viii have formed, HGF expression is found in patches of mesenchyme which he 
adjacent to the intervillous epithelium which will later develop into crypts. 
Transcripts of HGF in the developing human intestine at 14.6 weeks of gestation 
were also localised to regions of presumptive crypt development. These -results 
suggest that in vivo, HGF is involved in villus and crypt formation in,-the 
developing intestine. In vitro, HGF has been shown to induce intrinsic tissue 
specific morphogenic activities in a wide variety of epithelial cell lines (Brinkmann 
et al., 1995). These effects were only seen when the cell lines were grown within a 
collagen gel and so HGF signalling is thought to be mediated by the ECM. 
Stromal cells can support stem cell viability and proliferation in the culture 
of haematopoietic and keratinocyte stem cells. It has been shown that both the 
epithelium and the underlying mesenchyme contribute towards basement 
membrane composition and that mesenchymal cells secrete important growth 
factors. Fritsch et al. (1997) have shown that fibroblast cell lines derived from rat 
intestinal primary cultures can support intestinal morphogenesis and development 
when grafted with foetal intestinal endoderm in vivo. It would be of interest to 
examine the effect of culturing intestinal organoids on a layer of intestinal 
fibroblasts to see if they were capable of supporting stem cell viability and 
proliferation. 
5.3.8 Previous Report of Intestinal Epithelial Stem Cell Culture 
A number of normal cell lines have been generated from both foetal (Quaroni, 1985) 
- -and neonatal- rat intestinal epithelium (Quaroni et al., 1979). -The-lines derived from. 
post natal tissue were generated by collagenase digestion of small intestinal tissue 
fragments. Pure populations of epithelial cells were obtained using cloning 
cylinders to generate secondary cultures. These cells were propogated as cell lines 
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which when characterised, displayed an undifferentiated crypt-like phenotype 
(Quaroni et al., 1979; Quaroni and May, 1980). These cell lines are reported to be 
normal non-immortalised cells despite the fact they have been passaged at least 40- 
50 times, and indeed at least one of these cell lines (IEC-6) retained a normal 
karyotype even after 6 months in culture. However the growth rate has been 
shown to diminish after 30-40 passages and it has been reported that during 
prolonged culture the original epithelial phenotype of some cells appears to have 
changed (Sambuy and De Angelis, 1986). Also, at least one of these lines appears to 
have spontaneously immortalised (Vincentini et al., 1996). Attempts to induce 
differentiation in these cell lines in vitro has so far met with only limited success. 
However, in a paper by Kedinger et al. (1986) it was claimed that one of these cell 
lines (IEC-17) which was derived from duodenal fragments of 18-24 day old rat 
intestine was capable of forming intestinal epithelial structures with expression of 
digestive enzymes, when associated with 14 day old foetal rat intestinal 
mesenchyme and grafted under the kidney capsule of adult rats. The IEC-17 cell 
line did not show any such enzyme activity when maintained in culture. They also 
performed the same experiments with primary foetal rat intestinal epithelial cells. 
Differentiated intestinal architecture was obtained in 70% of grafts using the 
primary, cells but only 53 out of 516 (10%) of grafts were successful using the IE6-17 
cell line. The possibility that the intestinal epithelium was actually derived from 
contaminating epithelial cells from the foetal rat mesenchyme preparation was 
examined by repeating the experiments using 12 day old foetal mouse intestinal 
mesenchyme for recombination and performing immunohistochemistry on sections 
of the grafted material using antibodies directed against rat brush border enzymes 
which do not cross react with mouse enzymes. Results from the grafts obtained 
using primary rat cells were shown in the paper but those from the IEC-17 cell line 
were not. The paper states that the antibody results from the IEC-17 grafts could 
only detect 2 of the enzymes tested using these antibodies. Moreover, the signal 
was less pronounced and could only be found on the brush border of a few 
enterocytes at the very tips of the villi. It is therefore difficult to conclusively prove 
from these results that the intestinal epithelial architecture seen in these small 
number of grafts is genuinely derived from the IEC-17 cell line. If such cell lines are 
capable of forming a mature differentiated intestinal epithelium it suggests that the 
129 
Organoid Primary Culture 
	 Chapter Five 
cell line contains at least a proportion of stem cells which are capable of long term 
propagation. Unfortunately, there has been no further publications using the IEC-
17 cell line in this grafting system. It may be worthwhile to attempt to generate 
such cell lines from post natal mouse crypt intestinal epithelium since it would 
presumably be easier to manipulate a stem cell line than primary cells. The 
generation of such a line from Cftr mutant mice would provide an invaluable 
system for assessing the possibility of mutation correction by homologous 
recombination in an epithelial stem cell population. 
The primary cultures described here demonstrate the successful 
maintenance of intestinal epithelial cells in culture for up to a month. The epithelial 
colonies could be divided into 3 distinct types which appear to reflect the three 
different proliferative cell types present in the small intestine. One of the colony 
types displayed a large proliferative capacity and an undifferentiated phenotype 
which may represent a stem cell or early progenitor population. Ultimately the 
identification of stem cells within the primary cultures can only be achieved by 
functional studies using a suitable assay system. The maintenance of 
haematopoetic stem cell viability and function can be assayed for by testing the 
ability of these cells to rescue lethally irradiated mice (Bock, 1997). Functional stem 
cells can repopulate the bone marrow of these mice and regenerate the full range of 
haemopoetic lineages. Keratinocyte stem cells can be assayed for by their ability to 
repopulate the epidermis of a recipient (Gallico et at., 1984; Jones et al., 1995). A 
similar assay system is required for intestinal epithelial stem cells. 
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6.1 Introduction 
Before any attempt at ex vivo mutation correction in intestinal epithelial stem cells 
can be made, several major hurdles must first be overcome. Intestinal stem cells 
must be able to be isolated from the intestine without losing their stem cell 
properties. A stem cell is defined by its function and since there are no markers 
available to isolate individual stem cells, some type of functional assay is required. 
The assay system which has been used most successfully in the past to detect 
intestinal stem cells and to study their function is the microcolony assay (Withers 
and Elkind, 1970). This technique involves irradiating a region of mouse intestinal 
mucosa, to kill the majority of intestinal epithelial cells. The intestine is then 
allowed to regenerate by the few surviving stem cells. By removing and analysing 
the intestine of these animals at various time points after irradiation, the 
regeneration of the intestinal mucosa from individual surviving clones can be 
studied and their properties and numbers analysed. This system cannot be used to 
confirm the identify of stem cells which have been maintained ex vivo since it 
requires that they remain in situ in their correct environment. 
A suitable assay system should not only be capable of recapitulating the full 
repertoire of stem cell properties from isolated cells, but be technically simple to 
carry out. Before assays can be devised it is first necessary to decide which stem cell 
properties are essential to satisfy the definition of a stem cell. I considered the most 
important characteristics to be the ability to i) maintain a large proliferative 
capacity, ii) produce the 4 main epithelial lineages of the small intestine, iii) 
recapitulate full crypt-villus morphology, and iv) maintain crypt clonality and 
villus polydonality. Unfortunately, there have been no convincing reports of 
successful maintenance of stem cell properties from isolated individual intestinal 
epithelial cells. This is not surprising given the requirement for mesenchyme in 
regulating and maintaining intestinal epithelial proliferation and differentiation. 
The role of the mesenchyme in these processes suggests that it may also have a role 
in regulating epithelial stem cell function. 
Tait et al. (1994c) described a method in which aggregates of rat small 





grafted subcutaneously into isogenic rats or immunocompromised mice. After two 
weeks the grafts had developed into what was termed an intestinal neomucosa. 
The neomucosa displayed full crypt-villus architecture and contained all 4 epithelial 
cell lineages. This technique was relatively simple and appeared to satisfy at least 
two of the requirements for a functional assay. To date all the systems used to 
demonstrate some aspect of stem cell function have used either rat tissue, 
embryonic tissue or intact fragments of intestine. None of these are suitable for my 
purposes and so it was decided to use the technique described by Tait and 
colleagues and attempt to apply it to the mouse. Furthermore, if this was shown to 
be possible, a more detailed analysis of the neomucosa would be required to 
determine whether or not this system satisfied all the criteria for a stem cell assay. 
The basic technique as established by Tait and colleagues was taught to me by 
Tendra Patel, and all improvements thereafter were my own additions. 
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6.2 Results 
6.2.1 Isolation and Grafting of Mouse Small Intestinal Organoids 
Mouse intestinal organoids were obtained from neonatal (5-7 days) CBA mice as 
described in 8.1.6. The organoids were pelleted and aliquots grafted to the 
subcutaneous dorsal plane of recipient male scid mice. Grafts were retrieved at 
various time intervals and processed for paraffin wax sectioning. Sections were 
then examined histologically for evidence of intestinal mucosal development. 
At retrieval it was only possible to identify grafted material in 
approximately 10% of cases. At 7 days after grafting the tissue retrieved from the 
graft site was composed primarily of stromal cells, within which epithelial-like cells 
could be identified surrounding a small lumen. At this stage 31% (8/26) of cysts 
were found to be lined with a homogeneous population of large, undifferentiated 
epithelial-like cells which have open pale staining nuclei and cytoplasm when 
stained with haematoxylin and eosin (figure 6.1A), while 27 percent of cysts (7/26) 
were lined with a layer of flattened epithelial-like cells with darker staining nuclei 
(figure 6.1A). The remaining cysts (42%, 11/26) appeared to be lined with a more 
heterogeneous epithelium containing both large and flattened cells (data not 
shown). 
After 2 weeks the grafts had formed into well vascularised cysts (figure 
6.113) which were readily visible to the naked eye. Sectioning of this material 
revealed the formation of multiple epithelial lined cysts which varied in size from 
approximately 1 to 5 mm in diameter. The morphology of the epithelial lining was 
very heterogeneous. The lumen of some cysts was filled with material which 
stained positive for mucin and alkaline phosphatase activity. It was possible to 
identify a highly folded epithelium in some cysts (figure 6.1C) which was similar to 
crypt and villus structures found in the intact small intestine. However, it was 
difficult to accurately assess epithelial morphology because the accumulation of 
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Figure 6.1. Grafting of mouse intestinal organoids. 
(A). H&E stained section through organoid graft after 7 days. 
Cyst lined with flattened epithelium is shown on the left (*) next 
to a cyst lined with a layer of large epithelium shown on the 
right. (X70) (B). Grafts retrieved after 2 weeks showing well 
vascularised cysts. (C). Section through 2 week graft stained 
for alkaline phosphatase activity (red) and counterstained with 
haematoxylin. The epithelial lining is convoluted and is folded 
into structures reminiscent of intestinal villi (arrow). The cyst 
lumen (lu) is filled with material which stains strongly positive 
for alkaline phosphatase activity. (X70) 
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6.2.2 Grafting of Intestinal Organoids with Matrigel/ECM gel 
Detailed analysis of these structures was hampered by the small number of cysts 
retrieved from the graft site. The low success rate could have been due to a number 
of factors. One simple reason could be that the actual number of cells in any one 
organoid preparation, capable of forming a cyst may be very low. This is unlikely 
since there are large numbers of all epithelial cell types present in the starting 
tissue, including proliferative stem and TA cells. It may be that the enzymatic 
digestion process was too harsh and affected the ability of cells to form cysts, 
possibly by excessive degradation of the extracellular environment. Alternatively, 
it may be that dispersion of the organoids under the skin prohibits possible cellular 
interactions which could be required for cyst formation. In an attempt to counteract 
these latter two possibilities, organoids were resuspended in Matrigel or ECM gel 
prior to grafting. Both products are solubilised basement membrane preparations 
and are an abundant source of extracellular matrix proteins. The preparations are 
reconstituted in cell culture medium and form a gel at 37°C. I reasoned that 
suspension in these products could provide both nutritional support, prior to the 
establishment of a blood supply, and physical support to stop organoid dispersion 
under the skin. Hepatocyte growth factor (HGF) was also added to the 
Matrigel/ECM gel since the in vitro experiments described in chapter 5 (section 5.2) 
showed that HGF is capable of overcoming the growth inhibitory effects of 
Matrigel/ECM gel on intestinal organoids. 
Organoids were isolated as previously described (8.1.6), and resuspended in 
Matrigel/ECM gel prior to subcutaneous grafting into scid mice. The grafts were 
retrieved at various time intervals and examined for histological studies. Using this 
method, graft material could be retrieved in 100% of all experiments. Histological 
analysis revealed a similar variety of cyst structures as seen previously although the 
time taken to form the more extensively developed structures was almost doubled. 
At 7 days after grafting, cyst structures appeared identical to those described 
previously in the initial grafting experiments without Matrigel. By 14 days, cysts 
can be clearly identified at graft sites and sections through these cysts revealed an 
epithelial monolayer surrounding a central lumen. There was a large degree of 
morphological heterogeneity between the cysts but it was possible to identify three 
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different epithelial types based on their shape and differentiation status. 
Undifferentiated flattened epithelium could be identified (figure 6.2A) lining either 
entire cysts or specific regions of cysts. Cysts containing flattened undifferentiated 
epithelium only in distinct regions also contained differentiated columnar 
epithelium (figure 6.2B), similar to that found in intact small intestine. These two 
epithelial cell types were never found intermingled but in neighbouring patches. 
The differentiated phenotype of these cells was determined by staining for specific 
intestinal epithelial cell types. In some cases the epithelial lining of a cyst was made 
up entirely of differentiated cells. Cysts were also identified which contained a 
third epithelial cell type. These cells were large columnar epithelial cells which 
appeared hyperchromatic when stained with haematoxylin and eosin and had a 
smaller nucleus to cytoplasm ratio than the other epithelial cells (figure 6.2C). In 
contrast to the other columnar epithelial cells, these cells did not display a 
differentiated phenotype. This third cell type was either found lining the entire 
inner surface of the cyst or was found alongside the differentiated columnar cells. 
Again, the two cell types were never found mixed together but were in distinct 
regions of the cyst. However, both cell types were only found in the same cyst 
when the undifferentiated columnar cells were found in pockets which had grown 
down into the underlying mesenchyme resembling intestinal crypts. These 
undifferentiated columnar cells were never found in the same cysts as the 
undifferentiated flattened epithelial cells. 
The epithelium in all cysts was surrounded by a layer of fibroblast-like cells, 
which in turn were surrounded by multiple layers of smooth muscle cells. These 
cells could be identified using an antibody directed against a-smooth muscle actin 
(figure 6.213). This antibody also identified positive cells amongst the layer of 
fibroblast-like cells immediately adjacent to the epithelium. Fibroblast-like cells 
which express cc-smooth muscle actin are also found adjacent to intestinal 
epithelium in the intact intestine and have been identified as myofibroblasts 
(Kedinger et al., 1990). 
- Cysts lined with a flattened epithelium appeared swollen and -their lumen 
was filled with clear fluid whereas cysts lined with differentiated cells had opaque 
material filling their lumen. This material stained positive for alkaline phosphatase 
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Figure 6.2. Development of cysts from intestinal organoids. (A-C) H&E staining of 
sections through cysts showing the different morphology of the epithelium lining after 2 
weeks. Black arrows point to the epithelial lining. 
(A). Region of undifferentiated flattened epithelium. (X70) (B). Region of polarised 
differentiated columnar epithelium. (X70) (C). Region of undifferentiated columnar 
epithelium. (X70) 
(D). Section through cyst showing columnar epithelium (arrow) surrounded by a layer 
of fibroblast-like cells (me) which are in turn surrounded by several layers of smooth 
muscle cells (large arrowhead). These cells are stained brown using an antibody 
directed against a-smooth muscle actin. (X70) (E). Negative control: adjacent section 
to that shown in (D) treated in an identical manner except for the omission of the 
primary antibody. (X70) (F). Section through cyst stained with PAS identifies the 
accumulation of mucus (pink) within the cyst lumen. (X1O) Abbreviations: lu, lumen; 
me, mesenchyme. 
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activity (figure 61C) and with Periodic Acid Schiff (figure 6.2F) which identifies 
mucin. 
Grafts left for longer periods of time (2-4 weeks), showed a decrease in the 
number of individual cysts but an increase in cyst size. This, combined with the 
mixed epithelial morphology of many cysts suggests that cysts may be fusing 
together during development. The majority of cysts by this time are lined with 
differentiated, polarised columnar epithelium. Distinct crypt-like structures which 
lie below the level of the luminal epithelium can be clearly identified in many cysts 
(figure 6.3A). However, even at 4 weeks a number of cysts lined with flattened 
epithelium remain. In occasional cysts, epithelial folds have also developed which 
protrude in towards the lumen (figure 6.313). This marks the early stages of villus 
development, and by 5 weeks villi are readily identifiable (figure 63C). The grafts 
at this stage appear very similar to the mucosa of the mouse small intestine and is 
referred to as a neomucosa. After 11-14 weeks the majority of cyst lumen are filled 
with mucus and cell debris which distorts cyst morphology and makes histological 
analysis of the epithelial architecture increasingly difficult. 
Cyst development occurs in distinct steps beginning with the formation of 
simple epithelial lined cysts followed by the formation of crypt structures and 
finally the formation of viii. More detailed analysis showed that cryptogenesis 
begins when cysts lined with undifferentiated columnar epithelium develop small 
indentations. At these points, a region of the epithelium appears to migrate into the 
underlying mesenchyme (figure 6.4A). At the same time stromal cells directly 
underneath this region appear to penetrate through the underlying smooth muscle 
cells and surround the migrating epithelium. This downward epithelial migration 
continues to form well defined crypts. The non-crypt epithelium remains 
surrounded by a single layer of mesenchymal cells and multiple layers of smooth 
muscle cells while the epithelium of the crypts is surrounded by large numbers of 
mesenchymal cells. Myofibroblasts can be identified within this cell population 
based on their fibroblast-like morphology and their positive staining for a-smooth 
muscle actin. These regions appear very similar to the crypt regions of intact mouse 
small intestine (figure 63D). Villus formation was only ever found in regions 
where crypts had already formed. Epithelial cells and underlying mesenchymal 
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Figure 6.3. Neomucosal morphogenesis. 
(A). Crypt development in intestinal neomucosa. H&E stained section through cysts at 5 
weeks showing the formation of multiple crypt structures (arrowheads) around the 
epithelial monolayer. (X1O) (B). Early stages of villus development. Regions of 
epithelium lying between the crypt structures begin to protrude in towards the lumen 
(arrowheads). (X1O) (C). Villus formation in the neomucosa. Section through cyst at 5 
weeks stained using the alkaline diazo method shows the formation of well defined 
villus structures (vi) lying in the regions where crypts (arrowheads) have already 
developed. (X40) (D). H&E stained section through adult mouse small intestine showing 
distinct crypt (arrowheads) and villus (vi) structures. (X20) Abbreviations: lu, lumen; 
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Figure 6.4 Cryptogenesis. 
(A). Primary step in crypt morphogenesis. Section through cyst at 2 weeks stained with H&E reveals region of 
epithelium beginning to migrate down into the underlying mesenchyme (arrowhead). Stromal cells (me) from beneath 
the ring of smooth muscle (Sm) appear to migrate through the smooth muscle cells towards the epithelium in the 
direction of the arrows. (B-E) Sections through several different cysts showing different stages of cryptogenesis. 
Epithelial migration into the underlying mesenchyme continues to initially form a pouch-like structure (B-D) which 
eventually develops into a fully formed crypt (E). Arrowhead marks developing crypt structure. X80 magnification of all 
sections. Abbreviations: lu, lumen;me, mesenchyme; Sm, smooth muscle. 
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possible to determine which cell types were responsible for this migration. The 
continued migration of cells produced larger viii although structures were much 
smaller than those found in the intact intestine. 
6.2.3 Identification of Cell Lineages within Intestinal Neomucosa 
To determine which cell lineages were present in the intestinal neomucosa, the cyst 
epithelium was examined for the presence of the 4 main intestinal epithelial cell 
types. These are absorptive enterocytes, goblet cells, enteroendocrine cells and 
Paneth cells. Absorptive enterocytes can be identified by the presence of alkaline 
phosphatase activity within the apically localised brush border (figure 6.5A). These 
cells were never identified within the flattened epithelium or the large 
hyperchromatic cells, but are first identified with the emergence of the smaller 
columnar epithelial cells. Similarly, the emergence of this cellular phenotype is also 
coincident with the appearance of goblet cells (figure 6.513) and of enteroendocrine 
cells (figure 6.5C). Finally, the Paneth cell lineage can be identified by their 
distinctive large granules and their location at the base of crypts (figure 6.513), or 
using an antibody directed against lysozyme. As is the case with the developing 
small intestine, Paneth cells cannot be identified within the epithelium prior to 
crypt formation. The identification of all 4 main intestinal epithelial cell types 
suggests that stem cells are contained within the original organoids and that they 
have retained their capacity to differentiate into multiple lineages during 
neomucosal development. 
6.2.4 Epithelial Proliferation within the Neomucosa 
The majority of intestinal epithelial cells are terminally differentiated and have no 
proliferative capacity, but the TA cells of the crypt are thought to be capable of 4-6 
rounds of cell division (Potten and Loeffler, 1990) while stem cells are thought to 
have a large and possibly infinite proliferative capacity. In order to confirm the 
presence of a stem cell population within the developing neomucosa it is therefore 
important to show that active epithelial proliferation is taking place. Grafts 
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Figure 6.5. Identification of intestinal epithelial cell types in the 
neomucosa. 
(A). Apical localisation of alkaline phosphatase activity shown in red 
identifies a population of absorptive enterocytes (arrow). (B). PAS 
staining reveals the presence of pink mucin secreting goblet cells, 
examples of which are marked by arrowheads. The luminal contents 
are also heavily stained due to the accumulation of mucin into the 
enclosed environment. (C). Alkaline diazo staining identifies a subset of 
enteroendocrine cells which produce serotonin. This can be visualised 
by the presence of red staining granules (arrowhead) in the basal 
region of these cells. (D). Paneth cells (pc) can be identified by their 
location at the base of crypts and by their distinctive large granules. 
'U! 
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antigen (PCNA). The PCNA protein has been identified as an auxiliary protein for 
DNA polymerase-delta (Bravo et al., 1987) and can be used to identify cells 
undergoing DNA replication. In undifferentiated flattened epithelium displaying 
no crypt-vilus architecture, only the occasional positively stained cell could be seen 
scattered throughout the epithelium. Similar observations were made in 
differentiated columnar epithelium. However, clusters of positively staining 
epithelial cells can be identified in regions of undifferentiated columnar epithelium 
where cells are migrating down into the mesenchyme (figure 6.6A). In cysts which 
are more developed and have formed crypts, PCNA positive cells are restricted to 
the crypt epithelium (figure 6.6B) as is found in the intact intestine. 
Although these results confirm that cell proliferation is taking place, it could 
be argued that these proliferating cells are indeed progenitor cells but not actual 
stem cells. The exact length of the intestinal stem cell cycle is difficult to determine 
since calculations are based on the number of stem cells per crypt which is not 
known. However, estimations can be made based on the various models for stem 
and transit cell kinetics in the small intestinal crypts. At one extreme, models based 
on the existence of up to 16 stem cells per crypt and a TA population capable of 4-6 
rounds of cell division suggest that stem cells proliferate once every 24 hours 
(Bjerknes and Cheng, 1981; Potten and Loeffler, 1987). At the other extreme it has 
been proposed that crypts are supplied by only a single slowly cycling intestinal 
stem cell which renews the crypt population every 12 weeks (Winton and Ponder, 
1990). In order to confirm that there were proliferating stem cells within the 
organoid grafts I injected the thymidine analogue, bromodeoxyuridine (BrdU) into 
recipient scid mice which had received an organoid graft 14 weeks previously. 
Proliferating cells can incorporate BrdU into their DNA which can be identified 
using monoclonal antibodies. Identification of proliferating cells after 14 weeks 
should in theory, only be possible if a stem cell population is present within the 
grafts even according to the most extreme estimates of stem cell cycle length. 
Recipient scid mice were injected with BrdU once a day for 3 days prior to graft 
retrieval since the cell kinetics of the cyst epithelium were not known. Antibody 
staining for incorporated BrdU identified positive cells both within crypt (figure 
6.6C) and villus (figure 6.613) structures confirming that cell proliferation was still 
















Figure 6.6. Cell proliferation in the developing neomucosa. 
(A). PCNA positive cells (arrowheads) can be identified in regions of epithelium 
which are beginning to migrate into the underlying mesenchyme (me) at the onset 
of cryptogenesis. (X50) (B). Proliferative (PCNA positve) cells (arrowheads) 
become restricted to the crypts (Cr) in later stages of neomucosal development. 
(X50) (C). BrdU positve cells (red) can be identified in the neomucosal crypts (Cr) 
when injected 14 weeks after grafting suggesting the presence of a stem cell 
population. (X50) (D). BrdU positive cells (red) can also be found on the 
neomucosal villus structures (vi) at the same time point. (X50) Abbreviations: lu, 
lumen, or crypts; me, mesenchyme; vi, villus. 
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6.2.5 Grafting of Intestinal Organoids Containing a Transgene Cell Marker 
In order to confirm that the neomucosa generated at the graft site was indeed 
derived from donor tissue and also to determine the hosts contribution to the cyst, 
organoids containing an identifiable marker were grafted into scid mice. Organoids 
were obtained from neonatal ROSA 26 mice (Friedrich and Soriano, 1990) which 
ubiquitously express the gene encoding t3-galactosidase in all cells of the intestine 
(figure 6.7E) throughout intestinal differentiation and development (Wong et al., 
1996). These transgene marked organoids were resuspended in ECM gel and 
grafted into scid mice as previously described. Grafts were retrieved at 2 weeks 
and 16 weeks and sections were stained for 3-galactosidase activity. 
Analysis of grafted material revealed all the epithelium lining the cysts to be 
of donor origin as expected (figure 6.7A). However, stromal cells were made up of 
both staining and non-staining cells and were therefore of both host and donor 
origin. The majority of stromal cells were derived from the host with donor derived 
non-epithelial cells found in small distinct patches. The epithelium of both 2 week 
and 16 week grafts were stained blue showing that the f3-galactosidase transgene 
was not switched off during neomucosal development. There were however some 
variations in the intensity of staining between cell types with the epithelium and 
smooth muscle cells staining much more intensely. This staining pattern is 
equivalent to that seen in the small intestine of adult ROSA 26 mice (figure 6.71 7). 
6.2.6 Generation of Chimaeric Neomucosa 
In order to understand more about the process of neomucosal formation, a mixture 
of intestinal organoids obtained from both ROSA 26 and CBA animals were grafted 
together. Grafted material was retrieved after 3 and 11 weeks and stained for the 
presence of 13-galactosidase activity. 
At 3 weeks the majority of cysts were lined with epithelium derived, either from the 
ROSA 26 or from the CBA organoids. This data suggests that at these early stages 
the cysts develop from individual organoids. Cysts with epithelium derived solely 
from CBA organoids could be identified which were surrounded by regions of 
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Figure 6.7. (A). Identification of donor derived cells within the neomucosa. X-Gal 
staining of ROSA 26 derived neomucosa reveals all the epithelial lining the cyst 
lumen (lu) to be donor derived (blue/black staining), whereas the surrounding 
mesenchyme is a mixture of donor and host derived cells. (X5) (B). Generation of 
chimaeric neomucosa. Cyst generated from a mixture of ROSA 26 and CBA cells 
reveals that ROSA 26 derived smooth muscle cells (sm) are capable of associating 
with CBA derived epithelium with an intervening layer of host or CBA derived 
mesenchyme (me). (X70) (C). Cyst containing both ROSA 26 and CBA derived 
epithelium suggesting fusion during cyst development. An arrow denotes the 
boundary between cells derived from the two different strains. Crypts within the 
chimaeric neomucosa are derived from either ROSA 26 cells (solid arrowheads) or 
CBA cells only (open arrowheads). Crypts containing epithelial cels from both 
mouse strains are never detected, suggesting that these crypts are monoclonal. (X50) 
(D). A villus (vi) located the border of a patch of ROSA 26 epithelium and CBA 
derived epithelium. X-Gal staining reveals the presence of epithelial cells from both 
ROSA 26 (blue/black) and CBA (*) mouse strains present on the villus thus 
demonstrating the polyclonal origin of this structure. Surrounding crypts are either 
exclusively ROSA 26 (solid arrowheads) or CBA (open arrowheads) derived. Note 
that individual cells shed into the lumen (lu) are also derived from both mouse 
strains. (X100) W. A crypt derived from ROSA 26 organoids undergoing crypt 
fission. A bifurcation (arrow) can be seen at the base of the crypt. Such bifurcations 
normally continue up towards the crypt mouth and ultimately lead to he formation 
of two new crypts. (X100) (F). Intact intestine from ROSA26 mouse after X-Gal 
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stromal cells derived from ROSA 26 cells (figure 6.6B). This suggests that the donor 
mesenchymal contribution is not necessarily derived from the same organoid as the 
epithelium. It is more likely that individual mesenchymal aggregates from the 
original organoid preparation are recruited by the epithelium during neomucosal 
development. 
Grafted material retrieved after 11 weeks showed that the majority of cysts 
contained a mixture of ROSA 26 and CBA derived epithelium (figure 6.7C). 
Epithelium derived from each strain was found in neighbouring individual blocks 
rather than as a random mixture of cells, confirming previous observations of cyst 
fusion. The crypts in these chimaeric neomucosa were found to be derived solely 
from CBA or ROSA 26 cells (figure 6.7C) and crypts containing cells of both strains 
were never detected, even at the junction between epithelial patches from different 
strains. As expected, villus structures were generally composed of cells derived 
from a single strain. Occasionally however, villi were identified at the boundary 
between epithelium derived from the two different strains and these were shown to 
contain cells from both strains (figure 6.71)). These results are identical to that seen 
in the intestine of chimaeric mice (Schmidt et al., 1985; Wong et al., 1996), and 
demonstrate that in these neomucosa, crypts are clonal whereas viii are polydonal. 
These grafts also provided evidence for crypt fission taking place. This is 
the main mechanism used by the intestine to increase crypt number during the first 
few weeks of post natal life and during intestinal epithelial regeneration. During 
crypt fission, crypts enlarge and split in two to produce two daughter crypts, an 
example of this was found in one of the grafts (figure 6.7E). This process is thought 
to be regulated by crypt size and it is therefore interesting to note that the example 
we found was situated in a region containing elongated crypts. 
6.2.7 Development of Mouse Small Intestine 
In order to compare the development of the organoid grafts with the development 
of embryonic intestine into adult intestine, I sectioned and stained the intestine 
from mouse embryos at E14.5, E15.5 and E16.5. These time points were chosen 
because they cover the primary morphological changes which take place 
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Figure 6.8. Embryonic development of the mouse small intestine. 
(A). Section through the small intestine at E14.5 stained for alkaline 
phosphatase activity. The intestine is lined with a stratified epithelium which 
does not yet display alkaline phosphatase activity. (X20) (B). Section through 
the small intestine at E15.5 stained for alkaline phosphatase activity 
(blue/black). The epithelium has been converted into a monolayer and small 
villi have begun to develop. Alkaline phosphatase activity can now be 
detected on the small villi. (X20) (C). Section through the small intestine at 
E16.5 stained for alkaline phosphatase activity (red). Villi have formed 
covered in an epithelial monolayer which displays alkaline phosphatase 
activity. The intervillous epithelium which goes on to develop into crypts can 
be clearly identified at this point. (X50) 
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during intestinal development. At E14.5 the mouse embryonic small intestine 
consists of a small lumen lined with an undifferentiated stratified epithelium, 
which in turn is surrounded by a large number of stromal cells (figure 6.8A). By 
E15.5 major morphological changes have taken place and the stratified epithélium 
has become converted into an epithelial monolayer which has formed small villi 
that protrude into the lumen. Coincident with this process is the first sign of 
epithelial differentiation identified by the presence of apically localised alkaline 
phosphatase activity in the cells covering the viii (figure 6.8B). At E16.5 the villi 
have increased in size and regions of flat intervifious epithelium can be dearly 
identified which do not express alkaline phosphatase (figure 6.8C). Epithelial cell 
proliferation becomes restricted to the intervillous epithelium (Al-Nafussi and 
Wright, 1982) and it is from these regions during post natal intestinal development 
that crypts are formed by the downward migration of these cells into the 
underlying mesenchyme. The adult intestinal phenotype is acquired by P21, at 
which point full crypt-villus architecture and crypt clonality have been established. 
6.2.8 Grafting of Cultured Organoids 
The maintenance of functional intestinal stem cells in culture is a prerequisite for ex 
vivo gene therapy. In order to determine whether any of the epithelial cells grown 
in primary culture had the capacity to function as stem cells it was now possible to 
place the primary cultured cells into the functional assay that had been developed. 
Intestinal organoids were isolated and cultured for between 1 and 10 days. The 
cells were then removed by trypsinisation and resuspended in Matrigel before 
being grafted subcutaneously into scid mice. Grafts were retrieved after 4 weeks 
and examined histologically for evidence of neomucosal development. Using this 
approach, no epithelial structures were ever detected at the graft site. Since cell-cell 
and cell-ECM interactions are such an important part of intestinal epithelial 
regulation, I used a less rigorous procedure to remove the cells from the culture 
dish to ensure the maintenance of cell-cell and cell-ECM contacts. This was 
achieved by washing the cells in PBS followed by incubation of the cells at 37°C 
with a dilute solution of EDTA to loosen cell adhesion. After 24 hours in culture the 
cells were removed by gentle scraping so that they came off as intact sheets and the 
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central dome structure of the surviving organoids remained intact. At retrieval the 
grafts had formed epithelial lined cysts which had developed crypt-like structures 
- (data not shown). Unfortunately due to time restraints, I Whäb1etO Culture the 
cells for longer periods of time prior to grafting using this new approach which 
means it is not known if there is a time limit on the number of days stem cells can 
be successfully maintained in culture. 
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6.3 Discussion 
Any assay for intestinal epithelial stem cells must be capable of displaying their full 
range of in vivo functions. In addition, it would be beneficial if the assay was both 
technically simple to perform and amenable to manipulation. Such a system would 
not only be useful for ex vivo gene therapy but could be of great benefit in helping to 
identify stem cells and understand the factors that regulate their function and 
therefore regulate the tissue as a whole. The system described here appears to 
accurately recapitulate all aspects of stem cell properties tested so far. 
6.3.1 Organoid Grafts 
The original grafts, in which organoids were placed as a simple pellet under the 
skin of scid mice were relatively inefficient at generating epithelial structures. The 
small number of grafts which did succeed made it difficult to analyse neomucosal 
development and composition. The ability to generate cysts from grafted organoids 
was increased to 100% by resuspending the organoids in Matrigel or ECM gel prior 
to grafting. The gels solidify at 37°C and therefore provide physical support for the 
organoids, ensuring that they do not simply disperse under the skin upon grafting. 
They also provide nutrients to the grafted cells which may be important in 
maintaining cell survival prior to obtaining a blood supply from the host circulatory 
system. The gels contain large amounts of extracellular matrix proteins and it is 
possible that these played a part in promoting cell survival. Epithelial cells require 
contact with the basement membrane to maintain polarisation, differentiation and 
survival (Frisch and Francis, 1994; for review see Simonassmann et al., 1995). It may 
be that the ECM proteins present in the gels were able to provide a suitable 
extracellular environment for cell survival. 
By grafting transgenic marked cells I was able to assess the host's 
contribution to neomucosal development. Using a mixture of marked and 
unmarked cells, I have shown that it is possible to generate a chimaeric neomucosa 
demonstrating that cysts fuse together as they increase in size. However, the fusion 
of cysts does not cause mixing of the cell populations and the neomucosa resembles 
the intestine of chimaeric mice with epithelium from individual strains found in 
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distinct patches. All neomucosal crypts are derived from a single mouse strain 
whereas villi at the boundary of patches are composed of cells from both mouse 
strains. This also mimics the intestine of chimaeric mice and makesit possible to 
distinguish and compare mutant tissue directly with wild type tissue, even on the 
same vifius. This has been exploited successfully in chimaeric mice (Hermiston et 
al., 1993; Crossman et al., 1994; Hermiston and Gordon, 1995), however this grafting 
system has the advantages of being less time consuming and allows simple control 
over the degree of chimaerism within the neomucosa by altering the ratio of input 
organoids. 
6.3.2 Model for Neomucosal Development 
I have used the results presented in this chapter to generate a model of graft 
development from a simple cyst to a differentiated mucosa (figure 6.9). 
Understanding the developmental process of neomucosal formation is complicated 
by a large degree of heterogeneity in cyst morphology at each time point studied. I 
reasoned that this heterogeneity is a result of variation in the developmental 
potential of the organoids, combined with the constant fusing of these 
heterogeneous cysts. 
The isolated organoids can contain only two types of proliferative epithelial 
cell, the TA cell and the stem cell. Individual organoids may contain a mixed 
population of both proliferative cell types, one cell type only, or only differentiated 
cells. I believe that the organoids maintain these variations in proliferation and 
differentiation when grafted subcutaneously. This is supported by looking at the 
early stages of cyst development. Type I cysts are lined with an undifferentiated 
flattened epithelium which proliferates but only for a limited period. The cysts 
become filled with fluid before the epithelium converts to a columnar phenotype. 
This change in morphology is associated with differentiation of the epithelium as 
demonstrated by the presence of absorptive enterocytes, goblet cells and 
-enteroendocrine- cells.---The-conversion--to-a-columnar differentiated-epithelium-is 
also associated with a decrease in cyst swelling. These properties are similar to 
those exhibited by TA cells in the small intestine. TA cells have a limited 
proliferative capacity and will terminally differentiate after 1-6 rounds of cell 
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Figure 6.9. Model of neomucosal development. 
Initially, all cysts are derived from single organoids. (1A) Type I cysts are derived 
from organoids containing only TA cells which have a liuiiited ability to proliferate 
and ultimately produce only terminally differentiated epithelial cells. (1B) These 
cysts increase in size as the cells proliferate to produce an undifferentiated flattened 
epithelial lining and are involved in vectorial fluid transport causing the cysts to 
swell. (1C) These cells then take on a columnar phenotype as they differentiate into 
absorptive enterocytes, goblet cells and enteroendocrine cells. This differentiation 
is associated with a decrease in cyst swelling caused by the inability of 
differentiated intestinal epithelium to transport fluid across their apical membrane. 
(2A) Type II cysts are derived from organoids containing stem cells only while type 
ifi cysts are derived from organoids containing both stem cells and TA cells. Both 
types of cyst develop in a similar manner since it is the stem cell population which 
regulate cyst development. (2B) Undifferentiated epithelial cells proliferate to 
produce polarized columnar epithelial cells and cause the cyst to increase in size. 
(2C) At distinct sites along the epithelial monolayer (presumably the sites of 
intestinal stem cells), proliferating epithelium begins to migrate down towards the 
underlying mesenchyme. At the same time the mesenchyme migrates through 
layers of smooth muscle cells towards the epithelium. (2D) Cell migration continues 
leading to the generation of intestinal crypts which contain Paneth cells at their 
base. Epithelial cell proliferation becomes restricted to these crypts. (2E) Regions of 
epithelium between the crypts protrude in towards the central lumen, leading to the 
generation of intestinal viffi and full intestinal mucosal architecture. (3A) At any 
time after the formation of the original cysts, fusion may occur between 
neighbouring cysts. Fusion events lead to replacement of differentiated cells by the 
daughter cells of the stem cell population from type II and ifi cysts. 
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division (Potten and Loeffler, 1990). The undifferentiated TA cells of the crypt 
express Cftr (Cohn, 1994) and are involved in fluid secretion via cAMP regulated 
chloride conductance, whereas the terminally differentiated cells of the villus do not 
(Welh et al., 1982). This would explain the decrease in cyst swelling which 
accompanies the differentiation of the type I cyst epithelium. Experiments by 
Kirkland (1990) have shown that an undifferentiated intestinal cell line embedded 
in collagen can form cysts lined with columnar epithelium in vitro. Addition of 
various agents known to stimulate cAMP mediated chloride conductance, and 
therefore fluid transport, cause the cysts to swell as they fill with fluid and the 
epithelium becomes flattened. Also, in vivo experiments by Del Buono et al. (1991) 
using the same cell line demonstrate that xenografts of these cells leads to the 
formation of cysts lined with a flattened epithelium which then converts into a 
columnar epithelium via signals derived from host mesenchymal cells. This 
conversion from a flattened to a columnar epithelium is also associated with 
differentiation of the cells. The continued presence of flattened epithelium in cysts 
derived from grafted organoids after 4 weeks may be due to a lack of the 
appropriate signals from the surrounding mesenchyme to differentiate. 
Organoids containing a stem cell population could in theory be capable of 
reproducing an intestinal epithelial architecture if functional. The development of 
type H and ifi cysts appears to confirm this. These cysts contain large 
undifferentiated epithelial-like cells with a columnar phenotype. The epithelium is 
surrounded by a single layer of fibroblast-like cells and multiple layers of smooth 
muscle as previously described. However, changes in mesenchymal organisation 
occur in association with epithelial migration and proliferation during further 
development. At distinct foci within the columnar epithelium groups of cells 
appear to form small indentations in the epithelial lining. At the same time, 
mesenchymal cells from the distal side of the encircling smooth muscle appear to 
migrate towards this epithelium. The epithelial cells migrate down into the 
underlying stroma and simultaneously, the migrating mesenchymal cells appear to 
penetrate the -smooth 'muscle layer- to aggregate- around -the migrating epithelium-. ------- - - 
The epithelial migration continues to form an intestinal crypt complete with a 
Paneth cell population at the crypt base. This suggests that these regions of 
migrating epithelium contain at least one active stem cell. This conclusion is 
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consistent with the identification of PCNA positive cells within this population and 
from data showing that crypts form in the developing intestine from regions of 
proliferating epithelium in a similar manner (Schmidt et al., 1988). The 
mesenchymal cells appear to be attracted specifically to the migrating epithelium, 
and this may be due to factors secreted by the epithelium or to local changes in the 
ECM. The potential role of these mesenchymal cells is of great interest. In the 
mature small intestine, a population of myofibroblasts, known as pericryptal 
fibroblasts, adhere to the lower portion of the crypt epithelium (Neal and Potten, 
1981). This tight association with the proliferative compartment and some 
interesting in vitro data (Haffen et al., 1983; Ratineau et al., 1997; Fritsch et al., 1997) 
using intestinal fibroblasts suggests that these cells may be involved in regulating 
epithelial proliferation and differentiation. In the developing neomucosa we also 
observe myofibroblasts in close proximity to epithelial crypts. Foetal rat endoderm 
embedded in collagen and grafted subcutaneously into nude mice continues to 
develop and generates an intestinal epithelium with underlying fibroblasts and 
layers of smooth muscle (Del Buono et al., 1992). Interestingly, the pericryptal 
fibroblasts are derived from the mouse host while the smooth muscle is of donor rat 
origin.,. The mesenchymal cells destined to become pericryptal fibroblasts are 
apparently able to migrate through the smooth muscle layer in a similar manner to, 
that shown here. The authors suggest that some sort of cell sorting process may be 
taking place in the rat-mouse xenografts. This was also thought to be the case in 
xenografts of human embryonic intestine into scid mice where it was found that 
murine cells were rarely in contact with human cells (Savidge et al., 1995). In 
contrast, within the grafts shown here, using only mouse cells, I could detect 
mesenchymal cells from both donor and host contributing to the smooth muscle 
layer, and in the mesenchymal cells in contact with the donor epithelium. This 
supports the hypothesis that cell specific interactions are taking place and suggests 
that caution should be used in interpreting the results from xenograft experiments. 
It is only after the formation of crypts that alkaline phosphatase activity can 
be detected in the cyst lumen. This activity is most likely derived from the apical 
brush border of absorptive enterocytes and suggests a degree of cell turnover, with 
differentiated enterocytes being shed into the lumen as occurs in the small intestine 
(Creamer et al., 1961). It is interesting that in both the neomucosal system described 
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here and another enclosed experimental system for intestinal development (Del 
Buono et al., 1992) there is evidence for cell shedding into the lumen. This supports 
the long standing concept of cell thedding in the intestine =as a majorreguiator of 	- 
cell number. After crypt formation, regions of mesenchyme and overlying 
epithelium between the crypts move up towards the lumen to form viii, and a fully 
formed intestinal mucosa is generated. This also occurs during intestinal 
development and is mediated by the migration of underlying mesenchymal cells 
which push up through the intestinal epithelium (Mathan et al., 1976). I believe this 
pattern of development supports the hypothesis that the grafted stem cells maintain 
their proliferative and differentiation capacity. 
6.3.3 Generation of Chimaeric Neomucosa 
The results obtained by grafting organoids derived from ROSA 26 and CBA mice 
together, demonstrate a large degree of cyst fusion during neomucosal 
development. Fusion was possible between cysts of varying developmental stages 
and examination of grafts at 3 and 11 weeks showed an increase in the number of 
fusion events with time. This suggests that fusion occurs primarily as a result of 
enlargement of neighbouring structures. These fusion events can account for the 
heterogeneous phenotype of many cysts. 
Grafting experiments using marked cells revealed the hosts important 
contribution to the neomucosal mesenchyme. The interpretation of these results is 
based on the assumption that the transgene in the ROSA 26 derived cells is not 
switched off at any point during neomucosal development. This assumption is 
based on the fact that expression in the intestine of ROSA 26 mice has been detected 
at all stages of development and that expression in the ROSA 26 only grafts was 
detected at both 2 and 16 weeks. 
Host stromal cells were recruited to the graft site and a proportion of -these 
cells were induced to express a-smooth muscle actin. This induction is most likely 
-mediated-by-the-intestinal-epithelium-since-it-has- -been shown-that-grafted-intestinal-
endoderm is capable of inducing cc-smooth muscle actin not only in associated 
intestinal mesenchyme but also in skin fibroblasts (Kedinger et al., 1990). 
158 
Chapter Six 	 Organoid Grafts 
6.3.4 Comparison of Mouse and Rat Neomucosal Development 
The results described here exhibit various differences to those described by others 
using organoids isolated from the rat small intestine (Tait et al., 1994c; Tait et al., 
1995; Patel et al., 1996). The most obvious difference is the time taken for the grafts 
to develop full crypt-villus architecture. In the rat experiments, full architecture 
was obtained after 2 weeks yet it took 4-5 weeks for this to occur in the grafts 
described here using mouse tissue. This difference would appear to be caused by 
the Matrigel/ECM gel, since mouse organoids grafted alone were also capable of 
generating full architecture after 2 weeks. It is unclear why Tait and colleagues 
were able to obtain a neomucosa from -90% of grafts while I was only able to 
retrieve graft material from 10% of attempted grafts without the use of 
Matrigel/ECM gel. It may be that mouse intestinal stem cells are more susceptible 
to damage induced by the isolation procedure in comparison to rat tissue. 
However, a more likely explanation is that there were subtle technical differences in 
the isolation or grafting procedure which are important in maintaining epithelial 
stem cell viability. It may be, for example that the organoid isolation procedure 
whichwas originally optimised for rat small intestine is suboptimal for mouse 
small intestine which is considerably smaller. This may have led to increased 
enzymatic digestion of the intestinal tissue fragments giving rise to smaller tissue 
fragments and possibly loss of important cell-cell or epithelial-mesenchymal 
interactions necessary for the maintenance of intestinal epithelial stem cell function. 
The experiments by Tait and colleagues made no mention of any differences 
between the development of cysts within the same graft, and in particular did not 
identify any cysts which failed to develop crypt and villus structures. Again, this 
could also be explained by differences in the degree of enzymatic tissue digestion. 
A lesser degree of digestion in rat intestinal fragments may mean that all organoids 
which contain proliferative epithelial cells, contain both stem and TA cell 
populations. The presence of stem cells in all organoids capable of forming cysts 
would lead to a relatively uniform development of neomucosal structures. One 
other factor related to this explanation is that there are small but potentially 
significant differences in intestinal development between the mouse and the rat. 
The mouse small intestine develops slightly faster than the rat so that by post natal 
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day 6, the developing intestinal crypts are more pronounced in the mouse than in 
the rat. This developmental advantage will likely lead to 'a more developed stem 
cell hierarchy within the crypts which means a greater degree of physical 
separation between the stem and TA cell populations. An increase in the physical 
separation would mean there was an increased probability that mouse intestinal 
organoids would contain separate stem and TA cell populations following 
digestion. 
6.3.5 Intestinal Development and Regeneration 
The process of neomucosal generation from organoids demonstrates similar 
features to intestinal development in the mouse. However, comparison with mouse 
small intestinal development from E14.5 to E16.5 revealed that mucosal generation 
within the grafts is similar, but not identical to normal intestinal development. At 
E14.5 the intestinal endoderm is composed of an undifferentiated stratified 
epithelium (Hermiston and Gordon, 1995). Activity of the digestive enzyme 
alkaline phosphatase can not be detected at this stage. By E15.5 however, the 
underlying mesenchyme pushes up through the epithelium converting it to a 
monolayer, producing small viffi. At the same time, alkaline phosphatase activity is 
switched on at the apical surface of the differentiated villus epithelium. By E16.5 
the viffi are clearly visible and alkaline phosphatase negative cells are located in the 
intervifious epithelium. It is within these regions that cell proliferation becomes 
restricted during development and crypt formation occurs during the first two 
weeks of post natal life (Schmidt et al., 1988). Although the formation of crypts and 
villi, and the induction of alkaline phosphatase activity all take place during 
neomucosal development, these events occur in a different order. In the developing 
type II and ffi cysts, crypt formation is the primary morphogenic event. This is 
followed by induction of alkaline phosphatase activity in differentiated epithelium, 
and finally by the generation of villi. Alkaline phosphatase activity is also detected 
in the differentiated epithelium of cysts derived from TA cells, but these cysts do 
not contain stem cells and do not go on to develop crypts unless they fuse with a 
cyst which does. This process of events is strikingly similar to that of intestinal 
mucosal regeneration (figure 6.10) following damage to the epithelium (Inoue et al., 
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Figure 6.10. Intestinal regeneration. 
---------,-. 	.. 	 . 	. 	events _1 ------------------- cnematic snowing the main uuruig regenerauolLul the ULLSLULd1 epiueuiui 
following tissue damage. Damage to the epithelium is initially repaired by a process 
known as restitution in which the epithelium surrounding the damaged area 
flattens and spreads to seal the wound and so maintain the integrity of the 
epithelium. The flattened epithelium then resumes its columnar shape and its 
differentiated phenotype. Surviving stem cells in this region undergo extensive 
proliferation which leads to the formation of new crypts and the resumption of 
normal intestinal epithelial morphology and function. - 
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1988). During regeneration there is an initial response to seal the wound, termed 
epithelial restitution. This requires the flattening and spreading of the cells 
surrounding the wound to ensure the breach in the epithelial barrier is sealed 
quickly (Lacy, 1988). This is followed by the resumption of a columnar morphology 
by the cells. Proliferation takes place at distinct foci thought to be the location of 
surviving stem cells (Inoue et al., 1988) from which crypts are then formed and 
intestinal regeneration is completed with the formation of new villi. Therefore it 
would appear that there are distinct differences between the developmental 
program of undifferentiated intestinal progenitor epithelium and the regeneration 
program of undifferentiated post natal stem cells, despite the fact similar process 
are involved. 
This system may therefore be used as a model in which to study intestinal 
development and regeneration. The development of such a system in the mouse 
would be of particular interest, as it can be manipulated to a much greater extent 
than in other mammals. In particular, the large number of transgenic and knockout 
mice now available can provide tissue with specific gene mutations and would 
allow the role of specific genes in intestinal regeneration and development to be 
studied. The effects of altered cAMP mediated fluid transport on cyst development 
can be examined using the various cystic fibrosis mouse models that exist 
(Snouwaert et al., 1992; Dorin et al., 1992; Colledge et al., 1995; Delaney et al., 1996). 
Similarly, mice carrying mutations in genes involved in intestinal development and 
repair such as Cdxl (Subramanian et al., 1995 and personal communication) and 
Egfr (Miettinen et al., 1995) would be of great interest, as would mutations which 
cause susceptibility to intestinal neoplasia such as Cdx2 (Chawengsaksophak et al., 
1997) and Apc (Su et al., 1992). In addition it will be possible to identify important 
epithelial-mesenchymal interactions using this system because of the chimaeric 
nature of the mesenchymal contribution to the neomucosa. Grafting experiments 
could be carried out using transgenic or knockout tissue where the gene of interest 
is expressed in the mesenchymal component of the intestine. Fkh6 is expressed in 
the gut mesenchyme and has been shown to have a role in intestinal epithelial 
proliferation and differentiation (Kaestner et al., 1997). Neomucosal development 
from Fkh6 null mice would be of particular interest in view of the contribution by 
both donor and host mesenchyme to the grafts. The resultant cysts would have 
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epithelium lined with both mutant mesenchyme from the donor and wild-type 
mesenchyme from the host. This would allow a direct comparison between the 
effects of mutant and wild type mesenchyme on different aspects of intestinal 
development and regeneration. This system therefore represents a technically 
simple tool which can be used to aid our understanding of how intestinal stem cell 
function is regulated and how the stem cells themselves regulate proliferation, 
differentiation and crypt formation in the intestine. 
Current model systems for intestinal regeneration are somewhat limited. 
Frequently intestinal epithelial cell lines are used to study restitution (Lacy, 1988). 
As with any in vitro study using cell lines, this model system does not truly mimic 
the in vivo situation and does not correctly take into the account the complex 
extracellular environment which is crucial in regulating cell migration. An 
alternative in vivo system has been used which involves damaging the intestinal 
mucosa, followed by histological examination of the tissue at various time points 
afterwards. While this is clearly an accurate representation of intestinal 
regeneration, it is limited somewhat by the method used to induce the mucosal 
damage. Almost exclusively, irradiation of the intestinal mucosa is the method of 
choice to induce mucosal damage. While this system is relatively straightforward, 
the results can be potentially difficult to interpret because of potential novel 
mutations induced by the radiation. These mutations may affect genes which are 
involved in regulating cell proliferation, migration, and differentiation and 
therefore may effect the process of intestinal regeneration. This grafting system 
does not involve any potential mutation inducing steps, yet appears to accurately 
reflect the process of regeneration. 
One potential limitation of this system is that because of the physical 
isolation of the graft to an exogenous site, there can be no contribution to the 
noemucosal development by the luminal contents. It is thought that the flow of 
food material through the lumen and the secretion of regulatory factors from other 
tissue such as the pancreas and gallbladder contribute to regulation of the 
epithelium (for review see Rao, 1991). As a result, this potential limitation should 
always be remembered when interpreting results. However, processes such as 
intestinal development have been shown to progress normally in the absence of 
luminal contents (Kedinger et al., 1981). 
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6.3.6 Grafting of Cultured Organoids 
The apparent success of the organoids which had been cultured overnight to 
generate a cyst containing intestinal crypts suggests that stem cell function can be 
maintained in culture at least for a limited period of time. It is of concern that no 
vilus structures were observed in these grafts but this may simply be due to the 
limited number of grafts examined. The results from these experiments reveal the 
importance of cell-cell and cell-ECM contact in maintaining stem cell function. 
Treatment of the cells with trypsin to obtain a single cell suspension was not 
compatible with the maintenance of stem cell function. However, removing the 
same cells in a more gentle manner which preserves many of the cell-cell and cell-
ECM contacts does allow maintenance of stem cell function. The fact that stem cells 
can be maintained in culture is vital for ex vivo gene therapy. It will be interesting 
to determine exactly how long these-cells can survive in vitro without losing their 
stem cell properties. This ability to survive 24 hours in culture may also be used as 
a way to enrich for organoids containing stem cells. It would appear from the 
primary culture experiments that it is primarily proliferative cells which are able to 
adhere to the culture dish. Therefore, by allowing the organoids to adhere 
overnight, and removing the organoids still in suspension the next day, an organoid 
preparation enriched for proliferative cells will be obtained. 
6.3.7 Stem Cell Assay 
The system I have described here provides a technically simple functional assay for 
the identification of murine intestinal stem cells. It is important to havesuch an 
assay when considering intestinal stem cells as targets for gene delivery. If stem 
cells are to be removed from their in vivo environment and maintained in culture, it 
is imperative that they retain their stem cell functions. By grafting cultured cells in 
the manner described here, it should be possible to ascertain whether the stem cell 
population is viable after such manipulation. This assay can also be used to 
determine the efficiency of gene delivery into the stem cell population using 
reporter constructs prior to grafting. A possible limitation of this system however, 
is the requirement for the maintenance of cell-cell and/or epithelial-mesenchymal 
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interactions for correct stem cell function. This means that individual cells cannot 
be assayed but rather, small populations of cells are needed. However, it may be 
possible to identify organoids containing specific cell surface markers which are 
associated with stem cell activity, in a similar manner to that used for the 
identification of haemopoietic stem cells (Morrison et al., 1995; Berardi et al., 1995) or 
for epidermal stem cells (Jones and Watt, 1993; Jones et al., 1995; Li et al., 1998). In 
these systems single cells can be isolated by fluorescence activated cell sorting 
(FACSanalysis to identify cell populations containing not only specific cell surface 
markers but specific levels of expression of these markers. Although this is not 
directly applicable to organoids since they are multicellular aggregates, it may be 
possible to use a similar principle to identify whole organoids which contain a 
subpopulation of cells that are positive for specific markers. In this way, more 
specific markers for stem cell populations can be identified. 
Clearly it is imperative that the intestinal epithelial stem cells can regenerate 
a normal intestinal mucosa when grafted back onto intestinal submucosa and not 
just following subcutaneous grafting. Tait and colleagues (1994b) have used 
intestinal organoids isolated from the small intestine of postnatal rats to generate a 
small intestinal mucosa in the large intestine when grafted onto denuded colonic-. 
muscle. This makes an ex vivo gene therapy approach a distinct possibility. 
However, while this is a necessary requirement for any therapeutic approach it is 
not suitable for a stem cell assay. Stem cell assays for the haematopoietic and 
epidermal systems have a distinct advantage over the intestinal epithelium because 
of the relative ease of reconstituting the stem cell compartments of these systems. 
Despite the fact that the intestine is relatively accessible for removing epithelial 
cells, it is much more difficult to return the cells. In order to reconstitute the 
haemopoietic system with stem cells, an intravenous injection is all that is required. 
The injected stem cells are then capable of finding their way to the stem cell 
compartment in the bone marrow (Bock, 1997). In the skin, sheets of cells can be 
layered on top of cleared dermis and as long as stem cells are present the stem cell 
compartment will organise itself (Gallico et al., 1984; Jones et al., 1995). However, to 
return stem cells to the intestinal epithelium requires relatively complex surgical 
procedures. The continual flow of digested foodstuff through the gastrointestinal 
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tract means that simple application of cells onto denuded intestinal muscle is not 
possible. To avoid this, a region of intestine must be isolated and cells applied onto 
the intestinal muscle. The flanking regions of intestine have to be attached to allow 
continuation and function of the gastrointestinal tract. The system described here 
therefore offers a much simpler and more economic alternative. 
I have shown here that it is possible to generate an intestinal neomucosa 
efficiently from cell aggregates derived from neonatal mouse small intestine. I have 
also demonstrated the generation of a fully mature small intestinal architecture with 
crypt and villus structures containing all 4 epithelial cell types but have gone on to 
show further evidence that the neomucosa truly represents an accurate model of the 
murine small intestinal mucosa. The conclusion from the experiments described in 
this chapter are that functional stem cells present within the isolated intestinal 
organoids are able to maintain their stem cell function after removal from the 
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7.1 Discussion 
Current approaches to CF gene therapy are primarily directed towards the 
respiratory epithelium and involve the delivery of an essentially unregulated cDNA 
construct to a non-specific population of cells. The aim of the work presented here 
was to assess the possibility that gene therapy could be used to specifically correct 
Cftr mutations in a stem cell population, using an ex vivo approach. The intestinal 
epithelium was used as a model because of its clinical relevance and the proven 
existence of a stem cell population. 
I have generated a mutation correction vector which can successfully target 
the Cftr locus in mouse ES cells. Epithelial cell lines from the small intestine of CF 
mutant mice were then generated with which to test the mutation correction 
strategy. These cell lines were characterised and shown to display a relatively 
undifferentiated phenotype. To date, correct targeting of the Cftr locus has not been 
detected using these cell lines, however this may be a problem related to the 
detection of targeting events rather than the targeting itself. 
Primary cultures of mouse intestinal epithelial cells have been established as 
an imperative requirement of an ex vivo gene therapy approach. These cultures 
have revealed the presence of three different epithelial colonies which display 
proliferative capacities similar to that found in the intestinal epithelium in vivo, 
including a population of cells which are undifferentiated and display a large 
proliferative capacity. These cells may represent a stem cell population or at least a 
population of very early progenitor cells. This is extremely encouraging for the 
long term aim of the successful culture of epithelial stem cells. 
A functional stem cell assay has also been established for murine intestinal 
epithelial stem cells. This assay is necessary as an end point to determine the 
success of any stem cell manipulation, from in vitro culture to gene transfer. This 
assay has been used to show that cellular aggregates containing intestinal epithelial 
stem cells can be successfully isolated from the mouse and can regenerate an 
intestinal mucosa following subcutaneous grafting. Encouragingly, the cultured 
intestinal epithelial cells are also capable of forming intestinal mucosa structures 
suggesting the successful maintenance of functional intestinal stem cells in culture. 
Also, this stem cell assay also provides a model for intestinal regeneration and 
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development. This in conjunction with the fact that this system can be used to 
generate chimaeric intestinal mucosa, suggests that this provides a relatively simple 
yet powerful tool with which to examine the role of genes involved in intestinal 
repair and development as well as intestinal stem cell regulation and function. 
Stem cells are an attractive target for somatic gene therapy because of their 
extended life-span. In addition, mutation correction by homologous recombination 
in this cell population will result in correctly regulated gene expression in all 
resulting daughter cells. However, a lack of known cell surface markers makes it 
difficult to identify and isolate individual intestinal epithelial stem cells. The 
technique used here uses gentle enzymatic digestion to isolate individual 
aggregates of intestinal cells which contain a mixture of epithelial and 
mesenchymal cells. This approach allows intestinal epithelial stem cell viability to 
be maintained at least for a limited period of time. The success of this approach is 
presumably due to the maintenance of cell-cell and cell-extracellular matrix 
interactions. In the future it will be vital to establish exactly which of these 
interactions is necessary for intestinal epithelial stem cell survival. The ability of the 
current culture technique to maintain epithelial proliferation even for a limited time 
and the success of grafts from cultured cells is extremely promising. It is not known 
if the stem cell population is amplified during their time in culture. This is 
important to determine, since amplification will likely be necessary considering the 
apparently low efficiency of DNA transfer to the intestinal epithelial cells. The 
ability to amplify intestinal stem cell populations in vitro will also require a greater 
understanding of the environmental signals and growth factor requirements of the 
stem cell population. 
Many of the limitations of in vivo stem cell gene transfer to date are likely 
related to the difficulties in getting DNA through the mucous barrier covering the 
epithelium and gaining entry to the intestinal crypts as well as the apparent 
inefficiency of DNA transfer to the epithelium. An ex vivo approach to intestinal 
gene therapy allows the mucous layer to be removed by repeated washing, and 
enables direct exposure of the crypt epithelium to DNA delivery vehicles. The 
work presented here demonstrates that intestinal epithelial stem cells can be 
removed from the mouse small intestine and still maintain their stem cell properties 
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when maintained in the correct environment. This is fundamental if ex vivo gene 
transfer into intestinal epithelial stem cells is to become a feasible therapeutic 
approach. Increasing the efficiency of DNA delivery to the intestinal epithelial cells 
must now be investigated in greater detail. 
The limited amount of literature available on gene delivery to intestinal 
epithelial cells probably reflects the small number of genetic disorders which are 
confined to the intestinal epithelium. There has been some interest in using gene 
therapy to treat intestinal inflammatory conditions (Giladi et al., 1995) and intestinal 
neoplasia (Fichera et al., 1997). However, one interesting possibility, should the 
problems of inefficient DNA delivery be solved, is the use of the intestinal 
epithelium to correct defects arising in other tissues. Jones et al. (1990) 
inadvertently showed that phenotypic correction of the sparse fur mouse which 
lacks the gene coding for the omithine transcarbamylase enzyme normally 
expressed in liver cells, could be achieved by ectopic expression of the cDNA in the 
intestinal epithelium. This raises the possibility that intestinal gene delivery may 
prove a useful approach for other liver enzyme deficiencies. Also, it has been 
shown.that the intestinal epithelium is capable of secreting foreign proteins into the 
blood: circulation (Sweetser et al., 1988) and therefore this tissue may be used to 
express circulating proteins such as clotting factors and hormones in deficient 
individuals. 
The vast amount of media publicity surrounding gene therapy has created 
an unrealistic level of hope that cures are just around the corner. However, as more 
and more effort is put into developing gene therapeutic approaches, it is becoming 
clear that there are more hurdles to overcome than was first envisaged. This should 
not be a source of discouragement, as great advances in gene delivery technologies 
have already been made. The ability to specifically correct disease causing 
mutations in stem cell populations, which can then be successfully transferred back 
to the patient is undoubtedly all the more ambitious given our knowledge of 
current limitations. In principle, however there is no reason why this cannot be 
achieved given that each step is already an established technique, albeit spread over 
many different disciplines. The trick will be to combine these technologies to 
ultimately provide a life-saving clinical treatment. 
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MATERIALS AND METHODS 
8.1. Somatic Cell Culture 
8.1.1 Plastic and Glassware 
During all procedures in somatic cell culture, sterile technique was observed and 
sterile glass pipettes and plastic pastettes (Alpha Laboratories Ltd.) were used. 
Cells were grown in a variety of culture dishes depending on requirements. These 
dishes were; 
50m1 tissue culture flask (Nunc) 
200m1 tissue culture flask (Nunc) 
600m1 tissue culture flask (Nunc) 
96 well plates (Falcon) 
24 well plates (Corning) 
6 well plates (Falcon) 
60 x 15mm culture plates (Falcon) 
85mm diameter culture plates (Nunc) 
140 x 20mm culture plates (Nunc) 
8.1.2 Culture of Mouse Embryonic Stem Cells 
During all procedures in ES cell culture, sterile technique was observed, disposable 
sterile pipettes (Costar) were used and all reagents were stored in detergent-free 
containers. All solutions were pre-warmed to 37°C before use. 
The ES cell line D18.2 (originally derived from CGR8 ES cells) was cultured in BFIK-
21 medium (Glasgow MEM) (Gibco) supplemented with 15% FCS (Gibco), 0.3% 
glutamine (Gibco), 1mM sodium pyruvate (Sigma), 0.1mM MEM non-essential 
amino acids (Sigma), 0.1mM -mercaptoethanol (Sigma), penicillin at 60tg/ml 
(Sigma) and streptomycin sulfate at 60j.tg/ml (Sigma). The culture medium was also 
supplemented with Leukaemia Inhibitory Factor (LIF) to maintain the cells in their 
undifferentiated state. LIF was obtained from conditioned medium derived from 
Cos-7 cells, transfected with a LIF expression construct. The correct concentration of 
LIP conditioned medium added to the ES cell culture medium was derived from the 
results of titration experiments to determine the highest dilution of LIP which still 
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supported the undifferentiated growth of ES cells. The cells were grown in 24 well 
plates coated with gelatin solution. This was achieved by aliquoting approximately 
0.5m1 of a sterile 0.1% gelatin solution (Sigma) into each well of the dish, 20 minutes 
before plating. The gelatin solution was removed and the cells in their culture 
medium suspension were added. The cells were incubated at 37°C in 5% CO 2 and 
the culture medium was changed every two days. 
8.1.3 Somatic Cell Lines 
A variety of different cell lines were grown during this work; 
CFPAC-1 	derived from a human pancreatic adenocarcinoma from a 
Cystic Fibrosis patient 
C127 	derived from mouse mammary epithelium 
WT-2 	C127 cell line stably transfected with a human CFTR expression 
construct 
T84 	derived from human colonic epithelium 
293 	derived from human foetal kidney epithelial cells 
16HBE derived from human bronchial epithelium 
COS 	monkey fibroblasts 
MIE 	derived from mouse small intestinal epithelium 
CFMIE derived from the small intestinal epithelium of a CF mouse 
All cells were grown in DMEM culture medium (Gibco), supplemented with 10% 
FCS, penicillin at 60.tg/ml and streptomycin at 60p.g/ml unless otherwise stated, 
and maintained in a IR 1500 Automatic CO  Incubator (Flow Laboratories) at 37°C 
in 10% CO2. All solutions were pre-warmed to 37°C before use. 
8.1.4 Sub-Culture of Somatic Cells 
Wash the cells once with 5m1 PBS 
Add lml of trypsin-EDTA (0.05% trypsin, 0.02%EDTA in PBS) and incubate at 
37°C for 5mins. 
Create single cell suspension by repeated gentle pipetting using a fine-tipped 
plastic pastette and transfer to a lOmi conical based tube. 
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4. Make up to lOmis with PBS, invert tube several times to mix the cells and then 
spin at 1200rpm for 5 mins. 
5. Remove the supernatant and resUspend cells in lOmI growth medium. 
6. Add 2m1 of cell suspension to a fresh flask. 
8.1.5 Freezing of Mammalian Cells for Long Term Storage 
For long term storage of mammalian cell lines it was necessary to freeze away 
aliquots. Generally, the entire contents of a confluent 50m1 flask were frozen for 
storage, though if cell clones derived from targeting experiments were being frozen, 
a confluent well from a 24 well dish would suffice. 
Wash cells with 2m1 (50rnl flask) or 500p.l (24 well dish) PBS. 
Add 2m1 trypsin/versene and incubate at 37°C for 10 mins. 
Make into a single cell suspension by repeated gentle pipetting using a fine-
tipped plastic pastette. 
Place cell suspension in a iOn-il conical based tube and make up to lOmis with 
PBS. 
5:spin cells at 1200rpm for 5 mins and remove supernatant. 
6. Resuspend cells in 1.5m1 freezing mix (FCS plus 10% DMSO) and place in a 
CryoTube (Nunc). 
7. Place cells overnight at -70°C then store in liquid N 2 for long term storage. 
8.1.6 Isolation of Mouse Intestinal Organoids 
This technique was adapted from Evans et a! (1992). 
Solutions 
Wash solution: 1X HBSS - low calcium, low magnesium (Gibco), 2% d-glucose, 
0.035% NaHCO3 . 
Enzyme mix: Wash solution containing dispase I neutral protease (Boehringer) at 
lOOp.g/ml and crude collagenase type XI (Sigma) at 300U/ml. 
Solution C: (DMEM culture medium (Gibco), 5% foetal calf serum (FCS) (Gibco), 2% 
sorbitol, penicillin at 60pg/ml, streptomycin at 60j.tg/ml. 
1. Typically 6-12 neonatal mice, aged 5-7 days are sacrificed by decapitation. 
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The small intestine is removed with a minimal amount of mesentery attached, 
and placed into a 50m1 tissue culture flask containing ice cold wash solution and 
stored on ice until the intestine from each mouse is collected. 
The intestines are cut open along their length, rinsed briefly in a petri dish 
containing fresh wash solution and placed in a second 50m1 tissue culture flask 
containing fresh ice cold wash solution. 
Lengths of intestine are cut into approximately 0.5cm pieces using a sterile 
surgical scalpel. 
The luminal contents are washed from tissue by shaking in 50m1 fresh ice cold 
wash solution in a 50m1 tissue culture flask on a shaking platform at 200rpm for 
3mins. 
The flask is placed upright on the bench and the tissue fragments allowed to 
settle. The wash solution is poured off and 50m1 fresh wash solution is added. 
Repeat wash steps 5 and 6 approximately 7-10 times until the supernatant is 
clear. 
Place the tissue pieces in a fresh petri dish and remove all the wash solution. 
Finely chop the tissue into a paste using a sterile surgical scalpel (Swann-Morton 
no.24). 
Digest the tissue fragments in 20mls of enzyme mix for 20 minutes at room 
temperature on a shaking platform at 200rpm. 
From this stage on, all procedures were carried out in a sterile laminar flow culture 
hood. 
Gently pipette the contents of the flask for 5 mins using a sterile plastic lOmi 
pipette, and examine the tissue microscopically. If more than 70% of the 
intestinal villi are dissociated from the submucosa, the digestion of the tissue is 
stopped by the addition of 30 mis solution C. If less than 70% of the viffi have 
been removed, the tissue was shaken for a further 5 minutes at room 
temperature. 
The tissue is now digested into tissue fragments ranging in size from single cells 
to sheets of smooth muscle and large viii. The largest fragments are removed by 
inverting the culture flask 3 times and letting it stand for 1 minute to allow the 
larger fragments to settle. The supernatant is removed using a sterile lOmi plastic 
pipette (Costar), placed in sterile 25m1 tubes (Greiner Labortechrük) and stored 
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on ice. 50mls of fresh solution C is added to the flask and the process repeated 
one more time. 
Remove single cells, bacteria and small tissue fragments from the supernatant 
by centrifugation for 3 mins at 250rpm. 
Remove the supernatant and add and 20mls fresh solution C. Resuspend the 
tissue pellet by gentle pipetting and spin the sample again for 3 mins at 250rpm. 
Repeat step 13 approximately 5-6 times until the tissue pellet contains tissue 
fragments of a homogeneous size. These are termed intestinal organoids. 
8.1.7 Primary Culture of Mouse Intestinal Organoids 
Mouse intestinal organoids were cultured in a variety of different conditions 
throughout the different experiments detailed here. However, the basic culture 
conditions were incubation of the organoids (approximately 1x10 4 per 60xl5mm 
culture dish (Falcon)) in high glucose DMEM plus penicillin at 60jig/ml and 
streptomycin at 60pg/ml containing either 10% FCS only or 2.5%FCS plus human 
monocomponent insulin at 0.25 iu/ml (Novo Nordisk Pharmaceuticals Ltd.), EGF at 
'20ng/ml (Sigma), transferrin at l0j.tg/ml (Sigma), and glutamine at 0.3mg/mi 
(ibco), at 37°C in 5-10% CO 2. The tissue culture medium was replaced after the 
first 24hrs, then every 48brs. 
8.1.8 Primary Culture of Mouse Intestinal Organoids with Matrigel/ECM gel 
Matrigel (Collaborative Research, Inc.) or ECM gel (Sigma) were prepared and 
applied as recommended by the manufacturer. Organoids cultured on top of a thin 
K> layer of Matrigel/ECM gel required the incubation of thin gels at 37°C in order to 
solidify. Organoids and culture medium were then applied on top. If organoids 
were to be cultured within a thick gel layer, the organoids were mixed with the 
Matrigel/ECM gel at 4°C while still liquid. The organoid/gel mix was then 
allowed to set at 37°C and then culture medium was applied on top. 
8.1.9 Subcutaneous Grafting of Mouse Intestinal Organoids 
All surgical instruments were purchased from Agar Scientific Limited and were 
sterilised by autoclaving. The instruments were wiped with a tissue soaked in 70% 
ethanol immediately prior to use. 
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Mouse intestinal organoids were isolated and grafted subcutaneously into male 
isogenic or immunocompromised scid mice (2 grafts per mouse). 
Spin organoids in a conical tube (Sterilin) at 250rpm for 3 mins to create an 
organoid pellet. Keep pellet on ice and use 20il volumes directly for grafting. 
Alternatively, and more frequently, resuspend the organoid pellet in an equal 
volume (usually 100-200p.l) of Matrigel (Collaborative Biomedical Products) or 
ECM gel (Sigma) and use 50-75jil volumes in each graft. 
Anaesthetise host mice by inhalation of 5% Halothane carried with oxygen in a 
closed chamber. 
Shave mouse over its dorsal flanks and sterilise the graft site using 70% ethanol. 
Make a small incision using a pair of sterile iris scissors on either side of the 
dorsal midline, and create a subcutaneous tunnel by inserting the scissors into 
the incision and under the skin. 
Place intestinal organoids into the subcutaneous tunnel using a P200 Gilson 
pipette with a wide bore sterile plastic tip and eject the organoids. Carefully 
remove the tip so as not to draw the organoids out of the tunnel. 
Close the incision using a surgical clip (Becton Dickinson) and wipe clean with 
an alcohol soaked tissue. Repeat the process on the opposite 'flank and place the 
mouse back into its cage to recover. 
8.1.10 Retrieval of Organoid Grafts 
Anaesthetise host mice by inhalation of Halothane and oxygen in a closed chamber. 
Maintain the mouse under anaesthetic by continuous Halothane inhalation through 
a plastic tube. Make an incision into the skin just above the tail and cut the dorsal 
skin with scissors round to the forelimb on either side. Gently prise the skin from 
the mouse using a pair of sterile iris scissors and examine the resulting skin flap. 
The grafted material can be identified as either large fluid filled cyst structures, or 
small white lumps, ranging in size from -1-5 millimetres. Remove these structures 
using a pair of fine forceps and iris scissors. Depending on the method of analysis 
of the structures, either place the tissue into PBS, 10% neutral buffered formalin (to 
90mls dFl2O add 1.86g sodium dihydrogen orthophosphate and 0.42g sodium 
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hydroxide, stir till dissolved then add lOmis of 40% formaldehyde) or into a screw 
capped micro tube (Sarstedt) prior to immersion in liquid N 2 . 
8.1.11 Isolation and Subcutaneous Grafting of Cultured Organoids 
Mouse intestinal organoids were isolated as described and cultured on 140x20mm 
culture dishes (Nunc) in high glucose DMEM with 10% FCS plus penicillin at 
60p.g/ml and streptomycin at 60pg/ml for 1-4 days. Cultured organoids are washed 
in PBS at 37°C and submerged in sufficient versene to cover the cells. Place the 
cultures at 37°C in 5-10% CO 2  for 15 mins to inhibit cell adhesion to the culture dish. 
Detach the cells using a sterile cell scraper (Costar) and pipette the cell suspension 
into a lOmi conical tube. Centrifuge the cells at 1000rpm for 5 mins and remove the 
supernatant. Wash the cells in sterile PBS then spin as before. Remove the 
supernatant and resuspend the cells in 50jil Matrigel or ECM gel. Use the entire cell 
suspension to provide one graft. 
8.1.12 Picking ES cell Colonies 
D18.2 ES cell colonies which had survived selection were expanded so that frozen 
stocks could me made and DNA prepared and analysed. 
Rinse the plates containing the ES cell colonies with PBS. 
Remove the PBS then add a minimal but sufficient volume of fresh PBS to the 
dish to stop the cells drying out. 
Add 2-3 drops of pre-warmed trypsin/PBS to the wells of a V-bottomed 96 well 
plate (Sero-Wel). 
Using a fine tipped pastette, gently scrape an individual colony from the surface 
of the dish and immediately suck it up into the pastette. 
Transfer the colony into a well of a 96 well plate and leave cells to become a 
single cell suspension. It may be necessary to gently pipette the cells using a fine 
tipped pastette in order to obtain a single cell suspension. 
Transfer the single cell suspension to the well of a gelatinised flat bottomed 96 
well plate. 
Add fresh ES cell culture medium to the well and incubate the cells at 37°C in 5% 
CO 2- 
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8.1.13 Picking Somatic Cell Clones 
This method is adapted from Domann & Martinez, 1995 
Use a paper punch to cut out small discs of 3MM chromatography paper 
(Whatman) then cut the paper disc in half or quarters. This will give two 
different sizes of 3MM chromatography paper which can be used for large and 
small colonies. 
Sterilise the paper pieces and a pair of fine forceps by autoclaving. 
Wash the cells in 5m1 PBS then aspirate all liquid. While the dish is empty, hold 
it up to the light and mark round the colonies to be picked with a fine-tipped 
pen. 
Soak the sterile paper pieces in 0.2% trypsin for at least 5 mins. 
Place a piece of trypsin soaked paper on top of a colony using the forceps. Use a 
large or small piece of paper depending on the size of the colony. 
Once all the colonies to be picked are covered with a piece of paper, incubate the 
cells in an incubator at 37°C in 10% CO 2  for 10 mins. 
Fill the wells of a 96 well plate with selective medium. 
Lift the piece of paper from the colony. Cells from the colony should stick to the 
paper. Place the paper in one of the wells of the 96 well plate, shaking it a little in 
the process to remove any large sheets of attached cells. 
Incubate the cells at 37°C in 10% CO2. Over the next few days, cells should grow 
out from the paper until the well is confluent. The cells can then be trypsinised, 
the paper removed, and the cells grown in a 24 well plate. 
8.1.14 Isolation of Genomic DNA from Cultured Mammalian Cells 
The protocol described here is for cells grown in a single well of a 24 well plate. 
Volumes may need to be increased for cells grown in larger dishes. 
Wash cells in PBS. 
Add 500p.l of Quick Lysis buffer (100mM Tris.HC1 (pH 85), 5mM EDTA, 0.2% 
SDS, 200mM NaC1) plus Proteinase K (Boehringer Mannheim) at 0.5mg/mi and 
incubate at 37°C for -30 mins to lyse the cells. 
Remove the cell lysate and place it in a clean tube and incubate overnight at 50°C. 
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Add an equal volume of 100% ethanol to the DNA solution and mix gently by 
inversion until the DNA can be seen as a white precipitate. Mix the solution 
thoroughly by vortexing. 
Spool the DNA on to the end of a glass pasteur pipette (Bilbate) which has been 
sealed by heat. 
Rinse the DNA in an eppendorf tube containing 500gil of 70% ethanol to remove 
excess salt. 
Snap off the end of the glass pasteur into a fresh eppendorf containing 100.tl 
dH2O. Allow the DNA to dissolve in the water by incubating the tube at 60°C for 
1 hour. 
Routinely, 5d of the DNA solution was run out on a 0.7% agarose gel to estimate 
the DNA concentration. 
8.2 DNA Delivery into Somatic Cells 
8.2.1 Retroviral Infection of Organoid Primary Cultures 
Two different retroviral vectors were used in this work, the replication deficientti l 
BAG retrovirus (Price et al., 1987) which carries the lac Z gene, and an amphotropic 
retroyiral vector carrying the. non-origin-binding U19 mutant of SV40 large T 
antigen and the neomycin phosphotransferase gene (Bond et al., 1996). Aliquots of 
culture medium containing these supernatants were a kind gift from Dr. David 
Kipling. 
Mouse intestinal organoids were isolated and cultured in a 50m1 flask as 
described. 
After 8 days in culture remove the growth medium and replace with fresh 
medium containing polybrene at 8pg/ml for 1 hour. 
During the 1 hour incubation prepare the retrovirus containing supernatant. 
Flush through a 0.45j.tm  sterile Acrodisc filter (Gelman Sciences) with growth 
medium to block binding sites. 
Quickly thaw a frozen aliquot of supernatant in a 37°C water bath. 
Filter the supernatant through the 0.45pm filter. 
measure the volume of supernatant and add polybrene to a concentration of 
8jig/ml. 
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Remove the culture medium with polybrene from the cells but do not wash the 
cells. 
Add imi of retrovirus containing supernatant to the primary culture flask. 
Incubate at 37°C in 10% CO 2 for 2 hours, gently rocking the flask every 30 mins. 
Add 4 mls of normal culture medium to the flask without removing the 
supernatant and incubate overnight. 
Remove the supernatant and culture medium and replace with fresh culture 
medium the next day. 
After 72 hours, trypsinise the cells and replate in two 50ml culture flasks in 
normal growth medium. 
After another 6 days in culture replace normal culture medium with selective 
medium (DMEM plus 10% FCS plus G418 at 400igIml). 
8.2.2 Retroviral Infection of Organoids for Grafting 
This protocol was used for infection of freshly isolated intestinal organoids in 
suspension prior to grafting. 
Resuspend organoid pellet in DMEM plus 10% FCS plus polybrene at 8jiglml. 
Wash pellet and spin at 250rpm for 3 mins. Repeat 4 times. 
Prepare retroviral supernatant as previously described. 
After final spin of organoids, resuspend pellet in 800p1 of filtered retroviral 
supernatant. 
Incubate organoids plus supernatant at 37°C for 1 hour, gently mixing every 20 
mins. 
Spin organoids at 250 rpm for 3 mins. 
Remove most of the supernatant so that the total volume remaining is -200 p1. 
Resuspend the organoids in an equal volume of Matrigel/ECM gel. 
Graft the organoids subcutaneously into scid mice as previously described. 
8.2.3 Adenoviral Infection of Organoids 
Mouse intestinal organoids were infected with adenoviral vector containing the lac 
Z gene, prior to grafting or primary culture. 
1. Wash organoid pellet twice in 10 mis PBS. 
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Incubate 1 x105  organoids in 100 j.tl serum free DMEM plus the desired volume of 
adenoviral supernatant (depends on the multiplicity of infection (MOl) required 
and the number of organoids to be infected) at 37°C for 30 nuns. Shake the 
organoids manually every 10 mins. 
Mix the organoids gently with 200pJ of Matrigel/ECM gel, before grafting the 
organoids subcutaneously into scid mice. Plate the organoids for primary culture 
out into culture dishes at the required.concentration. 
8.2.4 Electroporation of Organoids 
Resuspend -3 x 105  organoids in 500g.tl PBS and add 50 or 100pg of vector DNA. 
Transfer the cell suspension to an electroporation cuvette and incubate on ice for 
10 nuns. As a control, transfer 500.tl of the cell suspension to an electroporation 
cuvette without the addition of any DNA. 
Set the electroporation apparatus (BioRad Genepulser) to 800V, 500 jiF 
capacitance and place the cuvette into the electoporation chamber. Apply the 
electric pulse and check the time constant. 
Leave the cells to stand for 10 mins, then dilute into 5 ml culture medium. 
Seed ml of cells into 5 culture dishes containing 5 ml culture medium and 
n. incubate the plates at 37°C in 5% CO 2. Plate ml of control cells over 2 plates. 
8.2.5 DNAlliposome Transfection of Somatic Cells 
8.2.5A Gene Targeting 
Plate out 1.5 x10 6  CFMIE-G cells in a 85mm tissue culture dish with fresh growth 
medium and incubate at 37°C in 10% CO 2 for 48 hours, after which time the cells 
should be -70% confluent. 
Prepare the following solutions in 12 x 75mm sterile tubes (Falcon): 
For each transfection mix 5.tg of targeting vector DNA with 500p.l serum-free 
medium (OPTIMEM 1; Gibco). 
For each transfection mix the required quantity of lipid with 500W serum-free 
medium. The precise amount of lipid will vary depending on the cell type 
used. Typically, a 6:1 ratio of DOSPER lipid:DNA was used for most 
experiments. 
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Add the DNA solution to the lipid solution and mix the contents by repeated 
gentle pipetting. Leave the mixture to form DNA/lipid complexes at room 
temperature for 30 mins. 
Wash the cells twice with 5m1 PBS. 
For each transfection add 4m1 serum-free medium to each tube containing the 
DNA/lipid complex and mix gently. Pipette the solution over the washed cells. 
Incubate the cells for 2 hours at 37°C in 10% CO'. 
7 Remove the DNA/lipid complex and wash the cells twice in PBS. 
Add fresh tissue culture medium to the cells and incubate overnight at 37°C in 
10% CO2 . 
The following day, remove the cells from the plate using 5m1 trypsin/versene. 
Place the cells in a lOmi conical based tube and add 5 ml PBS. Spin the cells at 
1200rpm for 5 mins, remove the supernatant and resuspend the cells in lOmis 
PBS. 
Count the number of cells using a Neubauer chamber and a haemocytometer, 
and from this figure estimate the number of transfected cells. 
Into a series of lOmi conical based tubes place 5 x 10 5 untransfected cells from a 
separate plate. Add to these cells various aliquots of transfected cells so that a 
range of transfected cells is present per tube (typically 1 to 200). This is 
performed in duplicate. Plate the contents of each tube onto a 85mm culture dish 
and incubate overnight at 37°C in 10% CO 2 . 
Note: a transfection efficiency is obtained from previous experiments using a 
reporter construct such as a plasmid containing the 3-galactosidase gene. In these 
experiments, this usually gave an efficiency of -1%. Transfection efficiency of an 
integrating construct may not be the same as an episomaly maintained reporter 
construct, therefore a range of transfected cell numbers is plated out in case the 
efficiency varies by up to 10-fold either way, from that obtained using the reporter 
construct.) 
13. After 48 hours remove the culture medium and replace with selective culture 
medium to identify transfected clones. 
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8.2.5BAssessment of Transfection Efficiency 
In experiments where the targeting efficiency of a particular cell line or DNA/lipid 
complex was the main purpose, the protocol was essentially the same as steps 1 to 8 
as described above except that cells were usually grown in 6 well plates and 
therefore cell number, volumes and quantities of DNA were reduced by one fifth. 
The reporter construct used in all the experiments mentioned here, was a plasrnid 
expressing the E.Coli 3-galactosidase gene under the control of the CMV promoter. 
After step 8 the cells were assayed for expression of the reporter construct. 
8.2.6 Gene Targeting in ES cells 
Delivery of the gene targeting vector into D18.2 ES cells for the purpose of mutation 
correction was achieved using electroporation. 
ES cells are grown to -80% confluency in a 200ml culture flask. Trypsinise the 
cells and wash in PBS then count the cells. 
Spin the cells at 1000rpm for 5 rnins, remove the supernatant and resuspend the 
cells to give a cell density of 1.25 x 107  cells/mi. 
Mix 800p1 of the cell suspension with lOOp.g of gel purified S70 targeting vector, 
transfer to an electroporation cuvette and incubate on ice for 10 mins. As a 
control, transfer 800 p1 of the cell suspension to an electroporation cuvetté 
without the addition of any DNA. 
Set the electroporation apparatus (BioRad Genepulser) to 800V, 500 jiF 
capacitance and place the cuvette into the electoporation chamber. Apply the 
electric pulse and check the time constant. A value of 0.1-0.2 should be observed 
for the time constant. Repeat this process for the control electroporation. 
Leave the cells to stand for 10 mins, then dilute into 10 ml of ES cell culture 
medium. 
Seed imI of cells into 10 gelatinised 100mm culture dishes containing 20 ml 
culture medium and incubate the plates at 37°C in 5% CO 2. Plate lml of control 
cells over 2 plates. 
After 24 hours remove the . medium and add selective medium containing 
hygromicin (Calbiochem) at 150 pg/mI. 
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8. Replace the selective medium every 48 hours until large individual hygromycin 
resistant colonies can be identified. Check the control plates to ensure that the 
selection is working and that all the cells in these plates are dead. 
8.3 Histology and Immunohistochemistry 
8.3.1 Preparation of Tissues for Paraffin Wax Sectioning 
Tissues which required paraffin wax sectioning were dissected from the animal and 
placed in sterile PBS. Only two types of tissue were removed for sectioning in this 
work, intact intestine and tissues obtained from the grafting of intestinal organoids. 
The intact pieces of intestine were flushed through with PBS to remove luniinal 
contents. This was achieved by inserting a syringe with a 21 gauge needle (Becton 
Dickinson) attached, into the luminal opening at one end and expressing PBS down 
through the length of the intestinal luminal to force out the lurninal contents from 
the other end. The intestine was then placed into 10% Neutral Buffered Formalin 
(NBF) and left at room temperature overnight to fix. The tissue obtained from 
grafting intestinal organoids was placed directly into 10% NBF and left at room 
temperature overnight to fix. The fixed tissues were then placed in a Tissue-Tek 
embedding machine and the tissue was put through a programme that consisted of 
the following steps; 
PBS - ihour at 40°C 
30% ethanol - ihour at 40°C 
50% ethanol - ihour at 40°C 
70% ethanol - ihour at 40°C 
85% ethanol - ihour at 40°C 
95% ethanol - ihour at 40°C 
100% ethanol - ihour at 40°C 
100% ethanol - ihour at 40°C 
xylene - ihour at 40°C 
xylene - lhour at 40°C 
wax - ihour at 60°C 
wax - ihour at 60°C 
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wax - ihour at 60°C 
wax - ihour at 60°C 
The tissue was then placed in a mould and covered with molten wax. The wax was 
allowed to cool and solidify on ice. The mould and tissue were stored overnight at 
4°C and the wax block containing the tissue was removed from the mould the 
following day, ready for sectioning. 
Wax blocks containing tissue pieces were sectioned on a Reichert-Jung 2030 
microtome using disposable blades. Routinely, 5-7pm sections were cut from the 
embedded tissue. The sections were floated on water in a water bath set at 42°C. 
The sections were then floated on to uncoated glass slides (Select Micro Slides - 
Chance Propper Ltd.), and left to dry at room temperature for at least 24 hrs. 
Sections which were not going to be used immediately were stored at room 
temperature in a slide box (Kartell®). 
8.3.2 Preparation of Tissues for Cryostat Sectioning 
Tissues to be used for cryostat sectioning were placed into a screw top micro tube 
then placed directly into liquid N 2  for approximately 30 mins. The tissue was then 
stored at -70°C until required. 
The protocol for making cryostat tissue sections was as follows. 
Set the temperature controls on the cryostat (Leica) to the desired settings. The 
conditions for cutting cryostat sections from mouse small intestine and organoid 
grafts were usually quite different; 
The cutting temperatures for sectioning mouse intestine were as follows; 
Chamber temperature: -25°C 	Cutting Head temperature: -15°C 
The precise cutting temperatures for cutting tissue retrieved from grafts varied 
greatly, depending on the luminal contents within the cysts. Typical settings for 
fluid-filled cysts were 
Chamber temperature: -30°C 	Cutting Head temperature: -20°C 
Typical settings for mucin-filled cysts were 
Chamber temperature: -25°C 	Cutting Head temperature: -15°C 
Remove the tissue from the -70°C storage and place in the cryostat chamber for 
at least an hour so that the tissue may equilibrate to the desired temperature. 
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Mount the tissue on to a chuck by placing a drop of O.C.T. embedding solution 
(Raymond A. Lamb) on to the chuck then placing a small square of card on top 
of the O.C.T. just as it begins to solidify. 
Once the card is firmly attached, place a second drop of O.C.T. on top of the card 
and place the tissue on top in the desired orientation as the O.C.T. begins to 
solidify. 
Label and orient the sample by marking the piece of card. 
Mount the chuck plus tissue on to the cutting head and fix in position. 
Typically 10pm sections were cut from mouse small intestine. Sections from 
organoid grafts varied in thickness from 10 - 30pm, depending on the luminal 
contents of the graft. 
Stick sections onto Vectabond (Vector Laboratories Ltd.) coated glass slides. 
Serial sections were placed on the same slide. 
Sections attached to glass slides were stored at -70°C until required. 
8.3.3 Coating of Glass Slides for Cryostat Sections 
Frozen tissue sections were placed on to VectabondTm coated glass slides to ensure 
the tissue did not dislodge during further procedures. This process was carried out 
using the manufacturers instructions. 
Immerse slides in acetone for 5 mins 
Immerse slides in VECTABONDTm Reagent solution for 5 mins 
Remove excess reagent by gentle dipping in deionized water. 
Allow the slides to air dry and store at room temperature. 
8.3.4 Rehydration of Paraffin Wax Embedded Tissue Sections 
Place glass slides holding the tissue sections in a 60°C oven for at least 2 hours to 
melt the wax. 
Place the slides in xylene (Fisher Scientific U.K. Limited) 
to remove the wax 	 5 mins. 
Place the slides in fresh xylene 	 5 mins 
Place the slides in 100% ethanol to remove the xylene 	5 mins 
Place the slides in fresh ethanol 	 5mins 
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Place the slides in 90% ethanol 	 5 mins 
Place the slides in 70% ethanol 	 5 mins 
Place the slides in 50% ethanol 	 5 mins 
Place the slides in 30% ethanol 	 5 mins 
Place the slides in water 	 5 mins 
8.3.5 Dehydrating and Mounting Tissue Sections 
 Place the glass slides in 30% ethanol 2 mins 
 Place the glass slides in 50% ethanol 2 nuns 
 Place the glass slides in 70% ethanol 2 mins 
 Place the glass slides in 90% ethanol 2 mins 
 Place the glass slides in 100% ethanol 2 mins 
 Place the glass slides in 100% ethanol 5 mins 
 Place the glass slides in xylene 5 mins 
 Place the glass slides in xylene 5 mins 
Allow the xylene to evaporate then add a thin strip of DPX mountant along the 
middle of a clean glass coverslip (Chance propper Ltd.). 
Place the coverslip gently over the tissue sections ensuring no air bubbles- are 
'trapped over the tissue sections. 
11.. Leave to dry overnight. 
8.3.6 Haematoxylin and Eosin Staining of Tissue Sections 
This is a general stain, used to examine basic tissue morphology. 
Solutions 
Haematoxylin (Sigma); Eosin (3 parts 1% aqueous eosin plus 1 part 1% ethanol 
containing 0.05% acetic acid); Acid Alcohol (1%HC1 in 70% ethanol) 
Method 
Rehydrate sections through graded alcohol to dH 20. 
Immerse slides in Haematoxylin solution 	5mins 
Wash well in running water. 
Differentiate tissue in acid alcohol 	 lOsecs 
Wash in running water. 
'Blue up' in saturated lithium carbonate 	lOsecs 
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Wash well in running water 
Immerse slides in Eosin stain 
Wash in water. 
Immerse slides in 100% ethanol 
Immerse slides in fresh 100% ethanol 
Dehydrate, clear and mount in DPX. 
Result 
Nuclei 	 blue 
Cytoplasm 	pink/red 
8.3.7 Periodic Acid Schiff Staining of Tissue Sections 
This stain is used to identify mucin. 
Method 
Rehydrate sections through graded alcohol to dH2O. 
Apply 1% Periodic Acid (Sigma) to slides 
Wash well in water. 
Apply Schiff Reagent (Sigma) to slides 
Wash well in running water 
Counterstain in haematoxylin 
Wash in water. 










Mucin and glycogen pink/red 
Nuclei 	 blue 
8.3.8 Alkaline Diazo Method for Tissue Sections 
This technique is used on paraffin wax embedded sections of formaldehyde or 
paraformaldehyde fixed tissues to demonstrate cells rich in 5-FIT and is based on 
the method used by Gomori (1952). 
Preparation of diazonium solution 
1% Fast Garnet GBC (Sigma) 	 5m1 
saturated aqueous lithium carbonate 	2mi 
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prepare solutions just before use and cool to 4°C. 
Mix the solutions just prior to staining, filter and use immediately. 
Method 
Rehydrate sections through graded alcohol to dH 2O. 
Place sections in the diazonium solution for 1 minute at 4°C. 
Wash well in dH20. 
Lightly stain nuclei in haematoxylin. 
Wash well in tap water. 
Dehydrate, clear and mount in DPX. 
Results 
Argentaffin granules 	 red 
Nuclei 	 blue 
Background 	 yellow 
8.3.9 Detection of Alkaline Phosphatase Activity 
Detection of alkaline phosphatase activity in cultured cells or within tissue sections 
was achieved by using one of two methods; 
Vector® Red Alkaline Phosphatase Substrate Kit 
This procedure leads to the formation of a red coloured precipitate in the presence 
of alkaline phosphatase activity, which is also highly fluorescent. The protocol was 
as described in the manufacturers instructions. 
GibcoBRL NBT/BCIP Stable Mix 
The NBT/BCIP (riitroblue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate) mix 
acts as a chromogenic substrate for alkaline phosphatase. The enzyme removes a 
phosphate group from the BCIP which now gives a blue colour. This process also 
+ 
produces H which reduces NBT to give an insoluble purple precipitate. The 
protocol was as described in the manufacturers instructions. 
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8.3.10 Immunohistochemistry on Wax Embedded Sections and Cultured Cells 
Tissue sections should be dewaxed, and rehydrated prior to immunohistochenstry. 
Cultured cells should be washed in PBS then fixed in 1:1 methanol:acetone for 5 
mins at 4°C. 
Rinse tissue/cells briefly in PBS 
Permeabilise cells if necessary with 0.2% Nonidet P-40 (Sigma) 20 mins 
Rinse tissue/cells briefly in PBS 
Block endogenous peroxidase activity with 3% 14202 in methanol 	10 mins 
Remove H202 and rinse gently with TBS (0.05M Tris HC1 (pH 7.6), 0.15M NaCl) 
using a wide bore pastette. 
Wash in TBS (place slides in Coplin jar containing PBS) 	 5 mins 
Remove TBS 
Add blocking serum (3 drops yellow bottle to 10 mIs TBS) 20 mins 
Remove serum and without rinsing, add 1° antibody at correct dilution in 
blocking serum solution (step 6) 30 mins at RT or o/n at 4°C 
Remove antibody and rinse with TBS. 
Wash in TBS 5 mins 
Remove TBS 
Add biotinylated 2° antibody (1 drop blue bottle to 10 mIs TBS also add 3 
drops of blocking serum) 30 mins 
During this incubation step make up ABC solution: 
add 2 drops reagent A to 5 mis TBS, mix then add 2 drops reagent B, 
mix and leave to stand 30 mins 
Remove biotinylated 2° antibody and rinse with TBS. 
Wash inTBS 5miris 
Remove TBS and add ABC solution 30 mins 
Remove ABC solution and rinse with TBS. 
Wash in TBS 5 mins 
Remove TBS and add DAB substrate 	 up to 10 mins 
Remove DAB substrate and rinse with I40 10 mitis 
Counterstain section, dehydrate, dear and mount in DPX. 
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8.3.11 Antibodies for Imuunohistochemistry 
The following mouse monoclonal antibodies were purchased from Sigma. Anti-cc 
smooth muscle actin (mouse IgG2a isotype) - Clone 1A4 - directed against the NI-4 
terminal synthetic decapeptide of a smooth muscle actin. 
Anti-cytokeratin peptide 18 (mouse IgGi isotype) - Clone CY-90 - directed against 
human cytokeratin 18. 
Anti- pan cytokeratin (mixture) (mouse IgGi and IgG2a isotypes) - Clones C-il, 
PCK-26, CY-90, Ks-1A3, M20, A53-B/A2 - mixture of monoclonal antibodies which 
recognise human cytokeratins 1, 4, 5, 6, 8, 10, 13, 18 and 19. 
Anti-vimentin (mouse 1gM isotype) - Clone VIM 13.2 - immunospecific for 
vimentin. 
Anti- large T antigen (a kind gift from Anne Seawright) 
The following rabbit polyclonal antisera were also used. 
Anti-desmin (Sigma) - directed against purified chicken desmin. 
Anti-lysosyme (Dako) - directed against human lysosyme. 
Anti-serotonin (Serotec) - directed against serotonin. 
8.3.12 X-Gal Staining of Cryostat Sections 
Staihing of tissue sections for 0-galactosidase activity using X-gal was always 
performed on cryosections of unfixed tissue. 
Solutions 
5 Litres X-gal Buffer Base (5X) 
disodium hydrogen phosphate anhydrous 
sodium dthydrogen phosphate.lH 2O 
magnesium chloride.6 112O 
dHO 




up to 5 litres 
Wash Solution 	 Fix 1 
lx X-gal Buffer Base 	 lx X-gal Buffer Base 
add 8m1/L 25% Gluteraldehyde 
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20m1/L 	0.25M EGTA 
Stain 
	 Fix 2 
wash buffer 




potassium ferricyanide 	0.082g 
X-gal (50mg/nil in DMF) 	hI 
Method 
Place slides in Fix 1 for 10 mins. 
Place slides in wash solution for 5 mins. 
I. Remove wash and add fresh wash solution for further 5 mins (repeat X2). 
Place slides in stain and incubate at 37°C overnight. 
Place slides in Fix 2 at 4°C for at least 2 hours to fix the stain. 
Wash slides in dH2O. 
Dehydrate, clear and mount in DPX. 
8.3.13 X-Gal Staining of Cultured Cells 
The protocol for staining cells to, detect -galactosidase activity is the same for all 
cell types, only volumes of solutions used may vary depending on the culture dish 
used to grow the cells. The details described here are for cells grown in a 60 x 15mm 
culture dish. Unless otherwise stated the volumes used were sufficient to cover the 
cells. 
Wash cultured cells with PBS. 
Fix the cells in PBS containing 2% formaldehyde and 0.2% glutaraldehyde for 5 
mins at 4°C. 
Rinse the cells with PBS to remove fixing solution. 
Make up the X-gal/Mg/ferro/ferricyanide reaction mixture fresh; 
5mM potassium ferrocyanide; 5mM potassium ferricyanide; 2mM MgC1 2 
X-gal at 1mg/mi (from 40mg/mi stock'made up in DMSO) in PBS. 
Add 5m1 of the X-gal/Mg/ferro/ferricyanide reaction mixture and incubate cells 
overnight at 37°C. 
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8.3.14 Microscopy and Photography 
All tissue sections were viewed and photographed through a Zeiss Axioplan 2 
Universal Microscope with a Yashica 108 multi program camera attached. 
8.4 Mice 
8.4.1 BrdU Injection of scid Mice 
In order to identify proliferating cells, 5-Bromo-2'-deoxy-uridine (BrdU; Boehringer 
Mannheim) was injected intraperitoneally into recipient scid mice at a 
concentration of lml 10mM BrdU per lOOg of body weight. The BrdU is 
incorporated into the DNA of replicating cells in place of thymidine and can be 
detected using an anti-BrdU antibody (Boehringer Mannheim). Typically, BrdU was 
injected into the animal once a day for 3 days prior to graft retrieval 
8.4.2 Mouse Housing Conditions 
Mice were housed under standard housing conditions 
8.5 Bacterial Cell Culture and Plasmid DNA Preparation 
8.5.1 Media and Solutions 
All media were sterilised by autoclaving. 
L-Broth and Agar 
In 11, of water dissolve 2.46g MgSO4, lOg tryptone (Difco), 5g yeast extract (Difco) 
and lOg NaCl. 15g agar (oxoid Ltd) was added per Litre broth for L-agar. 
Lambda Broth 
In 11, of water dissolve lOg tryptone and 2.5g NaCl. 
Lambda Agar 
In 11, of water dissolve lOg tryptone, 2.5g NaCl and lOg agar. 
Lambda Top Agar 
In 11, of water dissolve lOg tryptone, 2.5g NaCl, and 7g agar. 
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Amp icillin (Sigma) 
Ampicillin was added to agar and broth in order to select for bacteria carrying 
plasmids which confer resistance to this antibiotic. 
Make stock at 50mg/mi in dH2O, filter sterilise. Store at -20°C. 
Use at final concentration 50 jig/mI. 
5-Bromo-4-Chloro-3-Indolyl -D- Galactopyranoside (X-Gal) (Sigma) 
X-Gal acts as a substrate for 3-Galactosidase. It was added to agar for the growth of 
plasmids carrying blue/white colour selection. 
Make stock at 20mg/mi in DMF (Sigma). Store protected from light at -20°C. 
Use at final concentration of 40jig/ml. 
Isopropyl -D- Thiogalactopyranoside (IPTG) (Sigma) 
IPTG is a derepressor of the Lac operon. It was added to agar for the growth of 
plasmids carrying blue/white colour selection. 
Make stock at 100mM. Store protected from light at -20°C. 
Use at final concentration of 0.5mM. 
Hogness Solution 
3.6mM K2HPO4I 1.3mM KH2PO4, 2mM Na30.21- 20, 1mM MgSO4.7H20, 4.4% glycerol. 
Make stock at lOx concentration. Filter sterilise. 
GTE 
50mM glucose, 10mM EDTA, 25mM Tris.HC1 (pH 8) 
Use autoclaved Tris.HC1 and EDTA. Sterile filter the glucose. 
8.5.2 Growing Bacteria on Agar Plates 
Pipette the desired volume (up to -2000) of bacterial cells onto the surface of the L-
agar, and then spread evenly across the surface of the agar using a sterile bent glass 
rod until the liquid has thoroughly soaked into the agar. If more cells than are 
contained in 2000 are required, the cells may be concentrated by 15 second 
centrifugation in a microfuge followed by removal of excess L-Broth and 
resuspension of the pellet in a smaller volume. Invert the plates and incubate for 12-
16 hours at 37°C. Cells are viable from plates stored at 4°C for several weeks. 
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8.5.3 Frozen Stocks of Bacterial Colonies 
Restreak the selected colony on a fresh L-agar plus ampicillin plate, then inoculate 
5nil of L-Broth plus ampicillin using a single colony from the fresh plate. Incubate 
at 37°C for approximately 16hrs, then add a 1/10 volume of lOx Hogness solution to 
1ml of the culture in a CryoTube (Nunc). Store at 
-70°C. 
To reactivate cells from frozen stocks, a plastic loop was passed across the surface of 
the frozen culture and the adherent cells spread on an L-agar plate and grown at 
37°C. 
8.5.4 Extraction of Plasmid DNA (mini-prep) 
The method used was a modification of the alkaline lysis method of Jones and 
Schofield (1990). 
The desired colony was used to inoculate 5m1 of L-Broth plus ampicillin and was 
grown at 37°C overnight with continuous shaking at 250rpm. 1.5m1 of the culture 
was centrifuged for 3 mins in a standard 1.5m1 eppendorf tube, the bacterial cells 
were pelleted to the bottom of the tube and the supernatant removed. A further 1.5 
ml of the culture was added and the process repeated. The final pellet was then 
resuspended in 200p1 GTE (50mM glucose, 10mM EDTA, 25mM Tris.HCI (pH 8) 
and- left on ice for 5mins. Next, to lyse the bacterial cell wall and denature the DNA, 
500jil of freshly prepared 0.2M NaOH/1% SDS was added, mixed thoroughly by 
vortexing and left on ice for 5mins. To neutralise the solution and allow the DNA to 
re-anneal, 250p1 of 3M KAc (pH 4.8) was then added, mixed thoroughly as before 
and left on ice for 10 miris. 
To remove the cellular debris, the tube was centrifuged for 15 mins at 4°C at 
[11,000rpm] and the supernatant was retained. The supernatant was extracted with 
a 1/10th volume of water saturated phenol (Rathburn Chemicals Ltd). The sample 
was mixed thoroughly by vortexing and spun for 3 mins in a bench top microfuge. 
The upper aqueous phase was removed and placed in a clean tube and was further 
extracted by the addition of an equal volume of water saturated phenol (Rathburn 
Chemicals Ltd./chloroform (Fisons)/isoamyl alcohol (Sigma) in a 25:24:1 ratio, 
mixing the layers thoroughly by vortexing and then separating them by 
centrifugation for 3mins. 
197 
Materials and Methods 	 Chapter Eight 
The upper aqueous layer was removed to a clean tube and the DNA precipitated 
from it by adding an equivalent volume of 100% isopropanol (Fisons), mixing the 
sample by vortexing and immediately centrifuging for 15 mins at room 
temperature. The supernatant was discarded and the pellet then washed briefly in 
5000 70% ethanol and dried under vacuum. 
8.5.5 Extraction of Plasmid DNA (midi prep) 
The desired colony on an agar plate was used to inoculate 50m1 of L-Broth plus 
ampiciffin and was grown at 37°C overnight with continuous shaking at 250rpm. 
DNA was then extracted and isolated from the bacterial culture using a Plasmid 
Maxi Kit (Qiagen) following the manufacturers recommended protocol. 
8.5.6 Extraction of Plasmid DNA (maxi-prep) 
The selected bacterial colony was grown overnight at 37°C, with shaking at 250rpm, 
in 4m1 L-Broth plus ampidihin. This 4m1 was then used to inoculate a further 400m1 
of L-Broth for an overnight culture. This culture was then centrifuged in lOOmi 
volumes at 4000rpm for 20mins at 4°C. The pellet was resuspended in 16m1 GTE 
and left for 5mins on ice. Next, 32m1 of freshly prepared 0.2M NaOH/1% SDS was 
added, mixed thoroughly by vortexing and left for 5mins on ice, before adding 16m1 
3M KAc (pH 4.8), again mixing and leaving for 10 mins on ice. 
The tubes were centrifuged at 4000rpm for 20 mins at 4°C and the supernatant 
retained. This supernatant was filtered under gravity through 4 layers of gauze into 
fresh centrifuge bottles. 36m1 of isopropanol was then added and the bottles spun 
immediately at 4000rpm for 10 mins at 4°C. The supernatant was discarded and the 
pellet was washed with 20m1 of 70% ethanol and centrifuged at 4000rpm for 10 
mins at 4°C. The supernatant was once again discarded and the bottles drained. The 
pellet was resuspended in 2.5m1 TE (pH 8) and transferred to a Universal tube. 
3.55g CsC1 and 200d of EtBr (5mg/mi stock) (Boehringer Mannheim) were added 
and the solution transferred to a 'quickseal' tube (Beckmann). A balance tube was 
made up if necessary with TE and CsC1. The tube was then spun at 80,000rpm for 
20hrs at 20°C in a fixed angle rotor. The plasmid band was carefully extracted 
through the side of the tube with a needle and syringe and placed in a lOmi conical 
tube (Sterilin). The plasmid DNA was then extracted three times with a 0.25X 
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volume of CsCI-saturated isopropanol. A 2.5X volume of water was then added, 
and the DNA was ethanol precipitated. The resulting pellet was resuspended in in-il 
water and the concentration of plasmid DNA checked by specrophotometry and by 
running ijil on a 0.71/6 agarose gel to compare band intensities with DNA standards. 
8.5.7 Purification and Concentration of DNA 
Ethanol Precipitation 
To concentrate DNA and remove salts, a 1/10 volume of 3M NaAc, pH 5.5 was 
added to the DNA solution, followed by 2.5X volume of 100% ethanol at -20°C. The 
contents of the tube were mixed and then chilled at -70°C for ihour to overnight. 
The tube was then centrifuged at 13,000rpm for 30 mins at 4°C. The supernatant 
was poured off, and the pellet washed in 500i.d 70% ethanol and spun again for 5 
mins. The supernatant was removed and the pellet dried under vacuum before 
being resuspended in the desired volume of dH 2O. 
Concentration of Small Quantities of DNA 
Small quantities of DNA may be lost during ethanol precipitation therefore an 
alternative procedure was used in these circumstances. A drop of DNA solution not 
exceeding 20g.d was placed on a 0.025p.th  drop dialysis filter (Millipore) floating on a 
layer 'of 40% Polyethylene glycol (PEG) 6000 within a Petri dish. Water is drawn 
through the filter into the PEG therefore concentrating the DNA solution. The DNA 
solution is aspirated once a suitable volume has been reached. Volumes greater than 
20p1 can be concentrated in this manner by the sequential addition of DNA solution 
onto the original drop. 
8.5.8 Removal of Proteins from DNA Solutions 
To remove proteins from DNA samples, the DNA was extracted with organic 
solutions. A two step process was used: 
1)Phenol extraction: 
A 1/10 volume of water saturated phenol (Rathburn Chemicals Ltd.) was added to 
the DNA solution and vortexed vigorously before centrifugation at 11,000rpm for 3 
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mins. The upper, aqueous layer was then removed carefully, avoiding the 
precipitated protein at the interface between the two layers. 
2) Phenol/ Chloroform/Isoamyl alcohol: 
An equal volume of phenol/chioroform/isoamyl alcohol in a 25:24:1 ratio was 
added to the phenol extracted DNA solution. The sample was mixed by vortexing 
and the aqueous and organic phases separated by centrifugation at 11,000rpm for 3 
mins. The aqueous phase was removed to a clean tube, and then DNA was ethanol 
precipitated. 
8.5.9 Drop Dialysis of DNA Solutions 
DNA solutions were drop dialysed to remove salts. A 0.025pm drop dialysis filter 
(Millipore) was placed on the surface of a pool of sterile water in a Petri dish. After 
5 mins, the DNA solution (maximum 200) was placed as a drop onto the surface of 
the filter and left for 30 mins, during which the concentration of salts in the sample 
equilibrates with the water. The drop was then aspirated and placed into a clean 
tube. 
8.5.10 Purification of DNA from Agarose Gels 
Isolation of DNA fragments from a mixture of other fragments was achieved by 
separating the fragments by electrophoresing in low melting point agarose 
(Ultrapure LMP agarose, Gibco BRL) in lx TBE. Gels were viewed on a mid range 
UV transilluminator and the required fragment was excised using a sterile scalpel 
blade as quickly as possible to minimise nicking of the DNA. Care was taken to 
ensure that a minimum of agarose was excised with the required DNA band. 
Isolation of DNA from the gel slices was by GELase (Epicentre Technologies) 
treatment. The gel slice was cut into fragments not exceeding 2000 in volume, and 
each fragment was placed in an individual eppendorf tube. Each gel slice was 
incubated with imi of lx GELase buffer, diluted from the original 50X buffer 
supplied with the enzyme, for 1 hour. The buffer was then removed and the gel 
slices were melted at 70°C for 15 mins. The samples were vortexed and incubated at 
70°C for a further 5 mins. The slices were then incubated at 42°C for 15 mins before 
the addition of 1 unit of GELase enzyme. The samples were maintained at 42°C for 
a further 30 mins, then vortexed to ensure even mixing of the enzyme. Samples 
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were placed back at 42°C for overnight incubation. The next day, the DNA was 
precipitated by adding an equal volume of 5M Ammonium Acetate (NH 4Ac) and 
2.5X total volume of 100% ethanol. The samples were mixed and incubated at -70°C 
for a minimum of 2 hours before centrifugation at 13,000rpm for 30 nuns at 4°C. The 
supernatant was removed and the precipitated DNA washed in 500pJ of 70% 
ethanol. The sample was spun again for 5 mins and the supernatant removed. The 
DNA was resuspended in a suitable volume of dH 2O. 
8.5.11 Transfer of DNA to Membranes 
8.5.11A Southern Blot Transfer 
DNA was transferred from gels to nylon membranes by capillary blotting. This 
method was adapted from Southern (1975). 
Gels were photographed under LTV illumination next to a ruler to allow for future 
sizing of DNA fragments. 
Firstly the DNA was denatured by gently shaking the gel in denaturing solution 
(0.5M NaOH, 1.5M NaCl) for 30-45 minutes. The gel was then rinsed in water and 
neutralised by gently shaking in neutralising solution (1M Tris.HC1, 2M NaCl, pH 
5.5) for 20 minutes. The gel was then placed in water until ready to blot. A large 
stripof chromatography paper, 17 Chr (Whatman) was soaked in 20 X SSC (3M 
NaCI, 03M Na3C6H507.2H20, pH7.0) and placed on a glass plate so that the ends of 
the paper were in a reservoir of 20x SSC, forming a wick. A piece of 
chromatography paper 3MM Chr (Whatman) slightly larger than the size of the gel 
was then cut and soaked in 20X SSC, and placed on top of the paper wick. The gel 
was placed upside down, on top of the wet chromatography paper, then a piece of 
nylon membrane (Hybond-N, Amersham), soaked in 2X SSC was placed directly 
onto the gel so that the entire gel surface was covered. Two pieces of 3MM 
chromatography paper, pre-soaked in 2X SSC, were then placed on top of the 
membrane. Air bubbles were carefully removed and areas of exposed wick were 
covered with Saran wrap (Dow Chemical Company). A weighted stack of paper 
towels was placed on top to draw the fluid through the gel. 
Gels were blotted overnight. After blotting, the membranes were left to air dry and 
DNA was bound to the filter by exposing it to 1200pjoules of UV irradiation in a 
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Stratalinker (Stratagene), or baked at 80°C for ihour. Nylon membranes were stored 
in Saran wrap or between two sheets of 3MM chromatography paper at room 
temperature. 
8.5.11B Transfer of Bacterial Colonies to Filters and Replication of Filters 
Plates were incubated at 4°C for 15 mins prior to making filters. 82mm diameter 
nitrocellulose filters (Schleicher and Schuell) were labelled and marked with an 
asymmetric pattern of dots. The filter was laid gently on top of the agar ensuring no 
bubbles were formed, and left for 10 secs while the dots were copied onto the base 
of the plate. Duplicate filters could be made by laying a fresh nitrocellulose- filter on 
top of the first and pressing them firmly together so that a proportion of the bacteria 
was transferred to the fresh filter. While the filters were stuck together the 
orientation dots were copied onto the fresh filter. The bacterial colonies on the agar 
plates were left at 37°C for several hours to recover. 
8.5.11C Fixation of Bacterial Colonies I Phage Plaques to Filters by Lysis 
One sheet of 3MM chromatography paper was soaked in 10% SDS and the filters 
were placed face up on top of the paper and left for 3 minutes. The filters were then 
removed and placed on 3MM paper which had been soaked in denature solution 
(1.5M NaCl, 0.5M NaOH) and again left for 3 minutes before being transferred to 
neutraliser solution (1.5M NaCl, 0.5M Tris.HC1 (pH 8.5)) again on 3MM paper for 3 
minutes. Finally, the filters were placed on top of 3MM paper soaked in 2X SSC for 
3 minutes. The filters were left to air dry and were then baked at 80°C in a vacuum 
for 20 mins (nitrocellulose). 
8.5.12 Radiolabelling of DNA 
8.5.12A Preparation of DNA for Probes 
Probe DNA was in two forms, either in solution or contained within a gel slice. 
Approximately 50ng was labelled for a single hybridisation. DNA for gel slice 
hybridisation probes was excised from a Low Melting Point (LMP) gel after 
electrophoresis and diluted with an equal volume of water. The gel slice was melted 
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at 65°C and vortexed, before storage at -20°C. Before use in a labelling reaction, the 
gel slice was remelted at 70°C. 
8.5.12B Random Priming of DNA Probes 
This method is adapted from Feinberg and Vogeistein (1983 and 1984). 
A labelling reaction involves random priming from hexanucleotides and then 
polymerisation along the DNA strand catalysed by the Klenow fragment of E.Coli 
polymerase I. The reaction mix includes dATP, dTFP, dGTP and radiolabelled [a-
32P]-dCTP so that radioactivity is incorporated into the newly synthesized strand. 
The DNA strands were firstly denatured by heating to 100°C for 5 mins and then 
kept on ice to prevent reannealing of the strands. The labelling reaction was carried 
out using either a Random Prime kit (Boehringer Mannheim) or a Hi-Prime kit 
(Boehringer Mannheim). For the random prime kit, lijil total of DNA plus water 
was mixed with 3jtl 10tCi/p1 [a- 32P]-dCTP (Amersham), lj.il (2 units) Kienow 
enzyme, lj.fl each of dATP, dTFP and dGTP and 2j11 reaction buffer. For the Hi-
Prime kit, 13j.il of DNA plus water was mixed with 3M1  10l.LCi/Jd [cx22P]-dCTP and 
4.tl I-Ti-Prime (which contains the enzyme, nucleotides and buffer). The reactions 
were then incubated at 37°C for 1 hour (Random Prime) or a minimum of 30 mins 
(Hi-prime). The reaction was then stopped by a 1 min incubation at 100°C. 
The percentage incorporation of the radiolabelled nucleotide was checked by TCA 
precipitation of 0.5tl of the reaction mix on a GF/B circular filter (Whatinan). If the 
incorporation was 50% or above, the unincorporated nucleotides were removed by 
running the probe through a Sephadex G-50 Nick column (Pharmacia Biotech). The 
storage buffer was removed from the column and the column was washed by 
running through 1.5m1 TE. The probe (20pJ ) was made up to 5Oji.l with TE, then 
added to the top of the column, followed by 350p1 TE. The probe was then eluted 
with a further 400W TE, and collected in a fresh tube. 500 jig sonicated salmon sperm 
DNA (Sigma) was added to the probe and the mixture was denatured by heating to 
100°C for 10 mins and added to the prehybridisation solution in the bottle. 
Some probes were required to be stripped prior to hybridisation with the filter in 
order to minimise hybridisation occurring due to high copy number repetitive 
elements in the probe. In this case the probe was denatured at 100°C for 10 mins in 
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the presence of 250.Lg sonicated total mouse genomic DNA. The mixture was left to 
reanneal for 30 minutes at 68°C before addition to the hybridisation bottle. 
Denatured sonicated salmon sperm DNA was added separately to the hybridisation 
in this case. 
8.5.12C Radiolabelling of Oligonucleotides 
DNA oligonucleotides were used as probes following radiolabelling using the T4 
polynucleotide kinase enzyme, which catalyses the transfer of the terminal 
phosphate of [y22P] ATP to the 5-hydroxyl termini. 
50ng of oligonucleotide DNA was mixed with lp.l (10 units) polynucleotide kinase 
(PNK; Boehringer Mannheim) and 150 jiCi [y- 32P1 ATP (Boebringer Mannheim) in 
1/10 volume lOx PNK buffer (50mM Tris.HC1, pH 8.5, 10n -LM MgCl2, 5mM DTT) in 
a total volume of 20.tl. The reaction was incubated at 37°C for 30 mins. 
8.5.13 Hybridisation Protocols 
8.5.13A Hybridisation Solutions 
(Pre) hybridisation solution for random primed probes 
5X SSC, 10% dextran sulphate, 0.1% sodium pyrophosphate, 0.1% SDS and 5X 
Denhardt's solution. 5X Denhardt's solution contains 0.1% ficoll, 0.1% PVP and 
0.1% BSA (Sigma). Filter before use. 
(Pre) hybridisation solution for radiolabelled oligonucleotide probes 
6XSSC, 0.1% sodium pyrophosphate, and 0.5% SDS. 
8.5.13B Prehybridisation of Filters 
Under a solution of 2X SSC, the filter was placed between two slightly larger sheets 
of gauze. For hybridisation to multiple filters with a single probe, up to 3 layers of 
filters could be placed in the same bottle, with layers of gauze separating them. Air 
bubbles trapped between the filter and the gauze were removed. The filter and 
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gauzes were rolled up together, transferred to a glass hybridisation bottle (Hybaid) 
and unrolled onto the surface of the bottle. 
Denatured sonicated salmon sperm DNA was added to the prehybridisation 
solution at a concentration of 100tg/ni1. 12ml of prehybridisation solution was 
added to a small bottle and 18m1 to a large bottle, and the bottle rotated in an 
hybridisation oven (Hybaid) at 68°C for a minimum of 2 hours before adding the 
probe. 
8.5.13C Hybridisation Conditions 
For random-primed probes, hybridisations were generally carried out at 68°C 
overnight. 
8.5.13D Washing Conditions 
Following hybridisation, the hybridisation solution was removed from the bottle 
and approximately lOOmi of wash solution was added at room temperature. The 
bottle was rotated at 68°C for 15 mins to remove excess radiolabelled probe and the 
wash solution discarded. The filters were removed from the bottle and separated 
from the layers of gauze. In a plastic tray, the filters were washed with 3 changes of 
-500m1 washing solution (0.1-2X SSC, 0.1% SDS) using gentle agitation. The 
temperature of the wash and the concentration of SSC depended on the washing 
stringency required. For random-primed probes, a high stringency wash (3x 15 
mins in 0.1x SSC, 0.1% SDS at 68°C) was commonly used. 
The wet filters were then wrapped in Saran wrap (Dow Chemical Company), 
avoiding creases. 
8.5.13E Detection of Hybridisation Signal 
Autoradiography: 
The filters were placed in a light-tight cassette with a signal enhancing screen. They 
were then exposed to X-OMAT X-ray film (Kodak) for a length of time dependent 
on the amount of radiolabelled probe left bound to the filter (several minutes to 
several days). Filters hybridised to 32P-labelled probes were exposed at -70°C. 
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Stratagene Glogos II luminescent markers were used for alignment. The film was 
developed in a RGII (Fuji) automatic X-ray film processor. 
Phosphorimaging 
Alternatively, the filters were exposed to a phosphorimaging screen (Molecular 
Dynamics) for hours to several days. The screen was then scanned on a 
Phosphorlmager (Molecular Dynamics), to create a digital image, with variations in 
the pixel value proportional to the amount of radioactive signal present on the filter. 
The grey-scale image was adjusted as desired and was then printed on. a laser 
printer. 
8.5.13F Removal of Radioactive Probe from Filters 
Hybridisation filters can be used several times with different hybridisation probes, 
therefore removal of radioactive probes from the filters is often required. To remove 
the probe, the filters are placed in a metal tray containing water at 100°C. The heat 
is immediately removed from the tray and the contents allowed to cool. 
The filters were then exposed to x-ray film overnight to check that all the probe had 
been removed. 
8.6 Enzymatic Manipulation of DNA 
8.6.1 Restriction Enzyme Digestion of DNA 
Digestion of DNA with restriction endonucleases were carried out in the 
appropriate buffer at the temperature recommended by the manufacturer. 
Restriction enzymes were supplied by Boehringer Mannheim, NEB and Gibco BRL. 
l-lOp.g of DNA was digested in 10-40.tl containing 1/20 volume 0.1M spermidine 
(Sigma), using 1 unit of enzyme per pg of DNA cut. The reaction was left at the 
appropriate temperature for between 1 hour to overnight. Mouse genomic DNA 
was always digested overnight. If two different enzymes were used, both of which 
required the same buffer, the digests were carried out simultaneously. Otherwise, 
after digestion with one enzyme, the sample was heat treated to destroy any 
residual enzyme activity then drop dialysed for 30 mins or ethanol precipitated. The 
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appropriate buffer was then added and the second digestion carried out. Restriction 
digests which were to be run on gels were terminated by the addition of 1/10th of 
their volume of stop mix (100mM EDTA, pH8.0; 20% Ficoll and Orange G). 
8.6.2 Dephosphorylation of 5' Termini 
Calf intestinal phosphatase (CIP) or shrimp alkaline phosphatase (SAP) was used to 
dephosphorylate the 5' ends of vector molecules before cloning. This prevents 
recircularisation of vector molecules during the ligation step. 
Using CIP, the DNA was dephosphorylated with 1 unit CIP (Boebringer 
Mannheim) in 10-50VI lx CIP buffer (10n-A4 Tris.HCI, pH 8.3, 1mM ZnCl 2, 1mM 
MgCl2) at 37°C for 30 mins. The dephosphorylated DNA was then 
chioroform/isoamyl alcohol extracted and ethanol precipitated. The pellet was 
resuspended in an appropriate volume of dH 2O. 
Using SAP, the DNA was dephosphorylated with 1 unit SAP (Boehringer 
Mannheim) in 10-50pJ lx SAP buffer (50mIvI Tris.HC1, pH 8.5, 0.1mM EDTA) at 
370Cfor 30-60 mins. The SAP enzyme was then heat inactivated by incubation for 
15 miris at 65°C. 
8.6.3 Phosphorylation of 5' Termini 
Addition of a phosphate group to a DNA strand (kinasing) is by transfer of the 
terminal phosphate of yATP. 
An appropriate amount of DNA was mixed with lpJ (10 units) polynucleotide 
kinase (PNK; Boehringer Mannheim) and 0.5-1mM ATP (Boehringer Mannheim) in 
1/10 volume lOx PNK buffer (50mM Tris.HCI, pH 8.5, 10mM MgCl,, 5mM DTF) in 
a total volume of 50p1. The reaction was incubated at 37°C for 30 mins. The sample 
was then chioroform/isoamyl alcohol extracted and ethanol precipitated. 
8.6.4 Ligation of DNA Molecules with Cohesive Termini 
The DNA molecules to be ligated were mixed on ice. The reaction was carried out in 
10-50pJ using 1 unit of bacteriophage T4 DNA ligase (Boehringer Mannheim). in lx 
ligase buffer (66mM Tris.HCI, pH 8.5, 5mM MgCl 2, 1mM DYF, 1mM ATP). The 
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ligation mixture was incubated at 16°C overnight. The enzyme was inactivated by 
heating to 65°C for 15 mins. 
For a trial ligation, bOng of bacteriophage X DNA digested with Hind ifi was 
ligated under the same conditions. The extent of ligation could be visualised by 
running the ligation reaction on a 0.7% agarose gel. 
8.6.5 Ligation of DNA Molecules with Blunt Termini 
The DNA molecules to be ligated were mixed on ice. The reaction was carried out in 
10-50pJ using 5 units of bacteriophage T4 DNA ligase (Boehringer Mannheim). in lx 
ligase buffer (66mM Tris.HC1, pH 8.5, 5mM MgCl,, 1mM DTT, 1mM ATP) The 
ligation mixture was then incubated at room temperature overnight. The enzyme 
was inactivated by heating to 65°C for 15 mins. 
8.6.6 Oligonucleotide Synthesis 
Oligonucleotides were either synthesised (on site by Agnes Gallagher) as 
ammonium stocks from an Applied Biosystems 381A oligonucleotide synthesiser or 
were purchased from Genesis Ltd.. 
Oligonucleotides were precipitated from ammonium stocks by ethanol precipitation 
of 350il of the stock. The precipitated DNA was resuspended in 500.tl water and 
the concentration assessed by measuring the Abs.. An absorbance of 1 corresponds 
to a concentration of 25p.g/ml for single stranded DNA. 
The oligonudeotides obtained from Genesis Ltd were in lyophilised form. 
8.6.7 Oligonucleotide Primer Design 
The recombinant DNA inserts in the plasmid pBS were amplified using two 
published primers; 291 and 292 ('forward' and 'reverse' primers from Stratagene 
catalogue, see table 2.2 for sequences). 
Other primers were designed using the programme Oligo4 (Hybaid). Primers were 
between 18 and 24 nucleotides in length. They were chosen to be stable 
oligonucleotides with a T. between 50°C and 70°C. A maximum hairpin structure 
or potential dimerism of 3 nucleotides (preferably less) was permissible, but only a 
2 nucleotide internal match if it involved the 3' end. If possible the A+T : C+G ratio 
was near 50%. 
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8.6.8 Oligonucleotides 
Primer Primer Sequence (5'—*3') T. f 	Purpose Name .1 
oEHF GGGAAGCTAGCTTCAGTTAG 60°c probe 
M9AJ AGCAATGGTGACAGAp.AJCAT 680c PCR primer 
TCC  
M11B CTTGCTAAAGAAATCCrj'GCAC 660c PCR primer 
CC 	 I 
8.6.9 Amplification of DNA by the Polymerase Chain Reaction (PCR) 
PCR is a technique used for the amplification of specific DNA sequences (Saiki et 
al., 1988; Mullis and Faloona, 1995). The specificity is provided by oligonucleotide 
primers complementary to the 5' ends of the two strands of the sequence to be 
amplified. These primers anneal to the template DNA strand and direct 
amplification by a thermostable polymerase. The PCR reaction is a series of cycles, 
each consisting of three steps. The first is a short high temperature step (92-94°C) to 
denature the template DNA. This is followed by a reduction in temperature to allow 
the primers to anneal to the template (--50-65°C depending on the primers used), 
then finally the temperature is increased to 72°C to permit extension from the 
primers by the polymerase. Multiple cycles of these three steps result in exponential 
amplification of the desired sequence. 
8.6.10 PCR Conditions 
Commonly 100-200ng of template genomic DNA was amplified in 50jtl in 0.5m1 
microcentrifuge tubes (Robbins Scientific), with 0.2.tl (1 unit) Amplitaq (Perkin 
Elmer Cetus) in lx reaction buffer (10mM Tris.HC1, pH 8.3, 50mM KC1, 1.5mM 
MgCl2, 0.01% (w/v) gelatin) and 0.1% Triton X-100 (Sigma). The reaction employed 
300ng of each primer and 200pM each dNTP (Advanced Biotechnologies). The 
reaction was overlaid with 40p.l mineral oil (Sigma). 
PCR programmes were run on a Hybaid Omnigene machine or Perkin Elmer Cetus 
DNA thermal cycler. The basic programme was 30 cycles of denaturation annealing 
and extension steps. The denaturation step was usually short and at a temperature 
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of 93-94°C. Usually 30 secs in the first cycle and 10 or 15 secs thereafter. The 
annealing step temperature is critical in determining the success of the PCR 
reaction, and is dependent on the structure of the primer. Primer Tm'S  were 
determined using the Oligo 4 programme (Hybaid) and annealing temperatures of 
-5°C lower than the T. was used. Annealing steps were 30 secs to 1 min long. The 
extension step is carried out at 72°C. The extension time is also critical in 
determining the success of the PCR, since longer products need longer extension 
times (approximately 1 min per kb of sequence). The length of the extension time 
was generally the time estimated for effective elongation of the fragment required 
with a longer final extension time to ensure fragments were complete. 
After the reaction, 100 of the PCR reaction was visualised by electrophoresis on 1-
2% agarose gels. 
'Touch Down' PCR (Don et al., 1991) was also used to increase specificity of the 
PCR reaction and involves decreasing the annealing temperature by 2 °C per cycle 
until the final annealing temperature is reached. This means that during the first 
few critical cycles, only highly specific primer-template interactions can occur, 
which selects for amplification of the correct product during the rest of the reaction. 
An annealing temperature 10°C above the final annealing temperature was used in 
the first cycle, which decreased by 2°C each cycle until the final annealing 
temperature was reached. 
8.6.11 PCR Amplification of Vector Inserts from Bacterial Colonies 
This method was adapted from Taylor (1991). 
A toothpick stab of a bacterial colony was transferred to a tube containing 50.i.l of 
water. This tube was then heated to 100°C for 5 mins. lj.tl of this was then used as 
the template for a PCR reaction. Primers used were Universal primers designed to 
the polylinker sequence of pBS, 291 and 292 (see table 2.2). 
The PCR programme used was: 
Denaturing: 93°C for 30 secs in first cycle and 15 secs thereafter. 
Annealing: 55°C for 30secs. 
Extension: 72°C, 10 cycles of 1 mm, 10 cycles of 2 mins, 10 cycles of 3 mins. 
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8.6.12 Sequencing of DNA 
8.6.12A Cycle Sequencing of DNA 
Sequencing of DNA was done on an ABI automated sequencing machine (Applied 
Biosystems). Thermal cycling of sequencing reactions increases signal intensity and 
decreases sensitivity to reaction conditions. Dye terminator chemistry was used, 
that is dideoxy-nucleotides terminated the sequencing reaction at each base to 
generate a ladder of fragments. Each of the four dideoxy-nucleotides is labelled 
with a different dye, such that the attached computer can recognise the peak of dye 
corresponding to a particular base at each position. 
Plasmid DNA for sequencing was prepared by alkaline lysis followed by 
isopropanol precipitation. All other DNA was also prepared in this way where 
possible. The sequencing reactions were performed using a Taq DyeDeoxy 
Terminator Cycle Sequencing kit (Applied Biosystems) according to the 
manufacturer's instructions. Ideally, approximately 200ng plasmid DNA was used 
in the reaction. lOng of either primer 291 or 292 was used per reaction, depending 
on the orientation of the sequence required. 
The cycle sequencing reaction was performed on a Perkin Elmer Cetus DNA 
thermal cycler. The programme was as follows: Place tubes in rack preheated to 
96°C. Perform 25 cycles of 96°C for 30 secs, 50°C for 15 secs and 60°C for 4 mins. 
Rapid thermal ramp to 4°C and hold. 
As much as possible of the mineral oil was removed with a pipette, then the 
product was ethanol precipitated, using Applied Biosytems NaAc and 3 volumes of 
cold 95% ethanol. The tubes were then placed on ice for 15-30mins before 
centrifugation for 15-20 mins at 13,000rpm. The supernatant was then removed, and 
the pellet washed with 70% ethanol and spun at 13,000rpm for a further 10 minutes. 
The pellet was then vacuum dried for 3 minutes. Immediately before loading onto a 
sequencing gel, each pellet was resuspended in 4pJ stop mix (lj.tl of 50mM EDTA, 
pH 8, 30mg/mi Blue Dextran to 5j.tl deionised formamide) and heated to 90°C for 2 
minutes to allow the DNA to denature. 
The samples were loaded onto a 6% acrylamide gel (prepared by Agnes Gallagher), 
which was run in lx TBE at 2500V, 45mA for 12 hours. The sequence data was 
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gathered by the computer and displayed as a visual output of differently coloured 
peaks, or DNA sequence which was directly amenable to computer analysis. 
8.6.12B Analysis of Sequence Data 
The sequences obtained were edited and manipulated using GCG (Genetics 
Computer Group) programmes available through the HGMP Computing service 
(Devereux et al., 1984). Database searches were performed using the GCG Blast 
(Altschul et al., 1990) and Fasta (Pearson and Lipman, 1988) programmes. 
8.6.13 cDNA Synthesis 
First strand cDNA synthesis was performed using a kit from Boehringer 
Mannheim. The protocol is based on the manufacturers recommendations. 
Thaw RNA samples on ice. 
Aliquot 2p1 RNA to an eppendorf tube and add 5.8p1 DEPC treated water. 
Denature sample at 65°C for 15 mins then chill on ice. 
Makeup reaction mix 
lox buffer 	 2i1 
MgCl, solution 	 4jil 
dNTPs 	 21t1 
Gelatin 0.4.d 
p(dN)6 primer 2j.tl 
RNase inhibitor lp.1 
AMV-RT 0.80 
Spin down denatured RNA and add 12.2W of reaction mi: 
Mix by repeated pipetting. 
Incubate at 25°C for 10 mins to allow annealing of primer 
Place reaction at 42°C for 1 hour. 
Spin sample then denature at 95°C for 5 mins to inactivat 
Place sample immediately on ice. Spin sample and store 
8.6.14 Blunt Ending of DNA Fragments 
Double-stranded fragments of DNA containing a 3' or 5' ov 
to blunt-ended fragments by using the T4 DNA polymerase 
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The required amount of DNA was mixed with liii  (10 units) of T4 DNA polymerase 
(Boehringer Mannheim) and 100pM dNTPs in 1/10 volume of lOX T4 DNA 
polymerase buffer, supplied with the enzyme, in a total volume of 20p1. The 
reaction was incubated at 37°C for 30 miris. The enzyme was then heat killed 65°C 
for 15mins. 
8.6.15 RNA Extraction from Somatic Cell Lines 
All solutions used in the isolation of RNA were kept exclusively for this purpose to 
minimise contamination. All II2O was treated with DEPC (Sigma) before use to 
inhibit any RNase activity. This required the addition of 0.2m1 DEPC to lOOmi of 
II20 followed by vigorous shaking and finally autoclaving to inactivate the 
remaining DEPC. 
Grow cells to confluency in a 50m1 culture flask. 
Trypsinise the cells and spin at 1200rpm for 3 mins. 
Remove the supernatant and resuspend the cells in lOmis PBS. 
Spin cells again at 1200rpm for 3 mins and remove the supernatant. 
Resuspend the cells in 500 p.1 PBS and transfer to an eppendorf tube. 
Pellet the cells in a microfuge, remove the supernatant and add imi of RNAzo1 
(Biogenesis). 
Homogenise by repeated pipetting. 
Add 100p.l chloroform and homogenise by pipetting. 
Leave on ice for 15 mins. 
Spin at 13000rpm for 15 mins. 
Transfer the upper phase to a 2m1 microcentrifuge tube (Fisher Scientific UK) 
and add 1 volume of isopropanol and mix. 
Incubate at -20°C for a minimum of 15 mins. 
Spin at 13000rpm for 15 mins and discard supernatant. 
Add 600p.l of 75% ethanol and vortex. 
Spin at 10000rpm for 8 mins. 
Remove supernatant and dry pellet under vacuum. 
Resuspend pellet in lOOp.! DEPC treated dH 2O and store at -70°C. 
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8.7 Cloning of DNA Molecules into Plasmid Vectors 
8.7.1 Host Bacterial Strains 
The competent cells were made from E.coli, strain XL1-Blue (Stratagene). The 
genotype of XL1-Blue cells is: recAl endAl gyrA96 thi-1 hsdR17 supE4 relAl lac [F' 
proAB lacIZAM15 TnlO (Tetr)] 
8.7.2 Preparation of Competent Cells for Electro-Transformation 
XL1-Blue bacterial cells were taken from a frozen stock using a sterile loop :and 
streaked out onto a fresh L-agar plate and grown at 37°C overnight. One of the 
resulting colonies was then used to inoculate lOmis of L-Broth plus tetracycline, 
which was left at 37°C in a shaking incubator overnight. This whole culture was 
then used to inoculate 1L of L-Broth, and this was grown shaking at 37°C. The 
absorbance at 600nm of the culture was continually checked on a 
spectrophotometer. 
The cells were harvested when the Abs was between 0.5 and 1.0, which is still in600 
the log phase of growth. The flask containing the culture was then chilled on ice for 
15-30 mins then the contents were centrifuged 50m1 Falcon tubes (which had been 
left on ice) for 15 nuns at 4000rpm at 4°C. The supernatant was discarded and the 
pellets resuspended in a total of 1L of sterile water before centrifugation as before. 
The pellets were resuspended in a total of 500m1 sterile water and re-centrifuged. 
Pellets were then resuspended in 20m1 of 10% glycerol and centrifuged again. The 
final resuspension was in 2-3m1 of 10% glycerol. This cell suspension was then 
aliquoted into 40d volumes in 1.5nul eppendorf tubes and snap frozen on dry ice 
plus methanol (Fisons). The aliquots were stored at -70°C. 
8.7.3 Test Transformation of Competent Cells 
In order to quantify the competence of the cells prepared as above, they were 
subjected to a test transformation using ing of pBS vector alone as the transforming 
DNA. Cells transformed with pBS contain an ampicillin resistance gene and can 
therefore be selected for on L-agar plus ampicillin plates. The competence of the 
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cells is measured in colony forming units (cfu's) per pg of transformed DNA. 
Values of 107 to 5x108  cfu's/p.g pBS were routinely achieved. 
8.7.4 Electro-Transformation of Competent Cells 
An aliquot of competent cells was thawed on ice, and the DNA to be introduced 
into the cells (usually lp.l of the ligation reaction) was added, mixed with the cells 
and left on ice for 1mm. This mixture was then transferred to an ice-cold cuvette 
(Flowgen) and subjected to a pulse of 2.5kV in a BioRad Gene Pulser. The cells were 
swiftly mixed with imi of L-Broth, transferred to an eppendorf tube and left 
shaking at 37°C for lhr to enable the cells to express the ampidillin resistance gene 
conferred by the transformed plasmid. Aliquots of several different volumes were 
then spread onto L-agar plus ampicilhin plates and incubated overnight at 37°C. 
8.7.5 Selection for Colonies Containing Recombinant Plasmids 
Selection of colonies containing recombinant plasmids was achieved using 
blue/white colour selection. The polyhinker of the vector pBS interrupts the 13-
galactosidase producing gene, lac Z. This disruption is in-frame and results in a 
harmless insertion of a few amino acids into the (3-galactosidase gene. Expression of 
this gene within bacterial cells grown on medium containing the chromogenic 
substrate X-Gal and the derepressor of the Lac operon, IPTG produces a blue 
precipitate. If however the polylinker site in the plasmid is interrupted by an insert 
of foreign DNA, a functional 13-galactosidase enzyme is unlikely to be transcribed 
and hence the resultant colonies are white. 
8.8 Plating and Screening a Lambda Phage Library 
8.8.1 Determining the Titre of the Bacteriophage Library 
Materials 
41 Lambda broth containing 0.2% maltose plus 10mM Mg50 4 . 
Lambda Top Agar 
Suspension Medium (SM): 5.8g NaCl 
2g MgSO4.7FJ20 
50m1 1M Tris.HC1, pH 8.5 
0.01% gelatin (Sigma) 
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Method 
Grow a culture of Q358 cells to saturation in Lambda broth containing 0.2% 
maltose plus 10mM MgSO4 . 
Prepare 5 Lambda agar plates 
Melt lambda top agar. 
Add 30091  of the bacterial culture to five 8 x 80mm tubes. 
Make serial (100 fold) dilutions of the phage lysate in SM. 
Add 100t.l of each dilution to a separate tube of bacterial culture and mix gently. 
Incubate the tubes at room temperature for 20 mins to allow the phage to adsorb 
to the bacteria. 
Place the tubes in a 37°C water bath for 10 mins to allow the phage to inject their 
DNA into the cells. 
Remove the tubes one at a time from the water bath and add 2.5m1 of lambda top 
agar to the tube, mix gently and pour onto a lambda agar plate. Tilt the plate so 
the top agar covers the entire surface of the plate. Repeat this process for all the 
tubes. 
Incubate the plates at 37°C overnight. 
Count the number of plaques on a plate where the density allows accurate 
counting, and calculate the titre of the library. 
8.8.2 Plating a Lambda Library for Screening 
Once the titre of the library has been calculated, sufficient plaques can be plated 
and screened for the identification of the desired sequence. 
The method used is essentially the same as described above, except that L-agar and 
top agarose are used. The top agarose is used because top agar tends to lift off when 
removing nitrocellulose filters for screening. Using the calculated titre of the library, 
an appropriate quantity of phage lysate is used to give the desired number of 
colonies. L-agar plates are made using 245 x 245mm Nunc bioassay plates and 
sufficient top agarose to cover the plate. Sufficient phage lysate is used to give —1.2 
X 105 plaques per plate. 
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8.8.3 Transfer of Phage Plaques to Filters and Replication of Filters 
Phage plaques were grown in 245 x 245mm Bio-Assay dishes (Nunc). Dishes 
containing phage plaques had to be placed at 4°C for at least 1 hour prior to lifts 
being taken to ensure that the top agar was not removed during the procedure. 
Nitrocellulose (Schleicher and Schuell) filters (200 x 200mm) were placed carefully 
on the surface of the agar plate, avoiding air bubbles and marked with an 
asymmetric pattern of ink dots using a needle which pierced both the filter and the 
agar. The filter was left on the surface for approximately 5-10 mins while the pattern 
of orientation dots from the filter was transferred onto the bottom of the Petri dish. 
The filter was then removed carefully and placed face up on the benchtop to dry. 
Duplicate filters were made by repeating this process. 
8.9 Electrophoretic Analysis of DNA 
8.9.1 Electrophoresis Solutions 
20x TBE (1M Tris.HC1, pH8.0; 20mM EDTA; 1M boric acid, pH8.3.) 
Electrophoresis gels were run in 1X TBE. 
lOx DNA Loading Buffer (20% Ficoll (Pharmacia), 100mM EDTA, orange G 
(Sigma)). 
6% Polyacrylamide Gel (for ALF automated genotyping) 
Gels were made up with 6% Hydrolink (Long Ranger, AT Biochemicals Ltd) in 
0.6X TBE (0.06 M Tris base, 0.05M boric acid, 0.6mM EDTA) containing 7 M urea. 
8.9.2 Agarose Gel Electrophoresis 
DNA molecules were separated according to their size on horizontal agarose 
medium EEO (Sigma) gels. The percentage of agarose used to make the gel 
depended on the size range of the DNA molecules to be resolved. Digested genomic 
DNA or plasmid DNA was commonly run on 0.7-1% agarose gels, whereas smaller 
fragments, such as most PCR products, were run on 1-2% agarose gels. All agarose 
gels were made with and run in 1XTBE. To stain the DNA, ethidium bromide was 
added to all agarose gels and to the running buffer at a concentration of 250tg/ml 
of buffer. 1X loading buffer was added to the DNA prior to loading the sample on 
the gel. Gels were run at 20-10y depending on resolution and run-time required. 
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DNA fragments were visualised on a mid range UV transilluminator and 
photographed using a video copy processor (Mitsubishi). 
8.9.3 Size Markers used in Gel Electrophoresis 
250-500ng of the appropriate size marker was used per gel; 
X DNA digested with Flindlil (Boehringer Mannheim) 
4X174 digested with HaellI (Boehringer Mannheim) 
The sizes of the bands in 2J-lind III and 4X Hae ifi listed in Table 2.1. 
Table 7.1: Band sizes of markers ? Hind III, and OX Hae III. 
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